Healthpeak Properties 8K Other Events | DOC 4 May 09

Exhibit 99.1

ITEM 6. Selected Financial Data

Set forth below is our selected financial data as of and for each of the years in the five-year period ended December 31, 2008.

	Year Ended December 31,(1)
	2008		2007(2)		2006(2)		2005		2004
	(Dollars in thousands, except per share data)
Income statement data:
Total revenues	$	1,024,779	$	905,080	$	461,882	$	293,180	$	233,828
Income from continuing operations	232,271		137,535		47,853		58,906		61,748
Net income applicable to common shares	425,368		565,080		393,681		150,498		146,915
Income from continuing operations applicable to common shares:
Basic earnings per common share	0.79		0.43		0.03		0.17		0.19
Diluted earnings per common share	0.78		0.42		0.03		0.17		0.19
Net income applicable to common shares:
Basic earnings per common share	1.79		2.72		2.66		1.12		1.11
Diluted earnings per common share	1.79		2.70		2.65		1.11		1.11
Balance sheet data:
Total assets	11,849,826		12,521,772		10,012,749		3,597,265		3,104,526
Debt obligations(3)	5,937,456		7,510,907		6,202,015		1,956,946		1,487,291
Total equity	5,407,840		4,442,980		3,455,801		1,549,050		1,541,223
Other data:
Dividends paid	457,643		393,566		266,814		248,389		243,250
Dividends paid per common share	1.82		1.78		1.70		1.68		1.67

(1) Reclassification, presentation and certain computational changes have been made for: (i) the results of properties sold or held for sale reclassified to discontinued operations in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144, Accounting for the Impairment or Disposal of Long Lived Assets (“SFAS No. 144”); (ii) the adoption of presentation and disclosure requirements of SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB 51 (“SFAS No. 160”); and (iii) the adoption of FSP EITF 03-6-1, Determining Whether Instruments Granted in Share Based Payment Transactions Are Participating Securities (“FSP EITF 03-6-1”), to compute earnings per share under the two-class method.

(2) We completed our acquisitions of SEUSA on August 1, 2007, CRP and CRC on October 5, 2006 and the interest held by an affiliate of General Electric in HCP Medical Office Properties (“HCP MOP”) on November 30, 2006. The results of operations resulting from these acquisitions are reflected in our consolidated financial statements from those dates.

(3) Includes bank line of credit, bridge and term loans, senior unsecured notes, mortgage debt, mortgage debt on assets held for sale, mortgage debt on assets held for contribution and other debt.

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Language Regarding Forward-Looking Statements

Statements in this Annual Report on Form 10-K that are not historical factual statements are “forward-looking statements.” We intend to have our forward- looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectations as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. In addition, we, through our officers, from time to time, make forward-looking oral and written public statements concerning our expected future operations, strategies, securities offerings, growth and investment opportunities, dispositions, capital structure changes, budgets and other developments. Readers are cautioned that, while forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Therefore, readers should be mindful that forward-looking statements are not guarantees of future performance and that they are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth in Part I, Item 1A., “Risk Factors” in this report, factors that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include:

(a) Changes in national and local economic conditions, including a prolonged recession;

(b) Continued volatility in the capital markets, including changes in interest rates and the availability and cost of capital;

(d) Changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations of our operators, tenants and borrowers;

(e) Changes in the reimbursement available to our tenants and borrowers by governmental or private payors, including changes in Medicare and Medicaid payment levels and the availability and cost of third party insurance coverage;

(f) Competition for tenants and borrowers, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(g) Availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(h) The ability of our operators, tenants and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us;

(i) The financial weakness of some operators and tenants, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such operators’ and/or tenants’ leases;

(j) The risk that we will not be able to sell or lease properties that are currently vacant, at all or at competitive rates;

(k) The financial, legal and regulatory difficulties of significant operators of our properties, including Sunrise Senior Living, Inc.;

(l) The risk that we may not be able to integrate acquired businesses successfully or achieve the operating efficiencies and other benefits of acquisitions within expected time-frames or at all, or within expected cost projections;

(m) The ability to obtain financing necessary to consummate acquisitions or on favorable terms; and

(n) The potential impact of existing and future litigation matters, including related developments.

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 7 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

· Executive Summary

· 2008 Transaction Overview

· Dividends

· Critical Accounting Policies

· Results of Operations

· Liquidity and Capital Resources

· Off-Balance Sheet Arrangements

· Contractual Obligations

· Inflation

· Recent Accounting Pronouncements

Executive Summary

We are a self-administered REIT that, together with our consolidated subsidiaries, invests primarily in real estate serving the healthcare industry in the United States. We acquire, develop, lease, manage and dispose of healthcare real estate and provide financing to healthcare providers. At December 31, 2008, our portfolio of investments, excluding assets held for sale but including properties owned by our Investment Management Platform, consisted of interests in 691 facilities.

Our business strategy is based on three principles: (i) opportunistic investing, (ii) portfolio diversification, and (iii) conservative financing. We actively redeploy capital from investments with lower return potential into assets with higher return potential and recycle capital from shorter-term to longer-term investments. We make investments where the expected risk-adjusted return exceeds our cost of capital and strive to leverage our operator, tenant and other business relationships.

Our strategy contemplates acquiring and developing properties on terms that are favorable to us. We attempt to structure transactions that are tax- advantaged and mitigate risks in our underwriting process. Generally, we prefer larger, more complex private transactions that leverage our management team’s experience and our infrastructure.

We follow a disciplined approach to enhancing the value of our existing portfolio, including ongoing evaluation of potential disposition of properties that no longer fit our strategy. During the year ended December 31, 2008, we sold 51 properties for $643 million. At December 31, 2008, we had nine properties with a carrying amount of $19.8 million classified as held for sale.

We primarily generate revenue by leasing healthcare properties under long- term leases. Most of our rents and other earned income from leases are received under triple-net leases or leases that provide for substantial recovery of operating expenses; however, some of our MOBs and life science leases are structured as gross or modified gross leases. Accordingly, for such MOBs and life science facilities we incur certain property operating expenses, such as real estate taxes, repairs and maintenance, property management fees, utilities and insurance. Our growth depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; (ii) maximize tenant recoveries given underlying lease structures; and (iii) control operating and other expenses. Our operations are impacted by property specific, market specific, general economic and other conditions.

Access to external capital on favorable terms is critical to the success of our strategy. Generally, we attempt to match the long-term duration of most of our investments with long-term fixed-rate financing. At December 31, 2008, 15% of our consolidated debt is at variable interest rates, which includes a balance of $520 million outstanding under our bridge and term loans. We intend to maintain an investment grade rating on our senior debt securities and manage various capital ratios and amounts within appropriate parameters.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as to fund future acquisitions and development through the issuance of additional securities or secured debt. During 2008 we have raised $1.0 billion of equity capital, $656 million from asset dispositions, $566 million from the placement of Federal National Mortgage Association (“Fannie Mae”) secured debt and $197 million in a bank term loan. In 2008, there was a decline in the availability of financing from the capital markets and widening credit spreads. Our ability to continue to access capital could be impacted by various factors including general market conditions and the continuing slowdown in the economy, interest rates, credit ratings on our securities, and any changes to these ratings, the market price of our capital stock, the performance of our portfolio, tenants, borrowers and operators, including any restructurings, disruptions or bankruptcies of our tenants, borrowers and operators, the perception of our potential future earnings and cash distributions, any unwillingness on the part of lenders to make loans to us and any deterioration in the financial position of lenders that might make them unable to meet their obligations to us.

2008 Transaction Overview

Investment Transactions

During 2008, we made investments aggregating $228 million through the acquisition of a senior housing facility for $11 million, purchase of marketable debt securities for $30 million, purchase of a joint venture interest valued at $29 million and funding an aggregate of $158 million for construction, tenant and capital improvement projects primarily in the life science and medical office segments.

During 2008, we sold assets valued at $656 million, which included the sale of 51 properties for approximately $643 million and other investments for $13 million. Our sales of properties and other investments during 2008 were made from the following segments: (i) $438 million of hospital, (ii) $97 million of skilled nursing, (iii) $94 million of medical office and (iv) $27 million of senior housing.

During 2008, three of our life science facilities located in South San Francisco were placed into service representing 229,000 square feet.

Financing Transactions

During the year ended December 31, 2008, we raised $1.8 billion in capital through the issuance of common stock, placement of Fannie Mae secured debt and the bank term loan market, which includes the transactions discussed below:

In connection with HCP’s addition to the S&P 500 Index on March 28, 2008, we issued 12.5 million shares of our common stock on April 2, 2008. In a separate transaction, we issued 4.5 million shares to a REIT-dedicated institutional investor on April 2, 2008. The net proceeds received from these two offerings in the aggregate were approximately $560 million, which were used to repay a portion of the outstanding indebtedness under our revolving line of credit facility.

In May 2008, we placed $259 million of seven-year mortgage financing on 21 of our senior housing assets. The assets are cross-collateralized and the debt has a fixed interest rate of 5.83%. We received net proceeds aggregating $254 million, which were used to repay outstanding indebtedness under our revolving line of credit facility and bridge loan.

In June 2008, we settled two forward-starting swaps with an aggregate notional amount of $900 million. Upon settlement of these contracts and for the year ended December 31, 2008, we recognized ineffectiveness charges of $3.5 million, or $0.01 per diluted share of common stock, in interest and other income, net.

On August 11, 2008, we issued 14.95 million shares of our common stock. We received net proceeds of $481 million, which were used to repay a portion of our outstanding indebtedness under our bridge loan facility.

In September 2008, we placed mortgage financing on senior housing assets through Fannie Mae aggregating $319 million, which was comprised of $140 million of five-year mortgage financing on four assets and $179 million of eight-year financing on 12 assets. The assets are cross-collateralized and the debt has a weighted-average fixed interest rate of 6.39%. We received net proceeds aggregating $312 million, which were used to repay our outstanding indebtedness under our revolving line of credit facility.

On October 24, 2008, we entered into a credit agreement with a syndicate of banks for a $200 million unsecured term loan. The term loan accrues interest at a rate of LIBOR plus 2.00%, based on our current debt ratings, and matures in August 2011. The net proceeds of $197 million received by us from the term loan were used to repay a portion of our outstanding indebtedness under our bridge loan facility.

On December 19, 2008, we recognized a gain of $2.4 million related to the negotiated early repayment of $120 million of mortgage debt, at a discount, with an original maturity of January 27, 2009. The mortgage debt was repaid with funds available under our revolving line of credit facility.

Other Events

On July 30, 2008, we received and recognized lease termination income of $18 million from a tenant in connection with the early termination of three leases representing 149,000 square feet in our life science segment. Upon termination of the leases, we recognized an impairment of $4 million related to intangible assets associated with these leases.

On September 19, 2008, we completed the restructuring of our hospital portfolio leased to Tenet and settled various disputes. The settlement provided for, among other things, the sale of our hospital in Tarzana, California, valued at $89 million, the purchase of Tenet’s noncontrolling interest in a joint venture valued at $29 million and the extension of the terms of three other hospitals leased by us to Tenet. As a result of the sale of our hospital in Tarzana, California and the settlement of our legal disputes with Tenet, we recognized income of $47 million.

On December 1, 2008, we completed the transfer of an 11-property senior housing portfolio to Emeritus. In connection with the transfer, we recognized impairments of lease related intangible assets of $12 million.

Dividends

Quarterly dividends paid during 2008 aggregated $1.82 per share. On February 2, 2009, we announced that our Board of Directors declared a quarterly common stock cash dividend of $0.46 per share. The common stock dividend was paid on February 23, 2009 to stockholders of record as of the close of business on February 9, 2009.

Critical Accounting Policies

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. For a description of the risk associated with our critical accounting policies, see “Risk Factors—Risks Related to HCP” in Item 1A. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain.

Principles of Consolidation

The consolidated financial statements include the accounts of HCP, our wholly- owned subsidiaries and joint ventures that we control, through voting rights or other means. We apply Financial Accounting Standards Board (“FASB”) Interpretation No. 46R, Consolidation of Variable Interest Entities, as revised (“FIN 46R”), for arrangements with variable interest entities (“VIEs”). We consolidate investments in VIEs when we are the primary beneficiary of the VIE at either the creation of the variable interest entity or upon the occurrence of a qualifying reconsideration event. We also apply Emerging Issues Task Force (“EITF”) Issue 04-5, Investor’s Accounting for an Investment in a Limited Partnership When the Investor is the Sole General Partner and the Limited Partners Have Certain Rights (“EITF 04-05”), to investments in joint ventures.

Our judgment with respect to our level of influence or control of an entity and whether we are (or are not) the primary beneficiary of a VIE. Consideration of various factors including, but not limited to, the form of our ownership interest, our representation on the entity’s governing body, the size and seniority of our investment, various cash flow scenarios related to the VIE, our ability to participate in policy making decisions and the rights of the other investors to participate in the decision making process and to replace us as manager and/or liquidate the venture, if applicable. Our ability to correctly assess our influence or control over an entity at inception of our involvement or upon a reconsideration event and determine the primary beneficiary of a VIE, affects the presentation of these entities in our consolidated financial statements. If we were to perform a primary beneficiary analysis upon the occurrence of a future reconsideration event, our assumptions may be different, which could result in the identification of a different primary beneficiary.

If we determine that we are the primary beneficiary of a VIE our consolidated financial statements would include the results of the VIE (either tenant or borrower) rather than the results of our lease or loan to the VIE. We would depend on the VIE to provide us timely financial information, and we would rely on the internal controls of the VIE to provide accurate financial information. If the VIE has deficiencies in its internal controls over financial reporting, or does not provide us with timely financial information, this may adversely impact our financial reporting and our internal controls over financial reporting.

Revenue Recognition

Rental income from tenants is recognized in accordance with GAAP, including SEC Staff Accounting Bulletin No. 104, Revenue Recognition (“SAB 104”). We recognize rental revenue on a straight-line basis over the lease term when collectibility is reasonably assured and the tenant has taken possession or controls the physical use of the leased asset. For assets acquired subject to leases, we recognize revenue upon acquisition of the asset provided the tenant has taken possession or controls the physical use of the leased asset. If the lease provides for tenant improvements, we determine whether the tenant improvements, for accounting purposes, are owned by the tenant or us. When we are the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the physical use of the leased asset until the tenant improvements are substantially completed. When the tenant is the owner of the tenant improvements, any tenant improvement allowance funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term. The determination of ownership of the tenant improvements is subject to significant judgment. Tenant improvement ownership is determined based on various factors including, but not limited to:

· whether the lease stipulates how and on what a tenant improvement allowance may be spent;

· whether the tenant or landlord retains legal title to the improvements at the end of the lease term;

· whether the tenant improvements are unique to the tenant or general- purpose in nature; and

· whether the tenant improvements are expected to have any residual value at the end of the lease.

If our assessment of the owner of the tenant improvements for accounting purposes were to change, the timing and amount of our revenue recognized would be impacted.

Certain leases provide for additional rents contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds. The recognition of additional rents requires us to make estimates of amounts owed and to a certain extent are dependent on the accuracy of the facility results reported to us. Our estimates may differ from actual results, which could be material to our consolidated financial statements.

We maintain an allowance for doubtful accounts, including an allowance for straight-line rent receivables, for estimated losses resulting from tenant defaults or the inability of tenants to make contractual rent and tenant recovery payments. We monitor the liquidity and creditworthiness of our tenants and operators on an ongoing basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For straight-line rent amounts, our assessment is based on income recoverable over the term of the lease. We exercise judgment in establishing allowances and consider payment history and current credit status in developing these estimates. These estimates may differ from actual results, which could be material to our consolidated financial statements.

We use the direct finance method of accounting to record income from DFLs. For leases accounted for as DFLs, future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectibility of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized unearned income.

Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. Loans held-for-investment are carried at amortized cost, reduced by a valuation allowance for estimated credit losses. We recognize interest income on loans, including the amortization of discounts and premiums, using the effective interest method applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums and discounts are recognized as yield adjustments over the life of the related loans. Loans are transferred from held-for-investment to held-for-sale when management’s intent is to no longer hold the loans for the foreseeable future. Loans held-for-sale are recorded at the lower of cost or fair value.

Allowances are established for loans and DFLs based upon a probable loss estimate for individual loans and DFLs deemed to be impaired. Loans and DFLs are impaired when it is deemed probable that we will be unable to collect all amounts due on a timely basis in accordance with the contractual terms of the loan or lease. Determining the adequacy of the allowance is complex and requires significant judgment by us about the effect of matters that are inherently uncertain. The allowance is based upon our assessment of the borrower’s or lessee’s overall financial condition, resources and payment record; the prospects for support from any financially responsible guarantors; and, if appropriate, the realizable value of any collateral. These estimates consider all available evidence including, as appropriate, the present value of the expected future cash flows discounted at the loan’s or DFL’s effective interest rate, the fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors. While our assumptions are based in part upon historical data, our estimates may differ from actual results, which could be material to our consolidated financial statements.

Loans and DFLs are placed on non-accrual status at such time as management determines that collectibility of contractual amounts is not reasonably assured. While on non-accrual status, loans or DFLs are either accounted for on a cash basis, in which income is recognized only upon receipt of cash, or on a cost- recovery basis, in which all cash receipts reduce the carrying value of the loan or DFL, based on management’s judgment of collectibility.

Real Estate

Real estate, consisting of land, buildings and improvements, is recorded at cost. We allocate the cost of the acquisition, including the assumption of liabilities, to the acquired tangible assets and identified intangibles based on their estimated fair values in accordance with SFAS No. 141, Business Combinations. In December 2007, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 141R, Business Combinations, as revised (“SFAS No. 141R”). SFAS No. 141R is effective for fiscal years beginning after December 15, 2008. The adoption of SFAS No. 141R on January 1, 2009 will, among other things, require us to prospectively expense all transaction costs for business combinations. The implementation of SFAS No. 141R on January 1, 2009 could materially impact our future financial results to the extent that we acquire significant amounts of real estate, as related acquisition costs will be expensed as incurred rather than our past practice of capitalizing such costs and amortizing them over the estimated useful life of the assets acquired.

We assess fair value based on estimated cash flow projections that utilize appropriate discount and/or capitalization rates and available market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, and market and economic conditions. The fair value of the tangible assets of an acquired property considers the value of the property as if it was vacant.

We record acquired “above and below” market leases at fair value using discount rates which reflect the risks associated with the leases acquired. The amount recorded is based on the present value of the difference between (i) the contractual amounts to be paid pursuant to each in-place lease and (ii) our estimate of fair market lease rates for each in-place lease, measured over a period equal to the remaining term of the lease for above market leases and the initial term plus extended term for any leases with below market renewal options. Other intangible assets acquired include amounts for in-place lease values that are based on our evaluation of the specific characteristics of each tenant’s lease. Factors to be considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. In estimating carrying costs, we include estimates of lost rentals at market rates during the hypothetical expected lease-up periods, which are dependent on local market conditions. In estimating costs to execute similar leases, we consider leasing commissions, legal and other related costs.

We are required to make subjective assessments to allocate the purchase price paid to acquire investments in real estate among the assets acquired and liabilities assumed based on our estimate of the fair values of such assets and liabilities. This includes determining the value of the buildings and improvements, land, ground leases, tenant improvements, in-place tenant leases, favorable or unfavorable market leases and any debt assumed from the seller or loans made by the seller to us. Each of these estimates requires significant judgment and some of the estimates involve complex calculations and judgments

about useful lives. These allocation assessments have a direct impact on our results of operations as amounts allocated to some assets and liabilities are not subject to depreciation or amortization and those that are have different lives. Additionally, the amortization of value assigned to favorable or unfavorable market rate leases is recorded as an adjustment to rental revenue as compared to amortization of the value of in-place leases, which is included in depreciation and amortization in our consolidated statements of income.

Impairment of Long-Lived Assets and Goodwill

We assess the carrying value of real estate assets and related intangibles (“real estate assets”), whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable in accordance with SFAS No. 144, Accounting for the Impairment or Disposal of Long Lived Assets (“SFAS No. 144”). We test our real estate assets for impairment by comparing the sum of the expected undiscounted cash flows to the carrying amount of the real estate asset or asset group. If the carrying value exceeds the expected undiscounted cash flows, an impairment loss will be recognized by adjusting the carrying amount of the real estate assets to their estimated fair value. Our ability to accurately predict future operating results and cash flows and to accurately estimate and allocate fair values impacts the timing and recognition of real estate asset impairments. While we believe our assumptions are reasonable, changes in these assumptions, such as the anticipated hold period for an asset, may have a material impact on our financial results.

Goodwill is tested for impairment by applying the two-step approach defined in SFAS No. 142, Goodwill and Other Intangible Assets, at least annually and whenever we identify triggering events that may indicate impairment. Potential impairment indicators include a significant decline in real estate valuations, restructuring plans or a decline in our market capitalization below book value. We test for impairment of our goodwill by comparing the fair value of a reporting unit containing goodwill to its carrying value. If the carrying value exceeds the fair value, the second step of the test is needed to measure the amount of potential goodwill impairment. The second step requires the fair value of the reporting unit to be allocated to all the assets and liabilities of the reporting unit as if it had been acquired in a business combination at the date of the impairment test. The excess fair value of the reporting unit over the fair value of assets and liabilities is the implied value of goodwill and is used to determine the amount of impairment. We selected the fourth quarter of each fiscal year to perform our annual impairment test.

The evaluation of goodwill requires significant judgments and estimates when determining fair value, including, but not limited to, real estate market capitalization rates, projected future cash flows, discount rates and the fair value of HCP. We estimated the fair value of HCP based on the market capitalization of our outstanding shares at December 31, 2008 and a control premium of approximately ten percent. This control premium approximates comparable sale transactions during the 18 months prior to our impairment test. We also performed various sensitivity analyses in which real estate capitalization rates, discount rates and the control premium were expanded or contracted by 50 to 100 basis points, noting that the results would not lead to an impairment of our goodwill assets. Our estimates may differ from actual results due to, among other things, economic conditions or changes in operating performance. While we believe our assumptions are reasonable, changes in these assumptions, such as significant expansions in real estate market capitalization rates, may have a material impact on our financial results.

Investments in Unconsolidated Joint Ventures

Investments in entities which we do not consolidate but for which we have the ability to exercise significant influence over operating and financial policies are reported under the equity method of accounting. Under the equity method of accounting, our share of the investee’s earnings or losses are included in our consolidated results of operations.

The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the carrying value of the assets prior to the sale of interests in the joint venture. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to our carrying value. When we determine that a decline in the fair value of our investment in an unconsolidated joint venture is other-than-temporary and is below its carrying value, an impairment is recorded. The determination of the fair value of investments in unconsolidated joint ventures involves significant judgment. Our estimates consider all available evidence including, as appropriate, the present value of the expected future cash flows discounted at market rates, general economic conditions and trends, and other relevant factors. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results.

Income Taxes

As part of the process of preparing our consolidated financial statements, significant management judgment is required to evaluate our compliance with REIT requirements. Our determinations are based on interpretation of tax laws, and our conclusions may have an impact on the income tax expense recognized. Adjustments to income tax expense may be

required as a result of: (i) audits conducted by federal and state tax authorities, (ii) our ability to qualify as a REIT, (iii) the potential for built-in-gain recognized related to prior-tax-free acquisitions of C corporations, and (iv) changes in tax laws. Adjustments required in any given period are included in income, other than adjustments to income tax liabilities acquired in business combinations, which are adjusted through goodwill.

Results of Operations

We evaluate our business and allocate resources among our five business segments—(i) senior housing, (ii) life science, (iii) medical office, (iv) hospital, and (v) skilled nursing. Under the senior housing, life science, hospital and skilled nursing segments, we invest primarily in single operator or tenant properties through the acquisition and development of real estate and by providing financing to operators in these segments. Under the medical office segment, we invest through acquisition in MOBs that are primarily leased under gross or modified gross leases, generally to multiple tenants, and which generally require a greater level of property management. The acquisition of SEUSA on August 1, 2007 resulted in a change to our reportable segments. Prior to the SEUSA acquisition, we operated through two reportable segments—triple-net leased and medical office buildings. The senior housing, life science, hospital and skilled nursing segments were previously aggregated under our triple-net leased segment. SEUSA’s results are included in our consolidated financial statements from the date of acquisition of August 1, 2007. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the Consolidated Financial Statements).

Comparison of the Year Ended December 31, 2008 to the Year Ended December 31, 2007

We completed our acquisition of SEUSA on August 1, 2007 and an investment in mezzanine loans with an aggregate face value of $1.0 billion on December 21, 2007. SEUSA’s results of operations and the results of these mezzanine loans are reflected in our consolidated financial statements from those respective dates.

Rental and related revenues.

	Year Ended December 31,				Change
Segments	2008		2007		$			%
	(dollars in thousands)
Senior housing	$	289,834	$	293,259	$	(3,425	)	(1	)%
Life science	208,415		79,660		128,755			NM	(1)
Medical office	260,788		275,042		(14,254		)	(5	)
Hospital	82,841		79,660		3,181			4
Skilled nursing	35,982		35,172		810			2
Total	$	877,860	$	762,793	$	115,067		15	%

(1) Percentage change not meaningful.

· Senior housing. Senior housing rental and related revenues decreased by $3.4 million to $289.8 million, for the year ended December 31, 2008, primarily as a result of income of $9 million recognized in 2007, resulting from our change in estimate relating to the collectibility of straight-lined rents due from Emeritus, which was partially offset by the additive effect of our acquisitions during 2008 and 2007. No significant changes in estimates related to the collectibility of straight-lined rents were made during the year ended December 31, 2008.

· Life science. Life science rental and related revenues increased by $128.8 million, to $208.4 million, for the year ended December 31, 2008, primarily as a result of our acquisition of SEUSA on August 1, 2007. In addition, included in life science rental and related revenues for the year ended December 31, 2008, is lease termination income of $18 million received from a tenant in connection with the early termination of three leases on July 30, 2008 and rental revenues related to three development projects that were placed into service in 2008.

· Medical office. Medical office rental and related revenues for the year ended December 31, 2007 includes $18 million from assets that are no longer consolidated and are now in the HCP Ventures IV, LLC joint venture (“HCP Ventures IV”). The decrease in medical office rental and related revenues resulting from HCP Ventures IV was partially offset by the additive effect of our MOB acquisitions during 2007.

Tenant recoveries.

	Year Ended December 31,				Change
Segments	2008		2007		$		%
	(dollars in thousands)
Life science	$	33,914	$	19,311	$	14,603	76	%
Medical office	47,015		44,451		2,564		6
Hospital	1,918		1,092		826		76
Total	$	82,847	$	64,854	$	17,993	28	%

The increase in tenant recoveries for the year ended December 31, 2008 was primarily as a result of our acquisition of SEUSA on August 1, 2007, three development projects that were placed into service in 2008, and the additive effect of our other acquisitions during 2007, partially offset by tenant recoveries related to the assets contributed to HCP Ventures IV.

Income from direct financing leases. Income from DFLs decreased $5.7 million to $58.1 million for the year ended December 31, 2008. The decrease was primarily due to two DFL tenants exercising their purchase options on our leased assets during 2007 and two additional DFLs that were placed on non-accrual status and accounted for on a cost-recovery basis beginning October 2008. No purchase options were exercised during 2008. We expect that income from DFLs will decline in 2009 as a result of the two DFLs that are accounted for on a cost-recovery basis.

Investment management fee income. Investment management fee income decreased $7.7 million, to $5.9 million, for the year ended December 31, 2008. The decrease in investment management fee income was primarily due to the acquisition fees earned related to our HCP Ventures II joint venture of $5.4 million on January 5, 2007 and HCP Ventures IV of $3.0 million on April 30, 2007. No acquisition fees were earned for the year ended December 31, 2008.

Depreciation and amortization expenses. Depreciation and amortization expenses increased $55.1 million, to $314.0 million, for the year ended December 31, 2008. The increase was primarily related to our SEUSA acquisition and three development projects that were placed into service in 2008. The increase in depreciation and amortization related to SEUSA was partially offset by our other acquisitions in 2008 and 2007 and by the 2007 expenses related to the assets contributed to HCP Ventures IV.

Operating expenses.

	Year Ended December 31,				Change
Segments	2008		2007		$			%
	(dollars in thousands)
Senior housing	$	10,464	$	10,958	$	(494	)	(5	)%
Life science	43,541		26,220		17,321			66
Medical office	134,734		135,604		(870		)	(1	)
Hospital	3,202		1,907		1,295			68
Total	$	191,941	$	174,689	$	17,252		10	%

Operating expenses are predominantly related to MOB and life science properties where we incur the expenses and recover a portion of those expenses under the respective leases. Accordingly, the number of properties in our MOB and life science portfolios directly impact operating expenses. The presentation of expenses as general and administrative or operating is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expense.

· Life science. Life science operating expenses increased by $17.3 million, to $43.5 million, for the year ended December 31, 2008, primarily as a result of our acquisition of SEUSA on August 1, 2007 and three development projects that were placed into service in 2008.

· Medical office. Medical office operating expenses decreased $0.9 million, to $134.7 million, for the year ended December 31, 2008. Medical office operating expenses for the year ended December 31, 2007 include $7.2 million related to assets contributed to HCP Ventures IV. The decrease in medical office operating expenses resulting from HCP Ventures IV was partially offset by the additive effect of our MOB acquisitions during 2007 and increased operating expenses in 2008.

· Hospital. Hospital operating expenses increased $1.3 million, to $3.2 million, for the year ended December 31, 2008, primarily as a result the additive effect of our hospital acquisitions during 2007.

General and administrative expenses. General and administrative expenses increased $7.3 million, to $75.6 million, for the year ended December 31, 2008. The increase in general and administrative expenses was due to an increase in legal fees of $7 million primarily resulting from litigation and an increase of $11 million related to compensation related expenses and professional fees. These increases were partially offset by a decrease of $10 million in merger and integration-related expenses associated with the SEUSA acquisition and our merger with CNL Retirement Properties, Inc. and CNL Retirement Corp., and a $2 million decrease in costs related to acquisitions that were not consummated in 2007.

The information set forth under the heading “Legal Proceedings” of Note 14 to the Consolidated Financial Statements, included in this report, is incorporated herein by reference.

Impairments. During the year ended December 31, 2008, we recognized impairments of $24.7 million as follows: (i) $16.9 million related to intangible assets associated with the early termination of leases and (ii) $7.8 million related to three senior housing properties and one hospital as a result of a decrease in expected cash flows. No assets were determined to be impaired during the year ended December 31, 2007.

Gain on sale of real estate interest. On April 30, 2007, we sold an 80% interest in HCP Ventures IV, which resulted in a gain of $10.1 million. No similar transactions occurred during the year ended December 31, 2008.

Interest and other income, net. Interest and other income, net increased $81.1 million, to $156.7 million, for the year ended December 31, 2008. The increase was primarily related to an increase of $81.0 million of interest income from our HCR ManorCare mezzanine loan investment made in December 2007 and $28.6 million related to the settlement of litigation with Tenet. The increase in interest and other income, net was partially offset by (i) $7.1 million of lower interest earned on cash balances in 2008, (ii) a decrease in gains resulting from insurance proceeds of $4.9 million in 2007, (iii) an increase in losses from derivatives and hedge ineffectiveness of $6.4 million, (iv) an increase in recognized losses of marketable equity securities and investments in unconsolidated joint ventures of $4.4 million, (v) $3.5 million of fee income related to the early repayment of a loan in 2007, and (vi) a decrease in gains from the sale of marketable debt securities of $3.2 million.

Our mezzanine investment bears interest on the $1.0 billion aggregate face amount at a floating rate of LIBOR plus 4.0%. During the second half of 2008, LIBOR significantly declined. If interest rates stay at current levels or continue to decline, we expect interest income will decline in 2009 relative to amounts in 2008. For a more detailed description of our mezzanine loan investments, see Note 7 of the Consolidated Financial Statements included in this report. Our exposure to income fluctuations related to our variable rate loans is partially mitigated by our variable rate indebtedness. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A.

Interest expense. Interest expense decreased $7.1 million, to $348.4 million, for the year ended December 31, 2008. The decrease was primarily due to: (i) a decrease of $17 million related to the average outstanding balance under our bridge loan and a decline in LIBOR, (ii) an increase of $15 million of capitalized interest related to an increase in assets under development in our life science segment, (iii) a decrease of $10 million resulting from the repayment of $300 million senior unsecured floating rate notes in September 2008, and (iv) a charge of $6 million related to the write-off of unamortized loan fees associated with our previous revolving line of credit facility that was terminated in 2007. The decrease in interest expense was partially offset by: (i) an increase of $34 million of interest expense from the issuance of $1.1 billion of senior unsecured notes during 2007 and (ii) an increase of $6 million related to the average outstanding balances under our line of credit and term loan. Our exposure to expense fluctuations related to our variable rate indebtedness is mitigated by our variable rate investments. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

	As of December 31,
	2008			2007
Balance:
Fixed rate	$	5,059,910		$	4,704,988
Variable rate	892,431			2,822,316
Total	$	5,952,341		$	7,527,304
Percent of total debt:
Fixed rate	85		%	63		%
Variable rate	15			37
Total	100		%	100		%
Weighted average interest rate at end of period:
Fixed rate	6.34		%	6.18		%
Variable rate	2.57		%	5.90		%
Total weighted average rate	5.77		%	6.08		%

Income taxes. For the year ended December 31, 2008, income taxes increased $2.9 million to $4.3 million. This increase is primarily due to an increase in taxable income related to a portion of one of our mezzanine loan investments, which was contributed to a TRS in January 2008.

Equity income from unconsolidated joint ventures. For the year ended December 31, 2008, equity income from unconsolidated joint ventures decreased $2.3 million, to $3.3 million. This decrease is primarily due to a change in the expected useful life of certain intangible assets of one of our unconsolidated joint ventures that resulted in higher amounts of amortization expense.

Discontinued operations. Income from discontinued operations for the year ended December 31, 2008 was $238.7 million, compared to $476.6 million for the comparable period in the prior year. The decrease is primarily due to a decrease in gains on real estate dispositions. During the year ended December 31, 2008, we sold 51 properties for $643 million, as compared to 97 properties for $922 million in the year-ago period. Additionally, the decrease was attributable to a year over year decline in operating income from discontinued operations of $53.6 million and an increase in impairment charges of $9.2 million. Discontinued operations for the year ended December 31, 2008 included 60 properties compared to 157 for the year ended December 31, 2007. Also included in discontinued operations during the year ended December 31, 2007 was $6 million of rental income we recognized, as a result of a change in estimate related to the collectibility of straight-line rental income from Emeritus.

Noncontrolling interests’ and participating securities’ share in earnings. For the year ended December 31, 2008, noncontrolling interests’ and participating securities’ share in earnings decreased $3.4 million, to $24.5 million. This decrease is primarily due to the conversion of 2.8 million of DownREIT units into shares of our common stock during 2008, and to a lesser extent, the purchase in September 2008 of Tenet’s noncontrolling interest in Health Care Property Partners (“HCPP”), a joint venture between HCP and an affiliate of Tenet. We expect that these conversions and the purchase of Tenet’s noncontrolling interest in HCPP will decrease allocation of earnings to noncontrolling interests during 2009 relative to amounts in 2008. See Notes 2 and 4 to the Consolidated Financial Statements in this report for additional information on DownREIT units and HCPP. In December 2007, the FASB issued Statement of Financial Accounting Standards No. 160, Noncontrolling Interests in Consolidated Financial Statements—An Amendment of ARB No. 51 (“SFAS No. 160”). Upon adoption on January 1, 2009, SFAS No. 160 required us to include the net income attributable to the noncontrolling interests in our consolidated net income. However, the adoption of SFAS No. 160 did not significantly change the amount of net income applicable to common shares.

Comparison of the Year Ended December 31, 2007 to the Year Ended December 31, 2006

We completed our acquisition of SEUSA on August 1, 2007, mergers with CRP and CRC on October 5, 2006 and the acquisition of an interest held by an affiliate of General Electric (“GE”) in HCP MOP on November 30, 2006, which resulted in the consolidation of HCP MOP beginning on that date. The results of operations from our SEUSA, CRP and HCP MOP transactions are reflected in our consolidated financial statements from those respective dates.

Rental and related revenues.

	Year Ended December 31,				Change
Segments	2007		2006		$		%
	(dollars in thousands)
Senior housing	$	293,259	$	162,919	$	130,340	80	%
Life science	79,660		14,919		64,741		NM	(1)
Medical office	275,042		154,918		120,124		78
Hospital	79,660		48,127		31,533		66
Skilled nursing	35,172		32,955		2,217		7
Total	$	762,793	$	413,838	$	348,955	84	%

(1) Percentage change not meaningful.

· Senior housing. Senior housing rental and related revenues increased $130.3 million, to $293.3 million, for the year ended December 31, 2007. Approximately $98 million of the increase relates to properties acquired in the CRP merger. Additionally, the results for the year ended December 31, 2007, include income of $9 million resulting from our change in estimate relating to the collectibility of straight-line rents due from Summerville Senior Living, Inc. The remaining increase in senior housing rental and related revenues primarily relates to rent escalations and resets, and the additive effect of our other acquisitions in 2007 and 2006.

· Life science. Life science rental and related revenues increased by $64.7 million, to $79.7 million, for the year ended December 31, 2007, primarily as a result of our acquisition of SEUSA on August 1, 2007.

· Medical office. Medical office rental and related revenues increased $120.1 million, to $275.0 million, for the year ended December 31, 2007. Approximately $31 million of the increase relates to MOBs acquired in the CRP merger and $64.7 million relates to the consolidation of HCP MOP. The remaining increase in medical office rental and related revenues primarily relates to the additive effect of our MOB acquisitions in 2007 and 2006.

· Hospital. Hospital rental and related revenues increased by $31.5 million, to $79.7 million, for the year ended December 31, 2007. Approximately $29.7 million of the increase relates to the additive effect of our hospital acquisitions in 2007 and $1.9 million related to properties acquired in the CRP merger.

Tenant recoveries.

	Year Ended December 31,				Change
Segments	2007		2006		$		%
	(dollars in thousands)
Life science	$	19,311	$	3,935	$	15,376	NM	(1)
Medical office	44,451		25,172		19,279		77	%
Hospital	1,092		34		1,058		NM	(1)
Total	$	64,854	$	29,141	$	35,713	123	%

(1) Percentage change not meaningful.

· Life science. Life science tenant recoveries increased by $15.4 million, to $19.3 million, for the year ended December 31, 2007, primarily as a result of our acquisition of SEUSA on August 1, 2007.

· Medical office. Medical office tenant recoveries increased $19.3 million, to $44.5 million, for the year ended December 31, 2007. Approximately $10.3 million of the increase relates to MOBs acquired in the CRP merger and $7.7 million relates to the consolidation of HCP MOP. The remaining increase in medical office tenant recoveries primarily relates to the additive effect of our MOB acquisitions in 2007 and 2006.

· Hospital. Hospital tenant recoveries increased as a result of our hospital acquisitions in 2007.

Income from direct financing leases. Income from direct financing leases increased $48.8 million, to $63.9 million, for the year ended December 31, 2007, primarily as a result of properties acquired from CRP, which are accounted for using the direct financing method. At December 31, 2007, these leased properties had a carrying value of $640.1 million and accrued income at a weighted average interest rate of 8.5%. During the year ended December 31, 2007, two DFL tenants exercised their purchase options and we received proceeds of $51 million and recognized additional income of $4.3 million.

Investment management fee income. Investment management fee income increased $9.7 million, to $13.6 million, for the year ended December 31, 2007. The increase was primarily due to the acquisition fees related to HCP Ventures II of $5.4 million on January 5, 2007 and HCP Ventures IV of $3.0 million on April 30, 2007, partially offset by the decline in fees of $3.1 million resulting from our purchase of GE’s interests in HCP MOP on November 30, 2006.

Depreciation and amortization expenses. Depreciation and amortization expenses increased $141.7 million, to $258.9 million, for the year ended December 31, 2007. Approximately $64.8 million of the increase relates to properties acquired in the CRP merger, $19.2 million relates to the consolidation of HCP MOP and $33.5 million relates to the SEUSA acquisition. The remaining increase in depreciation and amortization primarily relates to the additive effect of our other acquisitions in 2007 and 2006.

Operating expenses.

	Year Ended December 31,				Change
Segments	2007		2006		$		%
	(dollars in thousands)
Senior housing	$	10,958	$	8,972	$	1,986	22	%
Life science	26,220		4,969		21,251		NM	(1)
Medical office	135,604		64,688		70,916		110
Hospital	1,907		—		1,907		100
Total	$	174,689	$	78,629	$	96,060	122	%

(1) Percentage change not meaningful.

Operating expenses are predominantly related to MOB and life science properties where we incur the expenses and recover a portion of those expenses under the lease. Accordingly, the number of properties in our MOB and life science portfolios directly impact operating expenses. The presentation of expenses as general and administrative or operating is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expense.

· Senior housing. Included in operating expenses are facility-level operating expenses for three senior housing properties that were previously leased on a triple-net basis. Periodically, tenants default on their leases, which causes us to take possession of the operations of the facility. We contract with third-party managers to manage these properties until a replacement tenant can be identified or the property can be sold. The operating revenues and expenses for these properties are included in healthcare rental revenues and operating expenses, respectively. The increase in reported operating expenses for these facilities of $0.9 million, to $9.6 million for the year ended December 31, 2007, was primarily due to an increase in the overall occupancy of such properties.

· Life science. Life science operating expenses increased by $21.3 million, to $26.2 million, for the year ended December 31, 2007, primarily as a result of our acquisition of SEUSA on August 1, 2007.

· Medical office. Medical office operating expenses increased $70.9 million, to $135.6 million, for the year ended December 31, 2007. Approximately $34.8 million relates to the consolidation of HCP MOP and $16.6 million of the increase relates to properties acquired in the CRP merger. The remaining increase in medical office operating expenses relates to the additive effect of our acquisitions in 2007 and 2006.

· Hospital. Hospital operating expenses increased as a result of our hospital acquisitions in 2007.

General and administrative expenses. General and administrative expenses increased $21.5 million, to $68.3 million, for the year ended December 31, 2007. Included in general and administrative expenses are merger and integration-related expenses associated with the CRC and CRP mergers and the SEUSA acquisition of $10 million for the year ended December 31, 2007, compared to $5 million in the prior year. Merger and integration-related expenses are primarily costs from our CRP merger, such as employee transition costs as well as severance costs for certain of our employees whose responsibilities became redundant after the completion of the merger. The remaining increase was primarily due to various items including increased professional and legal fees, federal and state taxes, and compensation related expenses.

Impairments. During the year ended December 31, 2006, we recognized impairments of $2.5 million as a result of the contribution of 25 properties into a senior housing joint venture in January 2007. No properties were determined to be impaired during the year ended December 31, 2007.

Gain on sale of real estate interest. On April 30, 2007, we sold an 80% interest in HCP Ventures IV, which resulted in a gain of $10.1 million. There were no interests in joint ventures sold during the year ended December 31, 2006.

Interest and other income, net. Interest and other income, net increased $40.9 million, to $75.6 million, for the year ended December 31, 2007. The increase was primarily related to an increase of $24.0 million of interest income from $275 million of marketable debt securities, $9.3 million of interest income from an $85 million loan acquired in the CRP merger and $7.6 million of interest income from cash and cash equivalents. During 2007, our marketable debt securities accrued interest at rates ranging from 9.25% to 9.625%, and our $85 million loan accrued interest at a rate of 14%.

Interest expense. Interest expense increased $144.0 million, to $355.5 million, for the year ended December 31, 2007. This increase was primarily due to (i) $106 million of interest expense from the issuance of $2.65 billion of senior unsecured notes during 2006 and 2007, (ii) $43 million increase in our outstanding mortgage debt resulting primarily from our acquisitions of CRP, consolidation of HCP MOP and other property acquisitions, (iii) $17 million from the increase in outstanding indebtedness under our bridge and term loans and line of credit facilities, and the related amortization and write-off of unamortized debt issuance costs. The increase in interest expense is partially offset by $11 million increase in the amount of capitalized interest relating to the increase in assets under development primarily from our acquisition of SEUSA and $10 million decrease related to the repayment of $275 million of maturing senior unsecured notes during 2006 and 2007.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

	As of December 31,
	2007			2006
Balance:
Fixed rate	$	4,704,988		$	4,541,237
Variable rate	2,822,316			1,669,031
Total	$	7,527,304		$	6,210,268
Percent of total debt:
Fixed rate	63		%	73		%
Variable rate	37			27
Total	100		%	100		%
Weighted average interest rate at end of period:
Fixed rate	6.18		%	5.91		%
Variable rate	5.90		%	6.13		%
Total weighted average rate	6.08		%	5.97		%

Equity income from unconsolidated joint ventures. For the year ended December 31, 2007, equity income decreased $2.7 million, to $5.6 million. This decrease is primarily due to our consolidation of HCP MOP, which was previously accounted for as an equity method investment, partially offset by equity income from HCP Ventures II, III and IV.

Discontinued operations. Income from discontinued operations for the year ended December 31, 2007 was $476.6 million, compared to $389.8 million for the comparable period in the prior year. The increase is primarily due to an increase in gains on real estate dispositions of $123.8 million and a decline in impairment charges of $7 million year over year. During the year ended December 31, 2007, we sold 97 properties for $922 million, as compared to 83 properties for $512 million in the year-ago period. The increase was partially offset by a year over year decline in operating income from discontinued operations of $44.0 million. Discontinued operations for the year ended December 31, 2007 included 157 properties compared to 240 for the year ended December 31, 2006. Included in discontinued operations during the year ended December 31, 2007 was income of $6 million, resulting from a change in estimate related to the collectibility of straight-line rental income from Emeritus Corporation.

Noncontrolling interests’ and participating securities’ share in earnings. For the year ended December 31, 2007, noncontrolling interests’ and participating securities’ share in earnings increased $5.1 million, to $27.9 million. This increase was primarily due to the issuance of 4.2 million non-managing member units of HCP DR MCD, LLC, in connection with our February 9, 2007 acquisition of a medical campus.

Liquidity and Capital Resources

Our principal liquidity needs are to (i) fund normal operating expenses, (ii) repay the $320 million outstanding balance on the bridge loan, (iii) meet debt service requirements, including $155 million of our mortgage debt maturing in 2009, (iv) fund capital expenditures, including tenant improvements and leasing costs, (v) fund acquisition and development activities, and (vi) make minimum distributions required to maintain our REIT qualification under the Code. We believe these needs will be satisfied using cash flows generated by operations, provided by financing activities and from sales of assets during the next twelve months.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as to fund future acquisitions and development through the issuance of additional securities or secured debt. During 2008, we raised $1 billion of equity capital, $656 million from asset dispositions, $566 million from the placement of Fannie Mae secured debt and $197 million in the bank term loan market. As of January 31, 2009, we had a credit rating of Baa3 (stable) from Moody’s, BBB (stable) from S&P and BBB (positive) from Fitch on our senior unsecured debt securities, and Ba1 (stable) from Moody’s, BB+ (stable) from S&P and BBB- (positive) from Fitch on our preferred equity securities. During 2008, there was a decline in the availability of financing from the capital markets and widening credit spreads. Our ability to continue to access capital could be impacted by various factors including general market conditions and the continuing slowdown in the economy, interest rates, credit ratings on our securities, and any changes to these ratings, the market price of our capital stock, the performance of our portfolio, tenants, borrowers and operators, including any restructurings, disruptions or bankruptcies of our tenants, borrowers and operators, the perception of our potential future earnings and cash distributions, any unwillingness on the part of lenders to make loans to us and any deterioration in the financial position of lenders that might make them unable to meet their obligations to us.

Net cash provided by operating activities was $568.7 million and $453.1 million for 2008 and 2007, respectively. Cash flow from operations reflects increased revenues partially offset by higher costs and expenses, as well as fluctuations in receivables, payables, accruals and deferred revenue. Our cash flows from operations are dependent upon the occupancy level of multi-tenant buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

Net cash provided by investing activities was $427.3 million during 2008 and principally reflects the net effect of: (i) $639.6 million received from the sales of facilities, (ii) $155.5 million used to fund acquisitions and development of real estate, and (iii) $30.1 million used to purchase marketable securities. During 2008 and 2007, we used $60.0 million and $49.7 million, respectively, to fund lease commissions and tenant and capital improvements. We expect to fund development commitments of $36.5 million for 2009.

Net cash used by financing activities was $1.0 billion for 2008 and included proceeds of (i) $1.1 billion from common stock issuances and exercise of options, (ii) $579.6 million from the placement of mortgage debt and draws on construction loans, and (iii) $200 million from borrowings under our term loan. These proceeds were partially offset by or used for (i) repayments of $801.7 million of borrowings under our line of credit, (ii) repayment of $1.0 billion of borrowings under our bridge loan, (iii) repayment of $300 million of senior unsecured notes, (iv) repayment of mortgage debt aggregating $225.3 million and (v) payment of common and preferred dividends aggregating $457.6 million. In order to qualify as a REIT for federal income tax purposes, we must distribute at least 90% of our taxable income, excluding capital gains, to our stockholders. Accordingly, we intend to continue to make regular quarterly distributions to holders of our common and preferred stock.

At December 31, 2008, we held approximately $15.0 million in deposits and $38.2 million in irrevocable letters of credit from commercial banks securing tenants’ lease obligations and borrowers’ loan obligations. We may draw upon the letters of credit or depository accounts, subject to certain restrictions by mortgage lenders, if there are defaults under the related leases or loans. Amounts available under letters of credit could change based upon facility operating conditions and other factors, and such changes may be material.

Debt

Bank line of credit and bridge and term loans. Our revolving line of credit with a syndicate of banks provided for an aggregate $1.5 billion of borrowing capacity at December 31, 2008. This revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 0.325% to 1.00%, depending upon our debt ratings. We pay a facility fee on the entire revolving commitment ranging from 0.10% to 0.25%, depending upon our debt ratings. Based on our debt ratings on December 31, 2008, the margin on the revolving line of credit facility was 0.55% and the facility fee was 0.15%. Our revolving line of credit facility matures on August 1, 2011. At December 31, 2008, we had $150 million outstanding under this revolving line of credit facility with a weighted-average effective interest rate of 1.36%.

At December 31, 2008, the outstanding balance of our bridge loan was $320 million. The bridge loan had an initial maturity date of July 31, 2008 that has been extended to July 30, 2009 through the exercise of two extension options. This bridge loan accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 0.425% to 1.25%, depending upon our debt ratings (weighted-average effective interest rate of 2.19% at December 31, 2008). Based on our debt ratings on December 31, 2008, the margin on the bridge loan facility was 0.70%.

Our revolving line of credit facility and bridge loan contain certain financial restrictions and other customary requirements. A portion of these financial covenants become more restrictive through the period ending March 31, 2009. Among other things, these covenants, using terms defined in the agreement, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 65%, (iii) require a Fixed Charge Coverage ratio of 1.75 times, and (iv) require a formula-determined Minimum Consolidated Tangible Net Worth of $4.2 billion at December 31, 2008. At December 31, 2008, we were in compliance with each of these restrictions and requirements of our credit revolving credit facility and bridge loan.

On October 24, 2008, we entered into a credit agreement with a syndicate of banks for a $200 million unsecured term loan, which matures on August 1, 2011. The term loan accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 1.825% to 2.375%, depending upon our debt ratings (weighted-average effective interest rate of 3.68% at December 31, 2008). Based on our debt rating on December 31, 2008, the margin on the term loan was 2.00%. We received net proceeds of $197 million, which were used to repay a portion of our outstanding indebtedness under our bridge loan facility. The term loan contains certain financial restrictions and other customary requirements, similar to those included in our revolving line of credit and bridge loan. At December 31, 2008, we were in compliance with each of these restrictions and requirements of the term loan.

Our revolving line of credit facility and bridge and term loans also contain cross-default provisions to other indebtedness of ours, including in some instances, certain mortgages on our properties. Certain mortgages contain default provisions relating to defaults under the leases or operating agreements on the applicable properties by our operators or tenants, including default provisions relating to the bankruptcy of such operator or tenant. Although we believe that we would be able to secure amendments under the applicable agreements if a default as described above occurs, such default may result in significantly less favorable borrowing terms than currently available, material delays in the availability of funding or other material adverse consequences.

Senior unsecured notes. At December 31, 2008, we had $3.5 billion in aggregate principal amount of senior unsecured notes outstanding. Interest rates on the notes ranged from 2.90% to 7.07% with a weighted average effective rate of 6.25% at December 31, 2008. Discounts and premiums are amortized to interest expense over the term of the related debt.

In September 2008, we repaid $300 million of maturing senior unsecured notes which accrued interest based on the three-month LIBOR plus 0.45%. The notes were repaid with funds available under our revolving line of credit facility.

The senior unsecured notes contain certain covenants including limitations on debt, cross-acceleration provisions and other customary terms. At December 31, 2008, we were in compliance with these covenants.

Mortgage debt. At December 31, 2008, we had $1.6 billion in mortgage debt secured by 198 healthcare facilities with a carrying amount of $2.8 billion. Interest rates on the mortgage notes ranged from 1.03% to 8.63% with a weighted-average effective interest rate of 6.10% at December 31, 2008.

In September 2008, we placed mortgage financing on our senior housing assets through Fannie Mae aggregating $319 million, which was comprised of $140 million of five-year mortgage financing on four assets and $179 million of eight-year financing on 12 assets. The assets are cross-collateralized and the debt has a weighted-average fixed interest rate of 6.39%. We received net proceeds aggregating $312 million, which were used to repay our outstanding indebtedness under our revolving line of credit facility.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by certain properties and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered properties, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the properties in good condition, requires maintenance of insurance on the properties and includes requirements to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple properties and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such properties.

Other debt. At December 31, 2008, we had $102.2 million of non-interest bearing Life Care Bonds at two of our CCRCs and non-interest bearing occupancy fee deposits at another of our senior housing facilities, all of which were payable to certain residents of the facilities (collectively “Life Care Bonds”). At December 31, 2008, $42.4 million of the Life Care Bonds were refundable to the residents upon the resident moving out or to their estate upon death, and $59.8 million of the Life Care Bonds were refundable after the unit is successfully remarketed to a new resident.

Derivative Financial Instruments. During October and November 2007, we entered into two forward-starting interest rate swap contracts with notional amounts aggregating $900 million. In June 2008, we terminated these hedges per the cash settlement provisions of the derivative contracts. The termination of the $500 million notional contract resulted in a payment of $14.8 million and the termination of the $400 million notional contract resulted in a cash receipt of $5.2 million. We also have three interest rate swap contracts outstanding at December 31, 2008, which hedge fluctuations in interest payments on variable rate secured debt. At December 31, 2008, these interest rate swap contracts had an aggregate notional amount of $45.6 million and a fair value of a $2.3 million liability, respectively. For a more detailed description of our derivative financial instruments, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A.

Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments, excluding debt premiums and discounts, at December 31, 2008 (in thousands):

Year	Bank Line of Credit(1)		Bridge and Term Loans		Senior Unsecured Notes		Mortgage Debt		Other Debt(2)		Total
2009	$	—	$	320,000	$	—	$	155,347	$	102,209	$	577,556
2010	—		—		206,421		298,499		—		504,920
2011	150,000		200,000		300,000		137,570		—		787,570
2012	—		—		250,000		60,919		—		310,919
2013	—		—		550,000		233,068		—		783,068
Thereafter	—		—		2,237,000		751,308		—		2,988,308
	$	150,000	$	520,000	$	3,543,421	$	1,636,711	$	102,209	$	5,952,341

(1) Funds from our bank line of credit were drawn for the early repayment of $120 million of mortgage debt with an original maturity date in January 2009.

(2) Other debt represents non-interest bearing Life Care Bonds and occupancy fee deposits at three of our senior housing facilities, which are payable on-demand, under certain conditions.

We have a prospectus on file with the SEC as part of a registration statement on Form S-3, using a shelf registration process which expires in 2009. Under this “shelf” process, we may sell from time to time any combination of the securities in one or more offerings. The securities described in the prospectus include common stock, preferred stock and debt securities. Each time we sell securities under the shelf registration, we will provide a prospectus supplement that will contain specific information about the terms of the securities being offered and of the offering. We may offer and sell the securities pursuant to this prospectus from time to time in one or more of the following ways: through underwriters or dealers, through agents, directly to purchasers or through a combination of any of these methods of sales. Proceeds from the sale of these securities may be used for general corporate purposes, which may include repayment of indebtedness, working capital and potential acquisitions. During 2008, we issued approximately $1.0 billion of common stock under the shelf.

Equity

On April 2, 2008, we issued 17 million shares of our common stock and used the net proceeds received of approximately $560 million to repay a portion of our outstanding indebtedness under our revolving line of credit facility.

On August 11, 2008, we issued 14.95 million shares of our common stock and used the net proceeds received of approximately $481 million to repay a portion of our outstanding indebtedness under our bridge loan.

At December 31, 2008, we had 4.0 million shares of 7.25% Series E cumulative redeemable preferred stock, 7.8 million shares of 7.10% Series F cumulative redeemable preferred stock and 253.6 million shares of common stock outstanding.

During the year ended December 31, 2008, we issued approximately 438,000 shares of our common stock under our Dividend Reinvestment and Stock Purchase Plan, at an average price per share of $30.71 for aggregate proceeds of $13.5 million. We also received $11.5 million in proceeds from stock option exercises. At December 31, 2008, stockholders’ equity totaled $5.2 billion and our equity securities had a market value of $3.8 billion.

As of December 31, 2008, there were a total of 4.8 million DownREIT units outstanding in six limited liability companies in which we are the managing member: (i) HCPI/Tennessee, LLC; (ii) HCPI/Utah, LLC; (iii) HCPI/Utah II, LLC; (iv) HCP DR California, LLC; (v) HCP DR Alabama, LLC; and (vi) HCP DR MCD, LLC. The DownREIT units are redeemable for an amount of cash approximating the then- existing market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications). For the year ended December 31, 2008, we issued 3.7 million shares of our common stock upon the conversion of 2.8 million DownREIT units.

Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures, including HCP Ventures II, HCP Ventures III and HCP Ventures IV, as described under Note 8 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 14 to the Consolidated Financial Statements. Our risk of loss for these properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under “Contractual Obligations.”

Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at December 31, 2008 (in thousands):

	Total		Less than One Year		2010-2011		2012-2013		More than Five Years
Senior unsecured notes and mortgage debt	$	5,180,132	$	155,347	$	942,490	$	1,093,987	$	2,988,308
Development commitments(1)	36,460		36,460		—		—		—
Bank line of credit(2)	150,000		—		150,000		—		—
Bridge and term loans	520,000		320,000		200,000		—		—
Ground and other operating leases	176,981		3,638		6,809		6,996		159,538
Other debt(3)	102,209		102,209		—		—		—
Interest	1,862,348		324,163		576,286		459,660		502,239
Total	$	8,028,130	$	941,817	$	1,875,585	$	1,560,643	$	3,650,085

(1) Represents construction and other commitments for developments in progress.

(2) Funds from our bank line of credit were drawn for the early repayment of $120 million of mortgage debt with an original maturity date in January 2009.

(3) Other debt represents non-interest bearing Life Care Bonds and occupancy fee deposits at three of our senior housing facilities, which are payable on-demand, under certain conditions.

Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Substantially all of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

Recent Accounting Pronouncements

See Note 2 to the Consolidated Financial Statements in this report for the impact of new accounting standards.

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk. At December 31, 2008, we were exposed to market risks related to fluctuations in interest rates on approximately $1.0 billion of variable rate mezzanine loans receivable and $111 million investment in leased assets whose rental payments fluctuate with changes in LIBOR. Our exposure to income fluctuations related to our variable rate investments is partially offset by (i) $150 million of variable rate line of credit borrowings, (ii) $520 million of variable rate bridge and term financing, (iii) $197 million of variable rate mortgage notes payable, excluding $46 million variable rate mortgage notes which have been hedged through interest rate swap contracts, and (iv) $25 million of variable rate senior unsecured notes. Of our consolidated debt of $6.0 billion at December 31, 2008, excluding the $46 million of variable rate debt where the rates have been swapped to a fixed rate, $892 million or 15% is at variable interest rates.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt, loans receivable and debt securities unless such instruments mature or are otherwise terminated. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate investments and variable-rate debt, and assuming no change in the outstanding balance as of December 31, 2008, net interest income would improve by approximately $2.2 million, or $0.01 per common share on a diluted basis. Assuming a 50 basis point decrease in interest rates under the above circumstances and taking into consideration that the index underlying many of our arrangements is currently below 50 basis points and is not expected to go below zero, net interest income would decline by $1.1 million.

We use derivative financial instruments in the normal course of business to manage or hedge interest rate risk. We do not use derivative financial instruments for speculative purposes. Derivatives are recorded on the balance sheet at fair value in accordance with SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. See Note 16 to the Consolidated Financial Statements in this report for further information in this regard.

At December 31, 2008, we had three interest rate swap contracts outstanding which are designated in qualifying cash flow hedging relationships. On December 31 2008, the interest rate swap contracts have an aggregate notional amount and fair value of $45.6 million and a $2.3 million liability, respectively. The derivative contracts mature in July 2020 and are currently recognized in accounts payable and accrued liabilities.

To illustrate the effect of movements in the interest rate markets, we performed a market sensitivity analysis on the noted hedging instruments. To do so, we applied various basis point spreads, to the underlying interest rates of the derivative portfolio in order to determine the instruments’ change in fair value. The following table summarizes the analysis performed (dollars in thousands):

		Effects of Change in Interest Rates
Date Entered	Maturity Date	50 Basis Points		-50 Basis Points			100 Basis Points		-100 Basis Points
July 13, 2005	July 15, 2020	$	2,140	$	(2,426	)	$	4,423	$	(4,709	)

Market Risk. We are directly and indirectly affected by changes in the equity and bond markets. We have investments in marketable debt and equity securities classified as available for sale. Gains and losses on these securities are recognized in income when realized and losses are recognized when an other-than-temporary decline in value is identified. The initial indicator of an other-than-temporary decline in value for marketable equity securities is a sustained decline in market price below the carrying value for that investment. We consider a variety of factors in evaluating an

other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our cost; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the stock or bond price, if any. At December 31, 2008, the fair value and cost, or the new basis for those securities where a realized loss was recorded, of marketable equity securities was $3.8 million and $4.2 million, respectively, and the fair value and cost of marketable debt securities was $229 million and $295 million, respectively.

The principal amount and the average interest rates for our loans receivable and debt categorized by maturity dates is presented in the table below. The fair value for our debt securities and senior unsecured notes payable are based on prevailing market prices. The fair value estimates for loans receivable and mortgage debt payable are based on discounting future cash flows utilizing current rates offered to us for loans and debt of the same type and remaining maturity.

	Maturity
	2009		2010		2011		2012		2013		Thereafter		Total		Fair Value
	(dollars in thousands)
Assets:
Loans receivable	$	94,769	$	19,374	$	3,028	$	—	$	1,009,747	$	36,134	$	1,163,052	$	981,128
Weighted average interest rate	13.35%		10.42%		10.34%		—%		5.41%		8.50%		6.25%
Debt securities available for sale	$	—	$	—	$	—	$	—	$	—	$	297,000	$	297,000	$	228,660
Weighted average interest rate	—%		—%		—%		—%		—%		9.60%		9.60%
Liabilities:
Variable-rate debt:
Bank line of credit	$	—	$	—	$	150,000	$	—	$	—	$	—	$	150,000	$	150,000
Weighted average interest rate	—%		—%		1.36%		—%		—%		—%		1.36%
Bridge and term loans	$	320,000	$	—	$	200,000	$	—	$	—	$	—	$	520,000	$	520,000
Weighted average interest rate	2.19%		—%		3.68%		—%		—%		—%		2.76%
Senior unsecured notes payable	$	—	$	—	$	—	$	—	$	—	$	25,000	$	25,000	$	11,470
Weighted average interest rate	—%		—%		—%		—%		—%		2.96%		2.96%
Mortgage debt payable	$	33,324	$	107,407	$	33,695	$	8,532	$	5,518	$	8,955	$	197,431	$	172,118
Weighted average interest rate	3.39%		2.70%		2.93%		3.48%		3.49%		2.08%		2.88%
Fixed-rate debt:
Senior unsecured notes payable	$	—	$	206,421	$	300,000	$	250,000	$	550,000	$	2,212,000	$	3,518,421	$	2,373,018
Weighted average interest rate	—%		4.93%		5.95%		6.45%		5.64%		6.30%		6.18%
Mortgage debt payable	$	122,023	$	191,092	$	103,876	$	52,387	$	227,549	$	742,353	$	1,439,280	$	1,365,938
Weighted average interest rate	6.94%		7.06%		6.31%		6.34%		6.13%		6.04%		6.29%
Other debt(1)	$	102,209	$	—	$	—	$	—	$	—	$	—	$	102,209	$	102,209
Weighted average interest rate	—%		—%		—%		—%		—%		—%		—%

(1)

Other debt represents non-interest bearing Life Care Bonds and occupancy fee deposits at three of our senior housing facilities, which are payable on-demand, under certain conditions.

ITEM 8. Financial Statements and Supplementary Data

See Index to Consolidated Financial Statements included in this report.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

		Page
Report of Independent Registered Public Accounting Firm		F-2
Consolidated Balance Sheets		F-3
Consolidated Statements of Income		F-4
Consolidated Statements of Equity		F-5
Consolidated Statements of Cash Flows		F-6
Notes to Consolidated Financial Statements		F-7
Schedule II: Valuation and Qualifying Accounts		F-45
Schedule III: Real Estate and Accumulated Depreciation		F-46

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of HCP, Inc.

We have audited the accompanying consolidated balance sheets of HCP, Inc. as of December 31, 2008 and 2007, and the related consolidated statements of income, equity, and cash flows for each of the three years in the period ended December 31, 2008. Our audits also include the financial statement schedules-Schedule II: Valuation and Qualifying Accounts and Schedule III: Real Estate and Accumulated Depreciation. These financial statements and schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of HCP, Inc. at December 31, 2008 and 2007, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2008, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedules, when considered in relation to the basic financial statements taken as a whole, present fairly in all material respects the information set forth therein.

As discussed in Note 2 to the consolidated financial statements, as a result of the adoption of Financial Accounting Standards Board (“FASB”) Statement No. 160, “Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51” and FASB Staff Position No. EITF 03-6-1, “Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities” on January 1, 2009, the Company retrospectively adjusted its consolidated financial statements to reflect the presentation and disclosure requirements of these new accounting standards.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), HCP, Inc.’s internal control over financial reporting as of December 31, 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 9, 2009 expressed an unqualified opinion thereon.

	/s/ ERNST & YOUNG LLP
Irvine, California February 9, 2009
except for the Consolidated Balance Sheets, the Consolidated Statements of Income, the Consolidated Statements of Equity, the Consolidated Statements of Cash Flows, Note 2 “Principles of Consolidation” section, “Noncontrolling Interests and Mandatorily Redeemable Financial Instruments” section, “Earnings Per Share” section and “Recent Accounting Pronouncements” section, Note 5 “Properties Held for Sale” and “Results from Discontinued Operations” sections, Note 9 “Intangibles”, Note 14 “Concentration of Credit Risk” section–third and fifth paragraphs, Note 15 “Preferred Stock” section, Note 16 “Segment Disclosures”, Note 18 “Income Taxes–first paragraph” and “Taxable Income Reconciliation” section, Note 23 “Earnings Per Common Share”, Note 25 “Selected Quarterly Financial Data” and “Schedule III: Real Estate and Accumulated Depreciation”, as to which the date is April 27, 2009

F-2

HCP, Inc.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

	December 31,
	2008			2007
ASSETS
Real estate:
Buildings and improvements	$	7,752,714		$	7,478,211
Development costs and construction in progress	224,337			372,314
Land	1,550,219			1,563,965
Less accumulated depreciation and amortization	820,441			598,946
Net real estate	8,706,829			8,815,544
Net investment in direct financing leases	648,234			640,052
Loans receivable, net	1,076,392			1,065,485
Investments in and advances to unconsolidated joint ventures	272,929			248,894
Accounts receivable, net of allowance of $18,413 and $23,109, respectively	34,211			44,892
Cash and cash equivalents	57,562			96,269
Restricted cash	35,078			36,427
Intangible assets, net	505,986			621,716
Real estate held for sale, net	19,799			436,360
Other assets, net	492,806			516,133
Total assets	$	11,849,826		$	12,521,772
LIABILITIES AND EQUITY
Bank line of credit	$	150,000		$	951,700
Bridge and term loans	520,000			1,350,000
Senior unsecured notes	3,523,513			3,819,950
Mortgage debt	1,641,734			1,277,291
Mortgage debt on assets held for sale	—			3,470
Other debt	102,209			108,496
Intangible liabilities, net	232,654			278,143
Accounts payable and accrued liabilities	211,691			238,093
Deferred revenue	60,185			51,649
Total liabilities	6,441,986			8,078,792

Commitments and contingencies

Equity:
Preferred stock, $1.00 par value: 50,000,000 shares authorized; 11,820,000 shares issued and outstanding, liquidation preference of $25 per share	285,173			285,173
Common stock, $1.00 par value: 750,000,000 shares authorized; 253,601,454 and 216,818,780 shares issued and outstanding, respectively	253,601			216,819
Additional paid-in capital	4,873,727			3,724,739
Cumulative dividends in excess of earnings	(130,068		)	(120,920		)
Accumulated other comprehensive loss	(81,162		)	(2,102		)
Total stockholders’ equity	5,201,271			4,103,709

Joint venture partners	12,912			33,436
Non-managing member unitholders	193,657			305,835
Total noncontrolling interests	206,569			339,271
Total equity	5,407,840			4,442,980
Total liabilities and equity	$	11,849,826		$	12,521,772

See accompanying Notes to Consolidated Financial Statements.

F-3

HCP, Inc.

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

	Year Ended December 31,
	2008				2007				2006
Revenues:
Rental and related revenues	$		877,860		$		762,793		$		413,838
Tenant recoveries	82,847				64,854				29,141
Income from direct financing leases	58,149				63,852				15,008
Investment management fee income	5,923				13,581				3,895
Total revenues	1,024,779				905,080				461,882
Costs and expenses:
Depreciation and amortization	314,026				258,947				117,289
Operating	191,941				174,689				78,629
General and administrative	75,600				68,348				46,865
Impairments	18,276				—				2,530
Total costs and expenses	599,843				501,984				245,313
Other income (expense):
Gain on sale of real estate interest	—				10,141				—
Interest and other income, net	156,718				75,576				34,692
Interest expense	(348,402			)	(355,479			)	(211,494			)
Total other income (expense)	(191,684			)	(269,762			)	(176,802			)
Income before income taxes and equity income from unconsolidated joint ventures	233,252				133,334				39,767
Income taxes	(4,307			)	(1,444			)	(245			)
Equity income from unconsolidated joint ventures	3,326				5,645				8,331
Income from continuing operations	232,271				137,535				47,853
Discontinued operations:
Income before impairments and gain on sales of real estate, net of income taxes	18,698				72,252				116,267
Impairments	(9,175			)	—				(7,051			)
Gain on sales of real estate, net of income taxes	229,189				404,328				280,549
Total discontinued operations	238,712				476,580				389,765
Net income	470,983				614,115				437,618
Noncontrolling interests’ and participating securities’ share in earnings	(24,485			)	(27,905			)	(22,807			)
Preferred stock dividends	(21,130			)	(21,130			)	(21,130			)
Net income applicable to common shares	$	425,368			$	565,080			$	393,681
Basic earnings per common share:
Continuing operations	$	0.79			$	0.43			$	0.03
Discontinued operations	1.00				2.29				2.63
Net income applicable to common shares	$	1.79			$	2.72			$	2.66
Diluted earnings per common share:
Continuing operations	$	0.78			$	0.42			$	0.03
Discontinued operations	1.01				2.28				2.62
Net income applicable to common shares	$	1.79			$	2.70			$	2.65
Weighted average shares used to calculate earnings per common share:
Basic	237,301				207,924				148,236
Diluted	237,972				208,920				148,631
Dividends declared per common share	$	1.82			$	1.78			$	1.70

See accompanying Notes to Consolidated Financial Statements.

F-4

HCP, Inc.

CONSOLIDATED STATEMENTS OF EQUITY

(In thousands, except per share data)

												Cumulative			Accumulated
									Additional			Dividends			Other			Total
	Preferred Stock			Common Stock					Paid-In			In Excess			Comprehensive			Stockholders’			Noncontrolling			Total
	Shares	Amount		Shares		Amount			Capital			Of Earnings			Income (Loss)			Equity			Interests			Equity
January 1, 2006	11,820	$	285,173	136,194		$	136,194		$	1,446,349		$	(467,102	)	$	(848	)	$	1,399,766		$	149,284		$	1,549,050
Comprehensive income:
Net income	—	—		—		—			—			417,547			—			417,547			20,071			437,618
Change in net unrealized gains (losses) on securities:
Unrealized gains	—	—		—		—			—			—			24,096			24,096			—			24,096
Less reclassification adjustment realized in net income	—	—		—		—			—			—			(640		)	(640		)	—			(640		)
Change in net unrealized gains (losses) on cash flow hedges:
Unrealized losses	—	—		—		—			—			—			(4,984		)	(4,984		)	—			(4,984		)
Change in Supplemental Executive Retirement Plan obligation	—	—		—		—			—			—			101			101			—			101
Total comprehensive income																								456,191
Issuance of common stock, net	—	—		62,025		62,025			1,648,327			—			—			1,710,352			(6,394		)	1,703,958
Repurchase of common stock	—	—		(50	)	(50		)	(1,458		)	—			—			(1,508		)	—			(1,508		)
Exercise of stock options	—	—		430		430			7,458			—			—			7,888			—			7,888
Amortization of deferred compensation	—	—		—		—			8,232			—			—			8,232			—			8,232
Preferred dividends	—	—		—		—			—			(21,130		)	—			(21,130		)	—			(21,130		)
Common dividends ($1.70 per share)	—	—		—		—			—			(245,684		)	—			(245,684		)	—			(245,684		)
Distributions to noncontrolling interests	—	—		—		—			—			—			—			—			(16,476		)	(16,476		)
Noncontrolling interests in acquired assets	—	—		—		—			—			—			—			—			15,280			15,280
December 31, 2006	11,820	$	285,173	198,599		$	198,599		$	3,108,908		$	(316,369	)	$	17,725		$	3,294,036		$	161,765		$	3,455,801
Comprehensive income:
Net income	—	—		—		—			—			589,015			—			589,015			25,100			614,115
Change in net unrealized gains (losses) on securities:
Unrealized gains	—	—		—		—			—			—			(10,490		)	(10,490		)	—			(10,490		)
Less reclassification adjustment realized in net income	—	—		—		—			—			—			176			176			—			176
Change in net unrealized gains (losses) on cash flow hedges:
Unrealized losses	—	—		—		—			—			—			(9,647		)	(9,647		)	—			(9,647		)
Change in Supplemental Executive Retirement Plan obligation	—	—		—		—			—			—			102			102			—			102
Foreign currency translation adjustment	—	—		—		—			—			—			32			32			—			32
Total comprehensive income																								594,288
Issuance of common stock, net	—	—		17,894		17,894			599,757			—			—			617,651			(3,702		)	613,949
Repurchase of common stock	—	—		(84	)	(84		)	(3,038		)	—			—			(3,122		)	—			(3,122		)
Exercise of stock options	—	—		410		410			7,704			—			—			8,114			—			8,114
Amortization of deferred compensation	—	—		—		—			11,408			—			—			11,408			—			11,408
Preferred dividends	—	—		—		—			—			(21,130		)	—			(21,130		)	—			(21,130		)
Common dividends ($1.78 per share)	—	—		—		—			—			(372,436		)	—			(372,436		)	—			(372,436		)
Distributions to noncontrolling interests	—	—		—		—			—			—			—			—			(22,345		)	(22,345		)
Noncontrolling interests in acquired assets	—	—		—		—			—			—			—			—			180,698			180,698
Purchase of noncontrolling interests	—	—		—		—			—			—			—			—			(2,245		)	(2,245		)
December 31, 2007	11,820	$	285,173	216,819		$	216,819		$	3,724,739		$	(120,920	)	$	(2,102	)	$	4,103,709		$	339,271		$	4,442,980
Comprehensive income:
Net income	—	—		—		—			—			448,495			—			448,495			22,488			470,983
Change in net unrealized gains (losses) on securities:
Unrealized gains	—	—		—		—			—			—			(88,266		)	(88,266		)	—			(88,266		)
Less reclassification adjustment realized in net income	—	—		—		—			—			—			7,230			7,230			—			7,230
Change in net unrealized gains (losses) on cash flow hedges:
Unrealized losses	—	—		—		—			—			—			(1,485		)	(1,485		)	—			(1,485		)
Less reclassification adjustment realized in net income	—	—		—		—			—			—			3,999			3,999			—			3,999
Change in Supplemental Executive Retirement Plan obligation	—	—		—		—			—			—			292			292			—			292
Foreign currency translation adjustment	—	—		—		—			—			—			(830		)	(830		)	—			(830		)
Total comprehensive income																								391,923
Issuance of common stock, net	—	—		36,233		36,233			1,126,769			—			—			1,163,002			(111,467		)	1,051,535
Repurchase of common stock	—	—		(99	)	(99		)	(3,085		)	—			—			(3,184		)	—			(3,184		)
Exercise of stock options	—	—		648		648			11,539			—			—			12,187			—			12,187
Amortization of deferred compensation	—	—		—		—			13,765			—			—			13,765			—			13,765
Preferred dividends	—	—		—		—			—			(21,130		)	—			(21,130		)	—			(21,130		)
Common dividends ($1.82 per share)	—	—		—		—			—			(436,513		)	—			(436,513		)	—			(436,513		)
Distributions to noncontrolling interests	—	—		—		—			—			—			—			—			(28,375		)	(28,375		)
Purchase of noncontrolling interests	—	—		—		—			—			—			—			—			(15,348		)	(15,348		)
December 31, 2008	11,820	$	285,173	253,601		$	253,601		$	4,873,727		$	(130,068	)	$	(81,162	)	$	5,201,271		$	206,569		$	5,407,840

See accompanying Notes to Consolidated Financial Statements.

F-5

HCP, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	Year Ended December 31,
	2008			2007			2006
Cash flows from operating activities:
Net income	$	470,983		$	614,115		$	437,618
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	314,026			258,947			117,289
Discontinued operations	7,210			22,232			36,780
Amortization of above and below market lease intangibles, net	(8,440		)	(6,056		)	(797		)
Stock-based compensation	13,765			11,408			8,232
Amortization of debt premiums, discounts and issuance costs, net	12,267			20,413			14,533
Recovery of loan losses	—			(386		)	—
Straight-line rents	(39,463		)	(49,725		)	(18,210		)
Interest accretion	(27,019		)	(8,739		)	(2,513		)
Deferred rental revenue	13,931			9,027			(518		)
Equity income from unconsolidated joint ventures	(3,326		)	(5,645		)	(8,331		)
Distributions of earnings from unconsolidated joint ventures	6,745			5,264			8,331
Gain on sales of real estate and real estate interest	(229,189		)	(414,469		)	(280,549		)
Gain on early repayment of debt	(2,396		)	—			—
Marketable securities (gains) losses, net	7,230			(2,233		)	(1,861		)
Derivative losses, net	4,577			—			—
Impairments of real estate and intangible assets, net	27,451			—			9,581
Impairments of equity method investments	400			—			—
Changes in:
Accounts receivable	10,681			(13,115		)	1,295
Other assets	(3,713		)	(14,621		)	(8,263		)
Accounts payable and accrued liabilities	(7,023		)	26,634			28,579
Net cash provided by operating activities	568,697			453,051			341,196
Cash flows from investing activities:
Cash used in other acquisitions and development of real estate	(155,531		)	(425,464		)	(480,140		)
Lease commissions and tenant and capital improvements	(59,991		)	(49,669		)	(18,932		)
Proceeds from sales of real estate	639,585			887,218			512,317
Cash used in SEUSA acquisition, net of cash acquired	—			(2,982,689		)	—
Cash used in CRP and CRC mergers, net of cash acquired	—			—			(3,325,046		)
Cash used in purchase of HCP MOP interest, net of cash acquired	—			—			(138,163		)
Contributions to unconsolidated joint ventures	(3,579		)	(3,641		)	—
Distributions in excess of earnings from unconsolidated joint ventures	8,400			478,293			32,115
Purchase of marketable securities	(30,089		)	(26,647		)	(13,670		)
Proceeds from sales of marketable securities	10,700			53,817			7,550
Proceeds from sales of interests in unconsolidated joint ventures	2,855			—			—
Principal repayments on loans receivable and direct financing leases	16,790			104,009			63,535
Investments in loans receivable and direct financing leases	(3,162		)	(923,534		)	(329,724		)
(Increase) decrease in restricted cash	1,349			192			(1,894		)
Net cash provided by (used in) investing activities	427,327			(2,888,115		)	(3,692,052		)
Cash flows from financing activities:
Net borrowings (repayments) under bank line of credit	(801,700		)	327,200			365,900
Repayments of term and bridge loans	(1,030,000		)	(1,904,593		)	(1,901,136		)
Borrowings under term and bridge loans	200,000			2,750,000			2,405,729
Repayments of mortgage debt	(225,316		)	(97,882		)	(66,689		)
Issuance of mortgage debt	579,557			143,421			619,911
Repayments of senior unsecured notes	(300,000		)	(20,000		)	(255,000		)
Issuance of senior unsecured notes	—			1,100,000			1,550,000
Settlement of cash flow hedges, net	(9,658		)	—			(4,354		)
Debt issuance costs	(12,657		)	(27,044		)	(32,313		)
Net proceeds from the issuance of common stock and exercise of options	1,060,538			618,854			989,039
Dividends paid on common and preferred stock	(457,643		)	(393,566		)	(266,814		)
Distributions to noncontrolling interests	(37,852		)	(23,462		)	(16,354		)
Net cash provided by (used in) financing activities	(1,034,731		)	2,472,928			3,387,919
Net increase (decrease) in cash and cash equivalents	(38,707		)	37,864			37,063
Cash and cash equivalents, beginning of year	96,269			58,405			21,342
Cash and cash equivalents, end of year	$	57,562		$	96,269		$	58,405

See accompanying Notes to Consolidated Financial Statements.

F-6

HCP, Inc.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1) Business

HCP, Inc., an S&P 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) which, together with its consolidated entities (collectively, “HCP” or the “Company”), invests primarily in real estate serving the healthcare industry in the United States. The Company acquires, develops, leases, manages and disposes of healthcare real estate and provides financing to healthcare providers.

(2) Summary of Significant Accounting Policies

Use of Estimates

Management is required to make estimates and assumptions in the preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”). These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of HCP, its wholly- owned subsidiaries and joint ventures that it controls, through voting rights or other means. All material intercompany transactions and balances have been eliminated in consolidation.

The Company applies Financial Accounting Standards Board (“FASB”) Interpretation No. 46R, Consolidation of Variable Interest Entities, as revised (“FIN 46R”), for arrangements with variable interest entities. FIN 46R provides guidance on the identification of entities for which control is achieved through means other than voting rights (“variable interest entities” or “VIEs”) and the determination of which business enterprise is the primary beneficiary of the VIE. A variable interest entity is broadly defined as an entity where either (i) the equity investors as a group, if any, do not have a controlling financial interest, or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company consolidates investments in VIEs when the Company is the primary beneficiary of the VIE at either the creation of the variable interest entity or upon the occurrence of a qualifying reconsideration event. Qualifying reconsideration events include, but are not limited to, the modification of contractual arrangements that affects the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. At December 31, 2008, the Company did not consolidate any significant variable interest entities.

The Company uses qualitative and quantitative approaches when determining whether it is (or is not) the primary beneficiary of a VIE. Consideration of various factors includes, but is not limited to, the form of our ownership interest, our representation on the entity’s governing body, the size and seniority of our investment, various cash flow scenarios related to the VIE, our ability to participate in policy making decisions and the rights of the other investors to participate in the decision making process and to replace the Company as manager and/or liquidate the venture, if applicable.

At December 31, 2008, the Company had 80 properties leased to a total of nine tenants that have been identified as VIEs (“VIE tenants”) and a loan to a borrower that has been identified as a VIE. The Company acquired these leases and loan on October 5, 2006 in its merger with CNL Retirement Properties, Inc. (“CRP”). CRP determined it was not the primary beneficiary of these VIEs, and the Company is required to carry forward CRP’s accounting conclusions after the acquisition relative to their primary beneficiary assessments, provided the Company does not believe CRP’s accounting to be in error. The Company believes that its accounting for the VIEs is the appropriate application of FIN46R. On December 21, 2007, the Company made an investment of approximately $900 million in mezzanine loans where each mezzanine borrower has been identified as a VIE. The Company has also determined that it is not the primary beneficiary of these VIEs.

F-7

The carrying amount and classification of the related assets, liabilities and maximum exposure to loss as a result of the Company’s involvement with VIEs are presented below (in thousands):

VIE Type	Maximum Loss Exposure(1)		Asset/Liability Type	Carrying Amount
VIE tenants—operating leases	$	783,714	Lease intangibles, net and straight-line rent receivables	$	36,748
VIE tenants—DFLs	662,148		Net investment in DFLs	212,758
Senior secured loans	79,120		Loans receivable, net	79,120
Mezzanine loans	918,169		Loans receivable, net	918,169

(1) The Company’s maximum loss exposure related to the VIE tenants represents the future minimum lease payments over the remaining term of the respective leases, which may be mitigated by re-leasing the respective properties. The Company’s maximum loss exposure related to loans to VIEs represents the carrying amount of the respective loan.

See Notes 7 and 14 for additional description of the nature, purpose and activities of the Company’s variable interest entities and the Company’s interests therein.

The Company applies Emerging Issues Task Force (“EITF”) Issue 04-5, Investor’s Accounting for an Investment in a Limited Partnership When the Investor is the Sole General Partner and the Limited Partners Have Certain Rights (“EITF 04-5”), to investments in joint ventures. EITF 04-5 provides guidance on the type of rights held by the limited partner(s) that preclude consolidation in circumstances in which the sole general partner would otherwise consolidate the limited partnership in accordance with GAAP. The assessment of limited partners’ rights and their impact on the presumption of control of the limited partnership by the sole general partner should be made when an investor becomes the sole general partner and should be reassessed if (i) there is a change to the terms or in the exercisability of the rights of the limited partners, (ii) the sole general partner increases or decreases its ownership of limited partnership interests, or (iii) there is an increase or decrease in the number of outstanding limited partnership interests. EITF 04-5 also applies to managing member interests in limited liability companies.

Investments in Unconsolidated Joint Ventures

Investments in entities which the Company does not consolidate but for which the Company has the ability to exercise significant influence over operating and financial policies are reported under the equity method of accounting. Under the equity method of accounting, the Company’s share of the investee’s earnings or losses are included in the Company’s consolidated results of operations.

The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the carrying value of the assets prior to the sale of interests in the joint venture. To the extent that the Company’s cost basis is different from the basis reflected at the joint venture level, the basis difference is generally amortized over the life of the related assets and liabilities and included in the Company’s share of equity in earnings of the joint venture. The Company evaluates its equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. When the Company determines a decline in the estimated fair value of an investment in an unconsolidated joint venture below its carrying value is other-than-temporary, an impairment is recorded. The Company recognizes gains on the sale of interests in joint ventures to the extent the economic substance of the transaction is a sale in accordance with the American Institute of Certified Public Accountants Statement of Position 78-9, Accounting for Investments in Real Estate Ventures, and Statement of Financial Accounting Standards (“SFAS”) No. 66, Accounting for Sales of Real Estate (“SFAS No. 66”).

Revenue Recognition

Rental income from tenants is recognized in accordance with GAAP, including SEC Staff Accounting Bulletin No. 104, Revenue Recognition (“SAB 104”). The Company recognizes rental revenue on a straight-line basis over the lease term when collectibility is reasonably assured and the tenant has taken possession or controls the physical use of the leased asset. For assets acquired subject to leases, the Company recognizes revenue upon acquisition of the asset provided the tenant has taken possession or controls the physical use of the leased asset. If the lease provides for tenant improvements, the Company determines whether the tenant improvements, for accounting purposes, are owned by the tenant or the Company. When the Company is the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the physical use of the leased asset until the tenant improvements are substantially completed. When the tenant is the owner of the tenant improvements, any tenant improvement allowance funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term. Tenant improvement ownership is determined based on various factors including, but not limited to:

· whether the lease stipulates how and on what a tenant improvement allowance may be spent;

F-8

· whether the tenant or landlord retains legal title to the improvements at the end of the lease term;

· whether the tenant improvements are unique to the tenant or general- purpose in nature; and

· whether the tenant improvements are expected to have any residual value at the end of the lease.

Certain leases provide for additional rents contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds. Such revenue is recognized in accordance with SAB 104, which requires that income is recognized only after the contingency has been removed (when the related thresholds are achieved), which may result in the recognition of rental revenue in periods subsequent to when such payments are received.

Tenant recoveries related to reimbursement of real estate taxes, insurance, repairs and maintenance, and other operating expenses are recognized as revenue in the period the applicable expenses are incurred. The reimbursements are recognized and presented in accordance with EITF Issue 99-19, Reporting Revenue Gross as a Principal versus Net as an Agent (“EITF 99-19”). EITF 99-19 requires that these reimbursements be recorded gross, as the Company is generally the primary obligor with respect to purchasing goods and services from third-party suppliers, has discretion in selecting the supplier and bears the credit risk.

For leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility is reasonably assured. Recognizing rental income on a straight-line basis for leases results in recognized revenue exceeding amounts contractually due from tenants. Such cumulative excess amounts are included in other assets and were $112 million and $76 million, net of allowances, at December 31, 2008 and 2007, respectively. If the Company determines that collectibility of straight-line rents is not reasonably assured, the Company limits future recognition to amounts contractually owed, and, where appropriate, establishes an allowance for estimated losses.

The Company maintains an allowance for doubtful accounts, including an allowance for straight-line rent receivables, for estimated losses resulting from tenant defaults or the inability of tenants to make contractual rent and tenant recovery payments. The Company monitors the liquidity and creditworthiness of its tenants and operators on an ongoing basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For straight-line rent amounts, the Company’s assessment is based on amounts recoverable over the term of the lease. At December 31, 2008 and 2007, the Company had an allowance of $40.3 million and $35.8 million, respectively, included in other assets, as a result of the Company’s determination that collectibility is not reasonably assured for certain straight-line rent amounts.

The Company receives management fees from its investments in certain joint venture entities for various services provided as the managing member of the entities. Management fees are recorded as revenue when management services have been performed. Intercompany profit for management fees is eliminated.

The Company recognizes gains on sales of properties in accordance with SFAS No. 66 upon the closing of the transaction with the purchaser. Gains on properties sold are recognized using the full accrual method when the collectibility of the sales price is reasonably assured, the Company is not obligated to perform significant activities after the sale, the initial investment from the buyer is sufficient and other profit recognition criteria have been satisfied. Gains on sales of properties may be deferred in whole or in part until the requirements for gain recognition under SFAS No. 66 have been met.

The Company uses the direct finance method of accounting to record income from direct financing leases (“DFLs”). For leases accounted for as DFLs, future minimum lease payments are recorded as a receivable. The difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectibility of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized unearned income.

Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. Loans held-for-investment are carried at amortized cost, reduced by a valuation allowance for estimated credit losses. The Company recognizes interest income on loans, including the amortization of discounts and premiums, using the effective interest method applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums and discounts are recognized as yield adjustments over the life of the related loans. Loans are transferred from held-for-investment to held-for-sale when management’s intent is to no longer hold the loans for the foreseeable future. Loans held-for-sale are recorded at the lower of cost or fair value.

F-9

Allowances are established for loans and DFLs based upon an estimate of probable losses for the individual loans and DFLs deemed to be impaired. Loans and DFLs are impaired when it is deemed probable that the Company will be unable to collect all amounts due on a timely basis in accordance with the contractual terms of the loan or lease. The allowance is based upon the Company’s assessment of the borrower’s or lessee’s overall financial condition, resources and payment record; the prospects for support from any financially responsible guarantors; and, if appropriate, the realizable value of any collateral. These estimates consider all available evidence including, as appropriate, the present value of the expected future cash flows discounted at the loan’s or DFL’s effective interest rate, the fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors.

Real Estate

Real estate, consisting of land, buildings and improvements, is recorded at cost. The Company allocates the cost of the acquisition, including the assumption of liabilities, to the acquired tangible assets and identifiable intangibles based on their estimated fair values in accordance with SFAS No. 141, Business Combinations.

The Company assesses fair value based on estimated cash flow projections that utilize appropriate discount and/or capitalization rates and available market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, and market and economic conditions. The fair value of tangible assets of an acquired property considers the value of the property as if it was vacant.

The Company records acquired “above and below” market leases at fair value using discount rates which reflect the risks associated with the leases acquired. The amount recorded is based on the present value of the difference between (i) the contractual amounts to be paid pursuant to each in-place lease and (ii) management’s estimate of fair market lease rates for each in-place lease, measured over a period equal to the remaining term of the lease for above market leases and the initial term plus the extended term for any leases with below market renewal options. Other intangible assets acquired include amounts for in-place lease values that are based on the Company’s evaluation of the specific characteristics of each tenant’s lease. Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. In estimating carrying costs, the Company includes estimates of lost rents at market rates during the hypothetical expected lease-up periods, which are dependent on local market conditions. In estimating costs to execute similar leases, the Company considers leasing commissions, legal and other related costs.

The Company capitalizes direct construction and development costs, including predevelopment costs, interest, property taxes, insurance and other costs directly related and essential to the acquisition, development or construction of a real estate project. In accordance with SFAS No. 34, Capitalization of Interest Cost, and SFAS No. 67, Accounting for Costs and Initial Rental Operations of Real Estate Projects, construction and development costs are capitalized while substantive activities are ongoing to prepare an asset for its intended use. The Company considers a construction project as substantially complete and held available for occupancy upon the completion of tenant improvements, but no later than one year from cessation of major construction activity. Costs incurred after a project is substantially complete and ready for its intended use, or after development activities have ceased, are expensed as incurred. Costs previously capitalized related to abandoned acquisitions or developments are charged to earnings. Expenditures for repairs and maintenance are expensed as incurred. The Company considers costs incurred in conjunction with re-leasing properties, including tenant improvement and lease commissions, to be the acquisition of productive assets and are reflected as investment activities in the Company’s statement of cash flows.

The Company computes depreciation on properties using the straight-line method over the assets’ estimated useful lives. Depreciation is discontinued when a property is identified as held for sale. Buildings and improvements are depreciated over useful lives ranging up to 45 years. Above and below market lease intangibles are amortized primarily to revenue over the remaining noncancellable lease terms and bargain renewal periods, if any. Other in-place lease intangibles are amortized to expense over the remaining noncancellable lease term and bargain renewal periods, if any.

F-10

Impairment of Long-Lived Assets and Goodwill

The Company assesses the carrying value of real estate assets and related intangibles (“real estate assets”), whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable in accordance with SFAS No. 144, Accounting for the Impairment or Disposal of Long Lived Assets (“SFAS No. 144”). The Company tests its real estate assets for impairment by comparing the sum of the expected undiscounted cash flows to the carrying amount of the real estate asset or asset group. If the carrying value exceeds the expected undiscounted cash flows, an impairment loss will be recognized by adjusting the carrying amount of the real estate assets to its estimated fair value.

Goodwill is tested for impairment by applying the two-step approach defined in SFAS No. 142, Goodwill and Other Intangible Assets, at least annually and whenever the Company identifies triggering events that may indicate impairment. Potential impairment indicators include a significant decline in real estate valuations, restructuring plans or a decline in the Company’s market capitalization below book value. The Company tests for impairment of its goodwill by comparing the fair value of a reporting unit containing goodwill to its carrying value. If the carrying value exceeds the fair value, the second step of the test is needed to measure the amount of potential goodwill impairment. The second step requires the fair value of the reporting unit to be allocated to all the assets and liabilities of the reporting unit as if it had been acquired in a business combination at the date of the impairment test. The excess fair value of the reporting unit over the fair value of assets and liabilities is the implied value of goodwill and is used to determine the amount of impairment. The Company selected the fourth quarter of each fiscal year to perform its annual impairment test.

Assets Held for Sale and Discontinued Operations

Certain long-lived assets are classified as held-for-sale in accordance with SFAS No. 144. Long-lived assets to be disposed of are reported at the lower of their carrying amount or their fair value less cost to sell and are no longer depreciated. Discontinued operations is defined in SFAS No. 144 as a component of an entity that has either been disposed of or is deemed to be held for sale if, (i) the operations and cash flows of the component have been or will be eliminated from ongoing operations as a result of the disposal transaction, and (ii) the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction.

Assets Held for Contribution

Properties classified as held for contribution to joint ventures qualify as held for sale under SFAS No. 144, but are not included in discontinued operations due to the Company’s continuing interest in the ventures.

Stock-Based Compensation

Share-based compensation expense is recognized in accordance with SFAS No. 123R, Share-Based Payments, as revised (“SFAS No. 123R”). On January 1, 2006, the Company adopted SFAS No. 123R using the modified prospective application transition method which provides for only current and future period stock-based awards to be measured and recognized at fair value.

SFAS No. 123R requires all share-based awards granted on or after January 1, 2006 to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Compensation expense for awards with graded vesting is generally recognized ratably over the period from the date of grant to the date when the award is no longer contingent on the employee providing additional services. Prior to the adoption of SFAS No. 123R, the Company applied SFAS No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation—Transition and Disclosure, for stock-based awards granted prior to January 1, 2006.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and short-term investments with original maturities of three months or less when purchased. The Company maintains cash deposits with major financial institutions which periodically exceed the Federal Deposit Insurance Corporation insurance limit. The Company has not experienced any losses to date related to cash or cash equivalents.

Restricted Cash

Restricted cash primarily consists of amounts held by mortgage lenders to provide for (i) future real estate tax expenditures, tenant improvements and capital improvements, and (ii) security deposits and net proceeds from property sales that were executed as tax-deferred dispositions.

F-11

Derivatives

During its normal course of business, the Company uses certain types of derivative instruments for the purpose of managing interest rate risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions.

The Company applies SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended (“SFAS No. 133”). SFAS No. 133 establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and hedging activities. It requires the recognition of all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Company’s consolidated balance sheet at fair value. Changes in the fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting under SFAS No. 133 are recognized in earnings. For derivatives designated as hedging instruments in qualifying hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss) whereas the change in fair value of the ineffective portion is recognized in earnings.

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions or recognized obligations in the balance sheet. The Company also assesses and documents, both at the hedging instrument’s inception and on a quarterly basis thereafter, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows associated with the respective hedged items. When it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, the Company discontinues hedge accounting prospectively and reclassifies amounts recorded to accumulated other comprehensive income (loss) to earnings.

Income Taxes

In 1985, HCP, Inc. elected REIT status and believes it has always operated so as to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue code of 1986, as amended (the “Code”). Accordingly, HCP, Inc. will not be subject to U.S. federal income tax, provided that it continues to qualify as a REIT and makes distributions to stockholders equal to or in excess of its taxable income. On July 27, 2007, the Company formed HCP Life Science REIT, a consolidated subsidiary, which elected REIT status for the year ended December 31, 2007. HCP, Inc., along with its consolidated REIT subsidiary, are each subject to the REIT qualification requirements under Sections 856 to 860 of the Code. If either REIT fails to qualify as a REIT in any taxable year, it will be subject to federal income taxes at regular corporate rates and may be ineligible to qualify as a REIT for four subsequent tax years.

HCP, Inc. and HCP Life Science REIT are subject to state and local income taxes in some jurisdictions, and in certain circumstances each REIT may also be subject to federal excise taxes on undistributed income. In addition, certain activities the Company undertakes must be conducted by entities which elect to be treated as TRSs. TRSs are subject to both federal and state income taxes.

On January 1, 2007, the Company adopted the provisions of Financial Interpretation No. 48, Accounting for Uncertainty in Income Taxes (“FIN 48”). This interpretation clarifies the accounting for uncertain tax positions recognized in a company’s financial statements in accordance with SFAS No. 109, Accounting for Income Taxes. It prescribes a recognition threshold as well as measurement criteria for evaluating tax positions taken or expected to be taken on a tax return. The interpretation also provides guidance on de-recognition of previously recognized positions and the treatment of potential interest and penalties related to uncertain tax positions. The Company recognizes tax penalties relating to unrecognized tax benefits as additional tax expense. Interest relating to unrecognized tax benefits is recognized as interest expense.

Marketable Securities

The Company classifies its marketable equity and debt securities as available- for-sale in accordance with the provisions of SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities. These securities are carried at fair value with unrealized gains and losses recognized in stockholders’ equity as a component of accumulated other comprehensive income (loss). Gains or losses on securities sold are determined based on the specific identification method. When the Company determines declines in fair value of marketable securities are other-than-temporary, a realized loss is recognized in earnings.

F-12

Capital Raising Issuance Costs

Costs incurred in connection with the issuance of common shares are recorded as a reduction in additional paid-in capital. Costs incurred in connection with the issuance of preferred shares are recorded as a reduction of the preferred stock amount. Debt issuance costs are deferred, included in other assets and amortized to interest expense based on the effective interest method over the remaining term of the related debt.

Segment Reporting

The Company reports its consolidated financial statements in accordance with SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information (“SFAS No. 131”). The Company’s segments are based on the Company’s method of internal reporting which classifies its operations by healthcare sector. The Company’s business includes five segments: (i) senior housing, (ii) life science, (iii) medical office, (iv) hospital and (v) skilled nursing.

Prior to the Slough Estates USA Inc. (“SEUSA”) acquisition on August 1, 2007, the Company operated through two reportable segments—triple-net leased and medical office buildings. As a result of the Company’s acquisition of SEUSA, the Company added a significant portfolio of real estate assets under different leasing and property management structures and made corresponding organizational changes. The Company believes the change to its reportable segments is appropriate and consistent with how its chief operating decision maker reviews the Company’s operating results. In addition, in accordance with SFAS No. 131, all prior period segment information has been reclassified to conform to the current presentation.

Noncontrolling Interests and Mandatorily Redeemable Financial Instruments

The Company applies SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB 51 (“SFAS No. 160”), for arrangements with noncontrolling interests. SFAS No. 160 requires that minority interests be recharacterized as noncontrolling interests and be reported as a component of equity separate from the parent’s equity. Purchases or sales of equity interests that do not result in a change in control should be accounted for as equity transactions. In addition, net income attributable to the noncontrolling interest is included in consolidated net income on the face of the income statement and, upon a gain or loss of control, the interest purchased or sold, as well as any interest retained, should be recorded at fair value with any gain or loss recognized in earnings. The Company adopted SFAS No. 160 beginning January 1, 2009, which applies prospectively, except for the presentation and disclosure requirements, which apply retrospectively. The adoption of SFAS No. 160 on January 1, 2009 did not have a material impact on the Company’s consolidated financial position or earnings per share.

As of December 31, 2008, there were 4.8 million non-managing member units outstanding in six limited liability companies, all of which the Company is the managing member: (i) HCPI/Tennessee, LLC; (ii) HCPI/Utah, LLC; (iii) HCPI/Utah II, LLC; (iv) HCP DR California, LLC; (v) HCP DR Alabama, LLC; and (vi) HCP DR MCD, LLC. The Company consolidates these entities since it exercises control and carries the noncontrolling interests at cost. The non-managing member LLC Units (“DownREIT units”) are exchangeable for an amount of cash approximating the then-current market value of shares of the Company’s common stock or, at the Company’s option, shares of the Company’s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company’s common stock, the carrying amount of the DownREIT units is reclassified to stockholders’ equity. In April 2008, as a result of the non-managing member converting its remaining HCPI/Indiana, LLC DownREIT units, HCPI/Indiana, LLC became a wholly-owned subsidiary. At December 31, 2008, the carrying value and market value of the 4.8 million DownREIT units were $193.7 million and $178.8 million, respectively.

SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity (“SFAS No. 150”), requires, among other things, that mandatorily redeemable financial instruments be classified as a liability and recorded at settlement value. Consolidated joint ventures with a limited-life are considered mandatorily redeemable. Implementation of the provisions of SFAS No. 150 that require the valuation and establishment of a liability for limited-life entities was subsequently deferred. As of December 31, 2008, the Company has nine limited-life entities that have a settlement value of the noncontrolling interests of approximately $6.2 million, which is approximately $4.6 million more than the carrying amount.

Preferred Stock Redemptions

The Company recognizes the excess of the redemption value of cumulative redeemable preferred stock redeemed over its carrying amount as a charge to income in accordance with FASB—EITF Topic D-42, The Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock (“EITF Topic D-42”). In July 2003, the SEC staff issued a clarification of the SEC’s position on the application of FASB EITF Topic D-42. The SEC staff’s position, as clarified, is that in applying EITF Topic D-42, the carrying value of preferred shares that are redeemed should be reduced by the amount of original issuance costs, regardless of where in stockholders’ equity those costs are reflected (see Note 15).

F-13

Life Care Bonds Payable

Two of the Company’s continuing care retirement communities (“CCRCs”) issue non-interest bearing life care bonds payable to certain residents of the CCRCs. Generally, the bonds are refundable to the resident or to the resident’s estate upon termination or cancellation of the CCRC agreement. An additional senior housing facility owned by the Company collects non-interest bearing occupancy fee deposits that are refundable to the resident or the resident’s estate upon the earlier of the re-letting of the unit or after two years of vacancy. Proceeds from the issuance of new bonds are used to retire existing bonds, and since the maturity of the obligations for the three facilities is not determinable, no interest is imputed. These amounts are included in other debt in the Company’s consolidated balance sheets.

Fair Value Measurements

Effective January 1, 2008, the Company implemented the requirements of SFAS No. 157, Fair Value Measurements (“SFAS No. 157”), for its financial assets and liabilities. SFAS No. 157 refines the definition of fair value, expands disclosure requirements about fair value measurements and establishes specific requirements as well as guidelines for a consistent framework to measure fair value. SFAS No. 157 defines fair value as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. Further, SFAS No. 157 requires the Company to maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.

SFAS No. 157 specifies a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

· Level 1—quoted prices for identical instruments in active markets;

· Level 2—quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

· Level 3—fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company measures fair value using a set of standardized procedures that are outlined herein for all financial assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but in an inactive or over-the-counter market where significant fluctuations in pricing can occur, the Company consistently applies the dealer (market maker) pricing estimate and classifies the financial asset or liability in Level 2.

If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, a financial asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Black Scholes valuation models.

Based on the guidelines of SFAS No. 157, the Company has amended its techniques used in measuring the fair value of derivative and other financial asset and liability positions. These enhancements include the impact of the Company’s or counterparty’s credit risk on derivatives and other liabilities measured at fair value as well as the election of the mid-market pricing expedient outlined in the standard. The implementation of these enhancements and the adoption of SFAS No. 157 did not have a material impact on the Company’s consolidated financial position or results of operations.

F-14

On February 12, 2008, the FASB postponed the implementation of SFAS No. 157 related to non-financial assets and liabilities until fiscal periods beginning after November 15, 2008. As a result, the Company has not applied the above fair value procedures to its goodwill and long-lived asset impairment analyses during the year ended December 31, 2008. The Company believes that the adoption of SFAS No. 157 for non-financial assets and liabilities will not have a material impact on its consolidated financial position or results of operations upon implementation for fiscal periods beginning after November 15, 2008.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (“SFAS No. 159”). SFAS No. 159 permits all entities to choose to measure eligible items at fair value at specified election dates. SFAS No. 159 was effective as of the beginning of an entity’s first fiscal year after November 15, 2007, and reporting periods thereafter. Currently the Company has not adopted the guidelines of SFAS No. 159 and continues to evaluate whether or not it will in future periods based on industry participant elections and financial reporting consistency with its peers.

Earnings per Share

The Company computes earnings per share in accordance with SFAS No. 128, Earnings Per Share (“SFAS No. 128”). Basic earnings per common share is computed by dividing net income applicable to common shares by the weighted average number of shares of common stock outstanding during the period.

On January 1, 2009, the Company adopted FASB Staff Position (“FSP”) No. EITF 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities (“FSP No. EITF 03-6-1”). FSP No. EITF 03-6-1 addresses whether instruments granted in share-based payment awards are participating securities prior to vesting, and therefore, need to be included in the earnings allocation when computing earnings per share under the two-class method as described in SFAS No. 128. In accordance with FSP EITF No. 03-6-1, unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and shall be included in the computation of earnings per share pursuant to the two-class method. Upon adoption, all prior-period earnings per share data presented was adjusted retrospectively with no material impact.

Recent Accounting Pronouncements

In December 2007, the FASB issued SFAS No. 141R, Business Combinations, as revised (“SFAS No. 141R”). SFAS No. 141R establishes principles and requirements for how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed (including intangibles), and any noncontrolling interest in the acquiree. SFAS No. 141R also provides guidance for recognizing and measuring goodwill acquired in a business combination and determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. SFAS No. 141R is effective for fiscal years beginning after December 15, 2008. The adoption of SFAS No. 141R on January 1, 2009 will require the Company to prospectively expense all transaction costs for business combinations for which the acquisition date is on or subsequent to that date. Retroactive application of SFAS No. 141R to fiscal years preceding the effective date is not permitted. The implementation of this standard on January 1, 2009 could materially impact the Company’s future financial results to the extent that it acquires significant amounts of real estate, as related acquisition costs will be expensed as incurred rather than the Company’s current practice of capitalizing such costs and amortizing them over the estimated useful life of the assets acquired.

In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133 (“SFAS No. 161”). SFAS No. 161 establishes, among other things, the disclosure requirements for derivative instruments and hedging activities. SFAS No. 161 requires entities to provide enhanced disclosures about (i) how and why an entity uses derivative instruments, (ii) how derivative instruments and related hedged

F-15

items are accounted for under SFAS No. 133 and its related interpretations and (iii) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for fiscal years and interim periods beginning after November 15, 2008. The Company does not expect the adoption of SFAS No. 161 on January 1, 2009 to have a material impact on its consolidated financial position or results of operations.

In April 2008, the FASB issued FASB Staff Position (“FSP”) Financial Accounting Standard 142-3, Determination of the Useful Life of Intangible Assets (“FSP FAS 142-3”). FSP FAS 142-3 amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142. In developing assumptions about renewal or extension, FSP FAS 142-3 requires an entity to consider its own historical experience (or, if no experience, market participant assumptions) adjusted for relevant entity-specific factors in paragraph 11 of SFAS No. 142. FSP FAS 142-3 expands the disclosure requirements of SFAS No. 142 and is effective for the Company beginning January 1, 2009. The guidance for determining the useful life of a recognized intangible asset shall be applied prospectively to intangible assets acquired after the effective date. The disclosure requirements shall be applied prospectively to all intangible assets recognized as of, and subsequent to, the effective date. The Company does not expect the adoption of FSP FAS 142-3 on January 1, 2009 to have a material impact on its consolidated financial position or results of operations.

Reclassifications

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. Assets sold or held for sale and associated liabilities have been reclassified on the balance sheets and operating results reclassified from continuing to discontinued operations in accordance with SFAS No. 144 (see Note 5). “Income taxes” have been reclassified from “general and administrative” expenses. In addition, in accordance with SFAS No. 131, all prior period segment information has been reclassified to conform to the current presentation.

(3) Mergers and Acquisitions

Slough Estates USA Inc.

On August 1, 2007, the Company closed its acquisition of SEUSA for aggregate cash consideration of approximately $3.0 billion. SEUSA’s life science portfolio is concentrated in the San Francisco Bay Area and San Diego County.

The calculation of total consideration follows (in thousands):

Payment of aggregate cash consideration	$	2,978,911
Estimated acquisition costs, net of cash acquired	3,800
Purchase price, net of assumed liabilities	2,982,711
Fair value of liabilities assumed, including debt	220,133
Purchase price	$	3,202,844

Under the purchase method of accounting, the assets and liabilities of SEUSA were recorded at their relative fair values as of the date of the acquisition. During the year ended December 31, 2008, the Company revised its initial purchase price allocation of its acquired interest in SEUSA, which resulted in the Company reallocating $51 million among buildings and improvements, development costs and construction in progress, land, intangible assets and investments in and advances to unconsolidated joint ventures from its preliminary allocation at December 31, 2007. The changes from the Company’s initial purchase price allocation did not have a significant impact on the Company’s results of operations for the year ended December 31, 2008.

F-16

The following table summarizes the estimated fair values of the SEUSA assets acquired and liabilities assumed as of the acquisition date of August 1, 2007 (in thousands):

Assets acquired
Buildings and improvements	$	1,664,156
Developments in process	254,626
Land	827,041
Investments in and advances to unconsolidated joint ventures	68,300
Intangible assets	351,500
Other assets	37,221
Total assets acquired	$	3,202,844

Liabilities assumed
Mortgages payable and other debt	$	33,553
Intangible liabilities	147,700
Other liabilities	38,880
Total liabilities assumed	220,133
Net assets acquired	$	2,982,711

In connection with the Company’s acquisition of SEUSA, the Company obtained, from a syndicate of banks, a financing commitment for a $3.0 billion bridge loan under which $2.75 billion was borrowed at closing. See Note 11 for further details.

CNL Retirement Properties, Inc. and CNL Retirement Corp.

On October 5, 2006, HCP acquired CRP. CRP was a REIT that invested primarily in senior housing and medical office buildings located across the United States. At the time of the CRP merger, CRP owned or held an ownership interest in 273 properties in 33 states.

Under the merger agreement with CRP, each share of CRP common stock was exchanged for $11.1293 in cash and 0.0865 of a share of HCP’s common stock, equivalent to approximately $2.9 billion in cash and 22.8 million shares. Fractional shares were paid in cash. The Company financed the cash consideration paid to CRP stockholders and the expenses related to the transaction through a $1.0 billion offering of senior unsecured notes and draw downs under term and bridge loans and a three year revolving line of credit facility. As of January 22, 2007, the term and bridge facilities had been repaid with proceeds from the issuance of senior notes, secured debt and common stock, disposition of certain properties and from real estate joint ventures. Simultaneously with the closing of the merger with CRP, HCP also merged with CNL Retirement Corp. (“CRC”) for aggregate consideration of approximately $120 million, which included the issuance of 4.4 million shares of HCP common stock.

The calculation of the aggregate purchase price for CRP and CRC follows (in thousands):

Cash consideration paid for CRP common shares exchanged	$	2,948,729
Fair value of HCP common shares issued	720,384
CRP and CRC merger consideration	3,669,113
CRP and CRC merger costs	27,983
Additional cash consideration paid to retire debt at closing, net of cash acquired	348,334
Total consideration, net of assumed liabilities	4,045,430
Fair value of liabilities assumed, including debt and noncontrolling interest	1,517,582
Total consideration	$	5,563,012

F-17

Under the purchase method of accounting, the assets and liabilities of CRP and CRC were recorded at their relative fair values as of the date of the acquisition, with amounts paid in the excess of the fair value of the assets acquired recorded as goodwill. The following table summarizes the relative fair values of the CRP and CRC assets acquired and liabilities assumed as of the acquisition date of October 5, 2006 (in thousands):

Assets acquired
Buildings and improvements	$	3,795,046
Land	516,254
Direct financing leases	675,500
Restricted cash	34,566
Intangible assets	417,479
Other assets	72,421
Goodwill	51,746
Total assets acquired	$	5,563,012

Liabilities assumed
Mortgages payable and other debt	$	1,299,109
Intangible liabilities	137,507
Other liabilities	75,705
Noncontrolling interests	5,261
Total liabilities assumed and noncontrolling interests	1,517,582
Net assets acquired	$	4,045,430

CRC maintained change-in-control provisions with certain of its employees that allowed for enhanced severance and benefit payments. Included in the acquired assets and assumed liabilities are intangible assets associated with employee non-compete agreements and a non-compete agreement with CNL Financial Group, CNL Real Estate Group and two other named individuals valued at $24 million. The value recorded for the non-compete agreements is being amortized over the non-compete contract period of four years.

The related assets, liabilities and results of operations of CRP, CRC and SEUSA are included in the consolidated financial statements from the respective dates of acquisition.

Pro Forma Results of Operations

The following unaudited pro forma consolidated results of operations for the year ended December 31, 2007 assume that the acquisition of SEUSA was completed as of January 1, 2007 as shown below (in thousands, except per share amounts):

Revenues	$	1,019,262
Net income	478,026
Basic earnings per common share	$	2.06
Diluted earnings per common share	2.05

Pro forma data may not be indicative of the results that would have been obtained had the acquisition actually occurred as of January 1, 2007, nor does it intend to be a projection of future results.

(4) Acquisitions of Real Estate Properties

During the year ended December 31, 2008, the Company acquired a senior housing facility for $11 million, purchased a joint venture interest valued at $29 million and funded an aggregate of $158 million for construction, and other capital projects, primarily in the Company’s life science segment. During 2008, three of the Company’s life science facilities located in South San Francisco were placed into service.

F-18

A summary of acquisitions for the year ended December 31, 2007, excluding SEUSA (Note 3), follows (in thousands):

	Consideration								Assets Acquired
Acquisitions(1)	Cash Paid		Real Estate		Debt Assumed		DownREIT Units(2)		Real Estate		Net Intangibles
Medical office	$	166,982	$	—	$	—	$	93,887	$	247,996	$	12,873
Hospitals	120,562		35,205		—		84,719		235,084		5,402
Life science	35,777		—		12,215		2,092		48,237		1,847
Senior housing	15,956		340		5,148		—		20,772		672
	$	339,277	$	35,545	$	17,363	$	180,698	$	552,089	$	20,794

(1) Includes transaction costs, if any.

(2) Non-managing member LLC units.

In addition to the SEUSA acquisition discussed in Note 3, during the year ended December 31, 2007, the Company acquired properties aggregating $573 million, including the following significant acquisitions:

On January 31, 2007, the Company acquired three long-term acute care hospitals and received proceeds of $36 million in exchange for 11 skilled nursing facilities (“SNFs”) valued at approximately $77 million. The Company recognized a gain of $47 million on the sale of these 11 SNFs. The three acquired properties have an initial lease term of ten years with two ten-year renewal options and escalators based on the lessee’s revenue growth. The acquired properties are included in a new master lease that contains 14 properties leased to the same operator.

On February 9, 2007, the Company acquired a medical campus that includes two hospital towers, six medical office buildings (“MOB”) and three parking garages for approximately $350 million, including DownREIT units valued at $179 million.

In November and December 2007, the Company acquired three life science facilities with an aggregate value of approximately $46 million, including $12 million of assumed debt.

For the year ended December 31, 2007, the Company funded an aggregate of $150 million for construction, tenant and capital improvements projects.

(5) Dispositions of Real Estate, Real Estate Interests and Discontinued Operations

Dispositions of Real Estate

During the year ended December 31, 2008, the Company sold 51 properties for approximately $643 million and recognized a gain on sales of real estate of $229 million. The Company’s sales of properties were made from the following segments: (i) $427 million of hospital, (ii) $97 million of skilled nursing, (iii) $95 million of medical office and (iv) $24 million of senior housing. The hospitals sold included a hospital located in Tarzana, California, which was sold for $89 million resulting in a gain on sale of real estate of $18 million.

During the year ended December 31, 2007, the Company sold 97 properties for $922 million and recognized gains on sales of real estate of approximately $404 million. The Company’s sales of properties were made from the following segments: (i) $641 million of skilled nursing, (ii) $243 million of senior housing and (iii) $38 million of medical office.

Dispositions of Real Estate Interests

On January 5, 2007, the Company formed a senior housing joint venture (“HCP Ventures II”), which included 25 properties valued at $1.1 billion and encumbered by a $686 million secured debt facility. The 25 properties included in this joint venture were acquired in the Company’s acquisition of CRP and were classified as held for contribution within three months from the close of the CRP acquisition. These assets were not depreciated or amortized prior to their contribution, as these assets were held for contribution, and the value allocated to these assets was based on the disposition proceeds received. The Company received approximately $280 million in proceeds, including a one-time acquisition fee of $5.4 million, which is included in investment management fee income. No gain or loss was recognized for the sale of a 65% interest in this joint venture. The Company acts as the managing member and receives asset management fees.

F-19

On April 30, 2007, the Company formed a MOB joint venture, HCP Ventures IV, LLC (“HCP Ventures IV”), which included 55 properties valued at approximately $585 million and encumbered by $344 million of secured debt. Upon the disposition of an 80% interest in this venture, the Company received proceeds of $196 million, including a one-time acquisition fee of $3 million, which is included in investment management fee income, and recognized a gain of $10.1 million. The Company acts as the managing member and receives asset management fees.

Properties Held for Sale

At December 31, 2008 and 2007, the number of assets held for sale was nine and 60 with carrying amounts of $19.8 million and $436.4 million, respectively.

Results from Discontinued Operations

The following table summarizes operating income from discontinued operations, impairments and gains on sales of real estate included in discontinued operations (dollars in thousands):

	Year Ended December 31,
	2008		2007		2006
Rental and related revenues	$	35,221	$	112,682	$	164,772
Other revenues	52		3,135		3,790
Total revenues	35,273		115,817		168,562
Depreciation and amortization expenses	7,210		22,232		36,780
Operating expenses	7,593		12,384		10,627
Other costs and expenses	1,772		8,949		4,888
Operating income from discontinued operations, net	$	18,698	$	72,252	$	116,267
Impairments	$	9,175	$	—	$	7,051
Gains on sales of real estate, net	$	229,189	$	404,328	$	280,549
Number of properties held for sale	9		60		157
Number of properties sold	51		97		83
Number of properties included in discontinued operations	60		157		240

(6) Net Investment in Direct Financing Leases

The components of net investment in direct financing leases (“DFLs”) consisted of the following (dollars in thousands):

	Year Ended December 31,
	2008			2007
Minimum lease payments receivable	$	1,373,283		$	1,414,116
Estimated residual values	467,248			468,769
Less unearned income	(1,192,297		)	(1,242,833		)
Net investment in direct financing leases	$	648,234		$	640,052
Properties subject to direct financing leases	30			30

The DFLs were acquired in the Company’s merger with CRP. CRP determined that these leases were DFLs, and the Company is required to carry forward CRP’s accounting conclusions after the acquisition date relative to their assessment of these leases, provided that the Company does not believe CRP’s accounting to be in error. The Company believes that its accounting for the leases is the appropriate accounting in accordance with GAAP. Certain leases contain provisions that allow the tenants to elect to purchase the properties during or at the end of the lease terms for the aggregate initial investment amount plus adjustments, if any, as defined in the lease agreements. Certain leases also permit the Company to require the tenants to purchase the properties at the end of the lease terms.

Lease payments due to the Company relating to three land-only DFLs, along with the land, with a carrying value of $58 million at December 31, 2008, are subordinate to and serve as collateral for first mortgage construction loans entered into by the tenants to fund development costs related to the properties. During the three months ended December 31, 2008, the Company determined that two of these DFLs were impaired and is recognizing income on a cost-recovery basis. At December 31, 2008, the carrying value of these two DFLs was $38 million.

F-20

During the year ended December 31, 2007, two DFL tenants exercised purchase options with the Company receiving proceeds of $51 million. The proceeds received in excess of the carrying value of the DFLs were $4 million are included in income from direct financing leases.

Future minimum lease payments contractually due under direct financing leases at December 31, 2008, were as follows (in thousands):

Year	Amount
2009	$	48,741
2010	50,131
2011	51,434
2012	52,774
2013	49,350
Thereafter	1,120,853
	$	1,373,283

(7) Loans Receivable

The following table summarizes the Company’s loans receivable (in thousands):

	December 31,
	2008								2007
	Real Estate Secured		Other			Total			Real Estate Secured		Other			Total
Mezzanine	$	—	$	999,891		$	999,891		$	—	$	1,000,000		$	1,000,000
Joint venture partners	—		7,055			7,055			—		7,055			7,055
Other	71,224		76,725			147,949			69,126		86,285			155,411
Unamortized discounts, fees and costs	—		(78,262		)	(78,262		)	—		(96,740		)	(96,740		)
Loan loss allowance	—		(241		)	(241		)	—		(241		)	(241		)
	$	71,224	$	1,005,168		$	1,076,392		$	69,126	$	996,359		$	1,065,485

Following is a summary of loans receivable secured by real estate at December 31, 2008 (in thousands):

Final Payment Due	Number of Loans	Payment Terms	Initial Principal Amount		Carrying Amount
2009	2	Monthly interest and principal payments of $19,000 at 11.00% secured by a skilled nursing facility in Montana and monthly interest-only payments of $24,000, at 6.00% secured by two assisted living facilities in Georgia and South Carolina.	$	6,700	$	6,686
2009	1	Monthly interest payments of $24,000 at 9.00% secured by an assisted living facility in Alabama.	3,200		3,200
2010	1	Monthly principal and interest payments of $189,000 at 11.10% secured by two skilled nursing facilities in Colorado.	18,397		13,146
2011	1	Monthly principal and interest payments of $37,000 at 10.34% secured by an assisted living facility in North Carolina.	3,859		3,028
2013	1	Monthly interest payments of $33,000 at 4.00% secured by an assisted living facility in Texas.	10,000		9,856
2016	1	Monthly interest payments of $250,000 at 8.50% secured by a hospital in Texas.	35,308		35,308
	7		$	77,464	$	71,224

At December 31, 2008, minimum future principal payments to be received on loans receivable, including those secured by real estate, are $95.7 million in 2009, $18.6 million in 2010, $2.8 million in 2011, $1.01 billion in 2013 and $36.1 million thereafter.

On October 5, 2006, through its merger with CRP, the Company assumed an agreement to provide an affiliate of the Cirrus Group, LLC with an interest-only, senior secured term loan. The loan provides for a maturity date of December 31, 2008, with a one-year extension at the option of the borrower, subject to certain conditions, under which amounts were borrowed to finance the acquisition, development, syndication and operation of new and existing surgical partnerships. This

F-21

loan accrues interest at a rate of 14.0%, of which 9.5% is payable monthly and the balance of 4.5% is deferred until maturity. The loan is subject to equity contribution requirements, borrower financial covenants, is collateralized by assets of the borrower (comprised primarily of interests in partnerships operating surgical facilities, some of which are on the premises of properties owned by HCP Ventures IV or the Company) and is guaranteed up to $34.6 million through a combination of (i) a personal guarantee of up to $9.0 million by a principal of Cirrus, and (ii) a guarantee of the balance by other principals of Cirrus under arrangements for recourse limited only to their interests in certain entities owning real estate. During the year ended December 31, 2008, the borrower made principal payments aggregating $11.8 million reducing the carrying value of this loan to $79 million at December 31, 2008. At December 31, 2008, the borrower did not meet the conditions necessary to exercise its extension option and new terms are being negotiated. The Company has determined the loan to be impaired but no allowance has been provided based on the value of the collateral underlying the loan.

On July 12, 2007, the Company received $44 million in proceeds, including $4 million in excess of the carrying value upon the early repayment of a secured loan receivable due December 28, 2015. The amount received in excess of the carrying value of the secured loan receivable is included in interest and other income. This loan was secured by a hospital in Texas and carried an interest rate of 8.75% per annum.

On December 21, 2007, the Company made an investment in mezzanine loans having an aggregate face value of $1.0 billion, for approximately $900 million, as part of the financing for The Carlyle Group’s $6.3 billion purchase of HCR ManorCare. These interest-only loans mature in January 2013 and bear interest on their face amounts at a floating rate of one-month LIBOR plus 4.0%. These loans are mandatorily pre-payable in January 2012 unless the borrower satisfies certain financial conditions. The loans are secured by an indirect pledge of equity ownership in 339 HCR ManorCare facilities located in 30 states and are subordinate to other debt of approximately $3.6 billion at closing. At December 31, 2008, the carrying amount of these loans was $918 million.

(8) Investments in and Advances to Unconsolidated Joint Ventures

The Company owns interests in the following entities which are accounted for under the equity method at December 31, 2008 (dollars in thousands):

Entity(1)	Properties	Investment(2)			Ownership %
HCP Ventures II	25 senior housing facilities	$	141,632		35
HCP Ventures III, LLC	13 MOBs	11,502			30
HCP Ventures IV, LLC	54 MOBs and 4 hospitals	45,567			20
HCP Life Science(3)	4 life science facilities	66,124			50-63
Suburban Properties, LLC	1 MOB	4,216			67
Advances to unconsolidated joint ventures, net		3,888
		$	272,929
Edgewood Assisted Living Center, LLC(4)(5)	1 senior housing facility	$	(410	)	45
Seminole Shores Living Center, LLC(4)(5)	1 senior housing facility	(884		)	50
		$	(1,294	)

(1) These joint ventures are not consolidated since the Company does not control, through voting rights or other means, the joint ventures. See Note 2 regarding the Company’s policy on consolidation.

(2) Represents the carrying value of the Company’s investment in the unconsolidated joint venture. See Note 2 regarding the Company’s policy for accounting for joint venture interests.

(3) Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships: (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%). The unconsolidated joint ventures were acquired as part of the Company’s purchase of SEUSA on August 1, 2007.

(4) As of December 31, 2008, the Company has guaranteed in the aggregate $4 million of a total of $8 million of notes payable for these joint ventures. No amounts have been recorded related to these guarantees at December 31, 2008.

(5) Negative investment amounts are included in accounts payable and accrued liabilities.

F-22

Summarized combined financial information for the Company’s unconsolidated joint ventures follows (in thousands):

	December 31,
	2008		2007
Real estate, net	$	1,703,308	$	1,752,279
Other assets, net	184,297		195,731
Total assets	$	1,887,605	$	1,948,010
Notes payable	$	1,172,702	$	1,192,270
Accounts payable	39,883		45,970
Other partners’ capital	488,860		511,290
HCP’s capital(1)	186,160		198,480
Total liabilities and partners’ capital	$	1,887,605	$	1,948,010

	Year Ended December 31,
	2008(2)			2007(2)(3)		2006(2)(4)
Total revenues	$	182,543		$	154,748	$	78,475
Discontinued operations	—			—		20,512
Net income (loss)	(1,720		)	8,532		24,402
HCP’s equity income (loss)	3,326			5,645		8,331
Fees earned by HCP	5,923			13,581		3,895
Distributions received, net	15,145			483,557		40,446

(1) Aggregate basis difference of the Company’s investments in these joint ventures of $82 million, as of December 31, 2008, is primarily attributable to real estate and related intangible assets.

(2) Includes the financial information of Arborwood Living Center, LLC and Greenleaf Living Centers, LLC, which were sold on April 3, 2008 and June 12, 2008, respectively.

(3) Includes the results of operations from HCP Ventures II, whose combined entities were wholly-owned consolidated subsidiaries of the Company prior to January 5, 2007. Includes the results of operations from HCP Ventures IV, LLC, whose subsidiaries were wholly-owned consolidated subsidiaries of the Company prior to April 30, 2007.

(4) Includes the results of HCP Medical Office Properties, LLC (“HCP MOP”), which was consolidated beginning on November 30, 2006. Includes the results of operations from HCP Ventures III, LLC, whose subsidiaries were wholly-owned consolidated subsidiaries of the Company prior to October 27, 2006.

(9) Intangibles

At December 31, 2008 and 2007, intangible lease assets, comprised of lease-up intangibles, above market tenant lease intangibles, below market ground lease intangibles and intangible assets related to non-compete agreements, were $680.0 million and $722.5 million, respectively. At December 31, 2008 and 2007, the accumulated amortization of intangible assets was $174.0 million and $100.8 million, respectively. The remaining weighted average amortization period of intangible assets was 10 years at December 31, 2008 and 2007.

At December 31, 2008 and 2007, below market lease intangibles and above market ground lease intangibles were $293.4 million and $311.0 million, respectively. At December 31, 2008 and 2007, the accumulated amortization of intangible liabilities was $60.7 million and $32.9 million, respectively. The remaining weighted average amortization period of unfavorable market lease intangibles is approximately 9 and 10 years at December 31, 2008 and 2007, respectively.

For the years ended December 31, 2008, 2007 and 2006, rental income includes additional revenues of $8.8 million, $6.3 million and $1.5 million, respectively, from the amortization of net below market lease intangibles. For the years ended December 31, 2008, 2007 and 2006, the Company recognized amortization expenses of $74.6 million, $58.8 million and $18.2 million, respectively, from the amortization of other intangible assets. For the years ended December 31, 2008, 2007 and 2006, operating expense includes additional expense of $0.4 million, $0.2 million and $0.7 million, respectively, primarily from the amortization of net above market ground lease intangibles.

F-23

Estimated aggregate amortization of intangible assets and liabilities for each of the five succeeding fiscal years and thereafter follows (in thousands):

	Intangible Assets		Intangible Liabilities		Net Intangible Amortization
2009	$	83,182	$	32,186	$	50,996
2010	69,479		27,673		41,806
2011	51,982		23,682		28,300
2012	46,335		22,792		23,543
2013	44,085		22,241		21,844
Thereafter	210,923		104,080		106,843
	$	505,986	$	232,654	$	273,332

(10) Other Assets

The Company’s other assets consisted of the following (in thousands):

	December 31,
	2008		2007
Marketable debt securities	$	228,660	$	289,163
Marketable equity securities	3,845		13,933
Goodwill	51,746		51,746
Straight-line rent assets, net	112,038		76,188
Deferred debt issuance costs, net	23,512		16,787
Other	73,005		68,316
Total other assets	$	492,806	$	516,133

The cost or amortized cost, estimated fair value and gross unrealized gains and losses on marketable securities follows (in thousands):

					Gross Unrealized
	Cost(1)		Fair Value		Gains		Losses
December 31, 2008:
Debt securities	$	295,138	$	228,660	$	—	$	(66,478	)
Equity securities	4,181		3,845		—		(336		)
Total investments	$	299,319	$	232,505	$	—	$	(66,814	)
December 31, 2007:
Debt securities	$	275,000	$	289,163	$	14,663	$	(500	)
Equity securities	13,874		13,933		300		(241		)
Total investments	$	288,874	$	303,096	$	14,963	$	(741	)

(1) Represents the original cost basis of the marketable securities reduced by other-than-temporary impairments recorded through earnings, if any.

Marketable securities with unrealized losses at December 31, 2008 are not considered to be other-than-temporarily impaired as the Company has the intent and ability to hold these investments for a period of time sufficient to allow for an anticipated recovery in fair value. The Company’s marketable debt securities accrue interest ranging from 9.25% to 9.625%, and mature between November 2016 and May 2017.

During the year ended December 31, 2008, the Company purchased $32 million of senior secured notes for $30 million that accrue interest at 9.625% and mature on November 15, 2016. During the year ended December 31, 2008 and 2007, the Company sold marketable debt securities for $11 million and $49 million, which resulted in gains of approximately $0.7 million and $3.9 million, respectively. During the years ended December 31, 2008, 2007 and 2006, the Company realized gains from the sale of various marketable equity securities totaling $0.2 million, $0.5 million and $2.0 million, respectively. During the years ended December 31, 2008 and 2007, the Company also recognized losses related to an other-than-temporary decline in the value of marketable equity securities of $8.1 million and $4.1 million, respectively. Gains and losses on marketable securities are included in interest and other income, net.

F-24

On July 30, 2008, the Company received and recognized lease termination income of $18 million from a tenant in connection with the early termination of three leases in its life science segment. Upon termination of the leases, the Company recognized an impairment of $4 million related to intangible assets associated with these leases.

(11) Debt

Bank Line of Credit and Bridge and Term Loans

In connection with the completion of the SEUSA acquisition, on August 1, 2007, the Company terminated its former $1.0 billion line of credit facility and closed on a $2.75 billion bridge loan and a $1.5 billion revolving line of credit facility with a syndicate of banks. The Company incurred a charge of $6.2 million related to the write-off of unamortized loan fees associated with its previous line of credit facility in the year ended December 31, 2007.

The Company’s revolving line of credit facility with a syndicate of banks provided for an aggregate borrowing capacity of $1.5 billion at December 31, 2008. This revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 0.325% to 1.00%, depending upon the Company’s debt ratings. The Company pays a facility fee on the entire revolving commitment ranging from 0.10% to 0.25%, depending upon its debt ratings. Based on the Company’s debt ratings at December 31, 2008, the margin on the revolving line of credit facility was 0.55% and the facility fee was 0.15%. The Company’s revolving line of credit facility matures on August 1, 2011. At December 31, 2008, the Company had $150 million outstanding under this revolving line of credit facility with a weighted-average effective interest rate of 1.36%.

At December 31, 2008, the outstanding balance of the Company’s bridge loan was $320 million. The bridge loan had an initial maturity date of July 31, 2008 that has been extended to July 30, 2009 through the exercise of two extension options. This bridge loan accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 0.425% to 1.25%, depending upon the Company’s debt ratings (weighted-average effective interest rate of 2.19% at December 31, 2008). Based on the Company’s debt ratings at December 31, 2008, the margin on the bridge loan facility was 0.70%.

The Company’s revolving line of credit facility and bridge loan contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. A portion of these financial covenants become more restrictive through the period ending March 31, 2009. Among other things, these covenants, using terms defined in the agreement (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 65%, (iii) require a Fixed Charge Coverage ratio of 1.75 times, and (iv) require a formula-determined Minimum Consolidated Tangible Net Worth of $4.2 billion at December 31, 2008. At December 31, 2008, the Company was in compliance with each of these restrictions and requirements of the revolving line of credit facility and bridge loan.

On October 24, 2008, the Company entered into a credit agreement with a syndicate of banks for a $200 million unsecured term loan, which matures on August 1, 2011. The term loan accrues interest at a rate per annum equal to LIBOR plus a margin ranging from 1.825% to 2.375%, depending upon the Company’s debt ratings (weighted-average effective interest rate of 3.68% at December 31, 2008). Based on the Company’s debt ratings on December 31, 2008, the margin on the term loan is 2.00%. The Company received net proceeds of $197 million, which were used to repay a portion of its outstanding indebtedness under the bridge loan facility. The term loan contains certain financial restrictions and other customary requirements, similar to those included in the revolving line of credit and bridge loan. At December 31, 2008, the Company was in compliance with each of these restrictions and requirements of the term loan.

Senior Unsecured Notes

At December 31, 2008, the Company had $3.5 billion in aggregate principal amount of senior unsecured notes outstanding. Interest rates on the notes ranged from 2.90% to 7.07% at December 31, 2008. The weighted-average effective interest rate on the senior unsecured notes at December 31, 2008 and 2007, was 6.25% and 6.18%, respectively. Discounts and premiums are amortized to interest expense over the term of the related debt.

On January 22, 2007, the Company issued $500 million in aggregate principal amount of 6.00% senior unsecured notes due in 2017. The notes were priced at 99.323% of the principal amount for an effective yield of 6.09%. The Company received net proceeds of approximately $493 million, which were used to repay its former term loan facility and reduce outstanding borrowings under its revolving line of credit facility.

F-25

On October 15, 2007, the Company issued $600 million in aggregate principal amount of 6.70% senior unsecured notes due in 2018. The notes were priced at 99.793% of the principal amount for an effective yield of 6.73%. The Company received net proceeds of approximately $595 million, which were used to repay outstanding borrowings under the Company’s bridge loan.

In September 2008, the Company repaid $300 million of maturing senior unsecured notes which accrued interest based on the three-month LIBOR plus 0.45%. The notes were repaid with funds available under the Company’s revolving line of credit facility.

The following is a summary of senior unsecured notes outstanding at December 31, 2008 (dollars in thousands):

Year Issued	Maturity	Principal Amount			Contractual Interest Rate	��
1995	2010	$	6,421		6.62%
2005	2010	200,000			4.88
2006	2011	300,000			5.95
2002	2012	250,000			6.45
2006	2013	550,000			5.63-5.65
2004	2014	87,000			2.90-6.00
2003	2015	200,000			6.00
1998	2015	200,000			7.07
2006	2016	400,000			6.30
2005	2017	250,000			5.63
2007	2017	500,000			6.00
2007	2018	600,000			6.70
		3,543,421
Net discounts		(19,908		)
		$	3,523,513

The senior unsecured notes contain certain covenants including limitations on debt, cross-acceleration provisions and other customary terms. As of December 31, 2008, the Company was in compliance with these covenants.

Mortgage Debt

At December 31, 2008, the Company had $1.6 billion in mortgage debt secured by 198 healthcare facilities with a carrying amount of $2.8 billion. Interest rates on the mortgage notes ranged from 1.03% to 8.63% with a weighted-average effective interest rate of 6.10% at December 31, 2008.

The following is a summary of mortgage debt outstanding by maturity date at December 31, 2008 (dollars in thousands):

Maturity	Amount		Weighted Average Interest Rate
2009	$	133,217	6.12%
2010	282,028		5.24
2011	121,813		5.44
2012	42,076		5.81
2013	230,029		6.05
2014	209,684		5.89
2015	294,975		5.71
2016	251,751		6.52
2019	4,831		5.20
Thereafter	66,307		5.73
	1,636,711
Net premiums	5,023
	$	1,641,734

F-26

In April 2007, in anticipation of the formation of HCP Ventures IV, $122 million of 10-year term mortgage notes were placed with an interest rate of 5.53%. The proceeds from the placement of these notes were used to repay borrowings under the Company’s previous $1.0 billion revolving line of credit facility and for other general corporate purposes.

In May 2008, the Company placed $259 million of seven-year mortgage financing on 21 of its senior housing assets through Federal National Mortgage Association (“Fannie Mae”). The assets are cross-collateralized and the debt has a fixed interest rate of 5.83%. The Company received net proceeds aggregating $254 million, which were used to repay outstanding indebtedness under the revolving line of credit facility and bridge loan.

In September 2008, the Company placed mortgage financing on its senior housing assets through Fannie Mae aggregating $319 million, which was comprised of $140 million of five-year mortgage financing on four assets and $179 million of eight-year financing on 12 assets. The assets are cross-collateralized and the debt has a weighted-average fixed interest rate of 6.39%. The Company received net proceeds aggregating $312 million, which were used to repay its outstanding indebtedness under the revolving line of credit facility.

On December 19, 2008, the Company recognized a gain of $2.4 million related to the negotiated early repayment of $120 million of mortgage debt, at a discount, with an original maturity of January 27, 2009. The mortgage debt was repaid with funds available under our revolving line of credit facility.

Other Debt

At December 31, 2008, the Company had $102.2 million of non-interest bearing Life Care Bonds at two of its CCRCs and non-interest bearing occupancy fee deposits at another of its senior housing facilities, all of which were payable to certain residents of the facilities (collectively “Life Care Bonds”). At December 31, 2008, $42.4 million of the Life Care Bonds were refundable to the residents upon the resident moving out or to their estate upon death, and $59.8 million of the Life Care Bonds were refundable after the unit is successfully remarketed to a new resident.

Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments, excluding debt premiums and discounts, at December 31, 2008 (in thousands):

Year	Bank Line of Credit(1)		Bridge and Term Loans		Senior Unsecured Notes		Mortgage Debt		Other Debt(2)		Total
2009	$	—	$	320,000	$	—	$	155,347	$	102,209	$	577,556
2010	—		—		206,421		298,499		—		504,920
2011	150,000		200,000		300,000		137,570		—		787,570
2012	—		—		250,000		60,919		—		310,919
2013	—		—		550,000		233,068		—		783,068
Thereafter	—		—		2,237,000		751,308		—		2,988,308
	$	150,000	$	520,000	$	3,543,421	$	1,636,711	$	102,209	$	5,952,341

(1) Funds from the Company’s bank line of credit were drawn to repay $120 million of mortgage debt with an original maturity of January 27, 2009.

(2) Other debt represents non-interest bearing Life Care Bonds and occupancy fee deposits at three of the Company’s senior housing facilities, which are payable on-demand, under certain conditions.

(12) Fair Value Measurements

The following tables illustrate the Company’s fair value measurements of its financial assets and liabilities measured at fair value in the Company’s consolidated financial statements. The second table includes the associated unrealized and realized gains and losses, as well as purchases, sales, issuances, settlements (net) or transfers for financial instruments classified as Level 3 instruments within the fair value hierarchy. Realized gains and losses are recorded in interest and other income, net on the Company’s consolidated statements of income.

F-27

The following is a summary of fair value measurements at December 31, 2008 (in thousands):

Financial Instrument	Fair Value			Level 1		Level 2			Level 3
Marketable equity securities	$	3,845		$	3,845	$	—		$	—
Marketable debt securities	228,660			216,060		12,600			—
Interest rate swaps(1)	(2,324		)	—		(2,324		)	—
Warrants(1)	1,460			—		—			1,460
	$	231,641		$	219,905	$	10,276		$	1,460

(1) Interest rate swaps and common stock warrants are valued using observable and unobservable market assumptions, as well as standardized derivative pricing models.

The following is a reconciliation of fair value measurements classified as Level 3 at December 31, 2008 (in thousands):

	Warrants
December 31, 2007	$	2,560
Total gains (losses) (realized and unrealized):
Included in earnings	(1,100		)
Included in other comprehensive income	—
Purchases, issuances, and settlements	—
Transfers in and/or out of Level 3	—
December 31, 2008	$	1,460

(13) Disclosures About Fair Value of Financial Instruments

The carrying amounts of cash and cash equivalents, restricted cash, receivables, payables, and accrued liabilities are reasonable estimates of fair value because of the short maturities of these instruments. Fair values for loans receivable, bank line of credit, bridge and term loans, mortgage debt and other debt are estimates based on rates currently prevailing for similar instruments of similar maturities. The fair values of the interest rate swaps and warrants were determined based on observable market assumptions and standardized derivative pricing models. The fair values of the senior unsecured notes, marketable equity and debt securities were determined based on market quotes.

	December 31,
	2008				2007
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
	(in thousands)
Loans receivable	$	1,076,392	$	981,128	$	1,065,485	$	1,068,897
Marketable debt securities	228,660		228,660		289,163		289,163
Marketable equity securities	3,845		3,845		13,933		13,933
Warrants	1,460		1,460		2,560		2,560
Bank line of credit	150,000		150,000		951,700		951,700
Bridge and term loans	520,000		520,000		1,350,000		1,350,000
Senior unsecured notes and mortgage debt	5,165,247		3,922,544		5,100,711		4,982,421
Other debt	102,209		102,209		108,496		108,496
Interest rate swaps-assets	—		—		2,022		2,022
Interest rate swaps-liabilities	2,324		2,324		12,519		12,519

(14) Commitments and Contingencies

Legal Proceedings

From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company’s business. Regardless of their merits, these matters may force the Company to expend significant financial resources. Except as described in this Note 14, the Company is not aware of any other legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s business, prospects, financial condition or results of operations. The Company’s policy is to accrue legal expenses as they are incurred.

F-28

On May 3, 2007, Ventas, Inc. filed a complaint against the Company in the United States District Court for the Western District of Kentucky asserting claims of tortious interference with contract and tortious interference with prospective business advantage. The complaint alleges, among other things, that the Company interfered with Ventas’ purchase agreement with Sunrise Senior Living Real Estate Investment Trust (“Sunrise REIT”); that the Company interfered with Ventas’ prospective business advantage in connection with the Sunrise REIT transaction; and that the Company’s actions caused Ventas to suffer damages. As set forth in a statement filed by Ventas on January 20, 2009, Ventas claims damages of $122 million representing the difference between the price it initially agreed to pay for Sunrise REIT and the price it ultimately paid, additional claimed damages of $188 million for alleged financing and other costs and punitive damages.

The Company believes that Ventas’ claims are without merit and intends both to vigorously defend against Ventas’ lawsuit and to aggressively pursue its counterclaims against Ventas as successor to Sunrise REIT. As set forth in a statement filed by the Company on January 20, 2009, the Company seeks recovery of damages in excess of $300 million against Ventas. The Company’s counterclaims allege, among other things, that Sunrise REIT (i) fraudulently or negligently induced the Company to participate in a rigged, flawed and unfair auction process, (ii) fraudulently or negligently induced the Company to enter into a confidentiality and standstill agreement that was materially different from the agreement entered into with Ventas, (iii) provided unfair assistance to Ventas, and (iv) changed the rules of the auction at the last minute and such change prevented the Company from bidding. The counterclaims further allege that at all times Sunrise REIT knew that the Company was the highest bidder and presumptive winner of the auction. Absent such misconduct by Sunrise REIT, the Company alleges that it would have succeeded in acquiring Sunrise REIT. The amended counterclaims allege that Ventas, in acquiring Sunrise REIT, assumed the liability of Sunrise REIT to the Company. On December 23, 2008, Ventas filed a motion for judgment on the pleadings seeking dismissal of the Company’s counterclaims, and the Company has responded to Ventas’ motion. The District Court has not rendered a decision on Ventas’ motion.

The Court has set a trial date of August 18, 2009. The Company intends to pursue its claims vigorously; however, there can be no assurances that it will prevail on any of the claims or the amount of any recovery that may be awarded. The Company expects that defending its interests and pursuing its own claims in the foregoing matters will require it to expend significant funds. The Company is unable to estimate the ultimate aggregate amount of monetary gain, loss or financial impact with respect to these matters as of December 31, 2008.

On June 30, 2008, the Company, Health Care Property Partners (“HCPP”), a joint venture between the Company and an affiliate of Tenet Healthcare Corporation (“Tenet”), and Tenet executed a definitive settlement agreement relating to complaints filed by certain Tenet subsidiaries against the Company in the Superior Court of the State of California for the County of Los Angeles in May, 2007, arbitration proceedings initiated by the Tenet subsidiaries during September, 2007, and counterclaims by the Company and HCPP, respectively, in such actions. The complaints and proceedings relate to disputes arising out of default notices and lease terminations sent out by the Company and HCPP to Tenet and certain Tenet subsidiaries on or about April, 2007. On September 19, 2008, the parties closed the transactions contemplated by the settlement agreement, effecting, among other things: (i) the sale of a hospital in Tarzana, California, by the Company to a Tenet affiliate, (ii) the extension of the terms of three other hospitals leased by the Company to affiliates of Tenet, (iii) and the acquisition by the Company of Tenet’s 23% interest in HCPP. The Company recognized $28.6 million of income from this settlement of the above disputes, which was included in interest and other income, net and a gain on sale of real estate for the sale of the hospital in Tarzana, California, of $18.0 million.

The fair value of consideration exchanged and related income recognized as a result of the Company’s settlement with Tenet follows (in thousands):

Consideration received
Cash proceeds for hospital in Tarzana, California and other settlement	$	105,760
Fair value of Tenet’s 23% interest in HCPP	29,137
Total consideration received	$	134,897

Consideration given
Fair value of hospital in Tarzana, California	$	88,900
Cash paid for Tenet’s interest in HCPP	17,379
Total consideration given	$	106,279
Settlement income	$	28,618

F-29

The gain on the sale of the Company’s hospital in Tarzana, California to Tenet consisted of the following (in thousands):

Fair value of hospital, net of costs	$	88,609
Carrying value of hospital sold	(70,590		)
Gain on sale of real estate	$	18,019

Development Commitments

As of December 31, 2008, the Company was committed under the terms of contracts to complete the construction of properties undergoing development at a remaining aggregate cost of approximately $36.5 million.

Concentration of Credit Risk

Concentrations of credit risks arise when a number of operators, tenants or obligors related to the Company’s investments are engaged in similar business activities, or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors various segments of its portfolio to assess potential concentrations of risks. Management believes the current portfolio is reasonably diversified across healthcare related real estate and does not contain any other significant concentration of credit risks, except as disclosed herein. The Company does not have significant foreign operations.

On December 21, 2007, the Company made an investment in mezzanine loans to HCR ManorCare with an aggregate face value of $1.0 billion, for approximately $900 million. At December 31, 2008, these loans represented approximately 77% of the Company’s skilled nursing segment assets and 7% of its total segment assets.

At December 31, 2008, the Company had 80 of its senior housing facilities leased to nine tenants that have been identified as VIEs (“VIE Tenants”). These VIE Tenants are thinly capitalized entities that rely on the cash flow generated from the senior housing facilities to pay operating expenses, including rent obligations under their leases. The 80 senior housing facilities leased to the VIE Tenants are operated by Sunrise Senior Living Management, Inc., a wholly-owned subsidiary of Sunrise Senior Living, Inc. (“Sunrise”). Sunrise is publicly traded and is subject to the informational filing requirements of the Securities and Exchange Act of 1934, as amended, and is required to file periodic reports on Form 10-K and Form 10-Q with the SEC.

To mitigate credit risk of certain senior housing leases, leases are combined into portfolios that contain cross-default terms, so that if a tenant of any of the properties in a portfolio defaults on its obligations under its lease, the Company may pursue its remedies under the lease with respect to any of the properties in the portfolio. Certain portfolios also contain terms whereby the net operating profits of the properties are combined for the purpose of securing the funding of rental payments due under each lease.

At December 31, 2008 and 2007, the Company’s gross real estate assets in the state of California, excluding assets held for sale, represented approximately 32% and 32% of the Company’s total segment assets, respectively.

DownREIT Partnerships

In connection with the formation of certain DownREIT partnerships, many partners contribute appreciated real estate to the partnership in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the partner. However, if the contributed property is later sold by the partnership, the unamortized pre-contribution gain that exists at the date of sale is specially allocated and taxed to the contributing partners. In many of the DownREITs, the Company has entered into indemnification agreements with those partners who contributed appreciated property into the partnership. Under these indemnification agreements, if any of the appreciated real estate contributed by the partners is sold by the partnership in a taxable transaction within a specified number of years after the property was contributed, HCP will reimburse the affected partners for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected partner under the Code (“make-whole payments”). These make-whole payments include a tax gross-up provision.

F-30

Master Trust Liabilities

Certain residents of two of the Company’s senior housing facilities have entered into a master trust agreement with the operator of the facilities whereby amounts paid upfront by such residents were deposited into a trust account. These funds were then made available to the senior housing operator in the form of a non-interest bearing loan to provide permanent financing for the related communities. The operator of the senior housing facility is the borrower under these arrangements; however, two of the Company’s properties are collateral under the master trust agreements. As of December 31, 2008, the remaining obligation under the master trust agreements for these two properties is $13.1 million. The Company’s property is released as collateral as the master trust liabilities are extinguished.

Earn-out Obligations

Pursuant to the terms of certain acquisition-related agreements, the Company may be obligated to make additional payments (“Earn-outs”) upon the achievement of certain criteria. If it is probable at the time of acquisition that the related properties Earn-out criteria will be achieved, the Earn-out payments are accrued. Otherwise, the additional purchase consideration is recognized when the performance criteria are met. At December 31, 2008 and 2007, the Company had Earn-out obligations of $2.1 million and $6.5 million, respectively.

Credit Enhancement Guarantee

Certain of the Company’s senior housing facilities are collateral for $136 million of debt (maturing May 1, 2025) that is owed by a previous owner of the facilities. This indebtedness is guaranteed by the previous owner who has an investment grade credit rating. These senior housing facilities, which are classified as DFLs, were acquired in the Company’s merger with CRP. As of December 31, 2008, the facilities have a carrying value of $352 million.

Environmental Costs

The Company monitors its properties for the presence of hazardous or toxic substances. The Company is not aware of any environmental liability with respect to the properties that would have a material adverse effect on the Company’s business, financial condition or results of operations. The Company carries environmental insurance and believes that the policy terms, conditions, limitations and deductibles are adequate and appropriate under the circumstances, given the relative risk of loss, the cost of such coverage and current industry practice.

General Uninsured Losses

The Company obtains various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental and terrorism related losses. The Company attempts to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically insurable. In addition, the Company has a large number of properties that are exposed to earthquake, flood and windstorm and the insurance for such losses carries high deductibles. Should a significant uninsured loss occur at a property, the Company’s assets may become impaired for a period of time.

Tenant Purchase Options

Leases with certain tenants contain purchase options whereby the tenant may elect to acquire the underlying real estate. Annualized lease payments to be received from leases, including DFLs, subject to purchase options, in the year that these purchase options are exercisable, are summarized as follows (dollars in thousands):

Year	Annualized Base Rent		Number of Properties
2009	$	14,450	7
2010	6,321		2
2012	15,753		2
2013	53,628		22
Thereafter	235,215		68
	$	325,367	101

F-31

Rental Expense

The Company’s rental expense attributable to continuing operations for the years ended December 31, 2008, 2007 and 2006 was approximately $4.9 million, $5.2 million and $4.2 million, respectively. These rental expense amounts include ground rent and other leases. Ground leases generally require fixed annual rent payments and may also include escalation clauses and renewal options. These leases have terms that expire during the next 95 years, excluding extension options. Future minimum lease obligations under non-cancelable ground leases as of December 31, 2008 were as follows (in thousands):

Year	Amount
2009	$	3,638
2010	3,390
2011	3,419
2012	3,470
2013	3,526
Thereafter	159,538
	$	176,981

(15) Stockholders’ Equity

Preferred Stock

The following summarizes cumulative redeemable preferred stock outstanding at December 31, 2008:

Series	Shares Outstanding	Issue Price	Dividend Rate		Callable at Par on or After
Series E	4,000,000	$25/share	7.25	%	September 15, 2008
Series F	7,820,000	$25/share	7.10	%	December 3, 2008

The Series E and Series F preferred stock have no stated maturity, are not subject to any sinking fund or mandatory redemption and are not convertible into any other securities of the Company. Holders of each series of preferred stock generally have no voting rights, except under limited conditions, and all holders are entitled to receive cumulative preferential dividends based upon each series’ respective liquidation preference. To preserve the Company’s status as a REIT, each series of preferred stock is subject to certain restrictions on ownership and transfer. Dividends are payable quarterly in arrears on the last day of March, June, September and December. The Series E and Series F preferred stock is currently redeemable at the Company’s option.

Dividends on preferred stock are characterized as ordinary income, capital gains, or a combination thereof for federal income tax purposes and are summarized in the following annual distribution table:

			Annual Dividends Per Share (unaudited)
	Dividend		Capital Gain Distribution						Ordinary Income
Series	Rate		2008		2007		2006		2008		2007		2006
Series E	7.250	%	$	0.9981	$	1.1444	$	0.5838	$	0.8144	$	0.6681	$	1.2287
Series F	7.100		0.9775		1.1208		0.5717		0.7975		0.6542		1.2033

On February 2, 2009, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.45313 per share on its Series E cumulative redeemable preferred stock and $0.44375 per share on its Series F cumulative redeemable preferred stock. These dividends will be paid on March 31, 2009 to stockholders of record as of the close of business on March 13, 2009.

F-32

Common Stock

Dividends on the Company’s common stock are characterized for federal income tax purposes as taxable ordinary income, capital gain distributions, nontaxable distributions or a combination thereof. Following is the characterization of the Company’s annual common stock dividends per share:

	Year Ended December 31,
	2008		2007		2006
	(unaudited)
Taxable ordinary income	$	0.8178	$	0.6561	$	1.1124
Capital gain distribution	1.0022		1.1239		0.5285
Nontaxable distribution	—		—		0.0591
	$	1.8200	$	1.7800	$	1.7000

Following is the characterization of distributions received by CRP stockholders prior to the merger on October 5, 2006:

	January 1, 2006 to October 5, 2006
Taxable ordinary income	—	%
Capital gain distribution (unrecaptured IRC Section 1250 gain income)	100
Return of capital	—
Nontaxable distribution	100	%

During 2008 and 2007, the Company issued 438,000 and 1.6 million shares of common stock, respectively, under its Dividend Reinvestment and Stock Purchase Plan (“DRIP”). The Company issued 648,000 and 410,000 shares upon exercise of stock options during December 31, 2008 and 2007, respectively.

During 2008 and 2007, the Company issued 157,000 and 282,000 shares of restricted stock, respectively, under the Company’s 2000 Stock Incentive Plan, as amended, and the Company’s 2006 Performance Incentive Plan. The Company also issued 142,000 and 121,000 shares upon the vesting of performance restricted stock units during December 31, 2008 and 2007, respectively.

During 2008 and 2007, the Company issued 3.7 million and 157,000 shares of our common stock upon the conversion of 2.8 million and 113,000 DownREIT units, respectively.

On January 19, 2007, the Company issued 6.8 million shares of its common stock and received net proceeds of approximately $261.1 million, which were used to repay outstanding borrowings under the Company’s former term loan facility and previous $1.0 billion revolving line of credit facility.

On October 5, 2007, the Company issued 9 million shares of common stock and received net proceeds of approximately $302.6 million, which were used to repay borrowings under the Company’s bridge loan facility.

In connection with HCP’s addition to the S&P 500 Index on March 28, 2008, the Company issued 12.5 million shares of its common stock on April 2, 2008. In a separate transaction, the Company issued 4.5 million shares to a REIT-dedicated institutional investor on April 2, 2008. The net proceeds received from these two offerings in the aggregate were approximately $560 million, which were used to repay a portion of the outstanding indebtedness under the Company’s revolving line of credit facility.

On August 11, 2008, the Company issued 14.95 million shares of common stock and received net proceeds of approximately $481 million, which were used to repay a portion of the outstanding indebtedness under the Company’s bridge loan.

On February 2, 2009, the Company announced that its Board declared a quarterly cash dividend of $0.46 per share. The common stock cash dividend was paid on February 23, 2009 to stockholders of record as of the close of business on February 9, 2009.

F-33

Accumulated Other Comprehensive Loss (“AOCI”)

	December 31,
	2008			2007
	(in thousands)
AOCI—unrealized gains (losses) on available-for-sale securities, net	$	(66,814	)	$	14,222
AOCI—unrealized losses on cash flow hedges, net	(11,729		)	(14,243		)
Supplemental Executive Retirement Plan minimum liability	(1,821		)	(2,113		)
Cumulative foreign currency translation adjustment	(798		)	32
Total Accumulated Other Comprehensive Loss	$	(81,162	)	$	(2,102	)

(16) Segment Disclosures

The Company evaluates its business and makes resource allocations based on its five business segments: (i) senior housing, (ii) life science, (iii) medical office, (iv) hospital, and (v) skilled nursing. Under the senior housing, life science, hospital and skilled nursing segments, the Company invests primarily in single operator or tenant properties through acquisition and development of real estate and provides financing to operators in these sectors. Under the medical office segment, the Company invests through acquisition and development of medical office buildings that are primarily leased under gross or modified gross leases, generally to multiple tenants, and which generally require a greater level of property management. The acquisition of SEUSA on August 1, 2007 resulted in a change to the Company’s reportable segments. Prior to the SEUSA acquisition, the Company operated through two reportable segments—triple- net leased and medical office buildings. The senior housing, life science, hospital and skilled nursing segments were previously aggregated under the Company’s triple-net leased segment. SEUSA’s results are included in the Company’s consolidated financial statements from the date of the Company’s acquisition on August 1, 2007. The accounting policies of the segments are the same as those described under Summary of Significant Accounting Policies (see Note 2). There were no intersegment sales or transfers during the year ended December 31, 2008 and 2007. The Company evaluates performance based upon property net operating income from continuing operations (“NOI”) of the combined properties in each segment.

Non-segment assets consist primarily of real estate held for sale and corporate assets including cash, restricted cash, accounts receivable, net and deferred financing costs. Interest expense, depreciation and amortization and non-property specific revenues and expenses are not allocated to individual segments in determining the Company’s performance measure. See Note 14 for other information regarding concentrations of credit risk.

Summary information for the reportable segments follows (in thousands):

For the year ended December 31, 2008:

Segments	Rental and Related Revenues		Tenant Recoveries		Income From DFLs		Investment Management Fees		Total Revenues		NOI(1)		Interest and Other Income, net
Senior housing	$	289,834	$	—	$	58,149	$	3,273	$	351,256	$	337,519	$	1,184
Life science	208,415		33,914		—		5		242,334		198,788		—
Medical office	260,788		47,015		—		2,645		310,448		173,069		—
Hospital	82,841		1,918		—		—		84,759		81,557		44,481
Skilled nursing	35,982		—		—		—		35,982		35,982		85,858
Total segments	877,860		82,847		58,149		5,923		1,024,779		826,915		131,523
Non-segment	—		—		—		—		—		—		25,195
Total	$	877,860	$	82,847	$	58,149	$	5,923	$	1,024,779	$	826,915	$	156,718

F-34

For the year ended December 31, 2007:

Segments	Rental and Related Revenues		Tenant Recoveries		Income From DFLs		Investment Management Fees		Total Revenues		NOI(1)		Interest and Other Income, net
Senior housing	$	293,259	$	—	$	63,852	$	8,579	$	365,690	$	346,153	$	1,462
Life science	79,660		19,311		—		—		98,971		72,751		—
Medical office	275,042		44,451		—		5,002		324,495		183,889		—
Hospital	79,660		1,092		—		—		80,752		78,845		45,482
Skilled nursing	35,172		—		—		—		35,172		35,172		4,899
Total segments	762,793		64,854		63,852		13,581		905,080		716,810		51,843
Non-segment	—		—		—		—		—		—		23,733
Total	$	762,793	$	64,854	$	63,852	$	13,581	$	905,080	$	716,810	$	75,576

For the year ended December 31, 2006:

Segments	Rental and Related Revenues		Tenant Recoveries		Income From DFLs		Investment Management Fees		Total Revenues		NOI(1)		Interest and Other Income, net
Senior housing	$	162,919	$	—	$	15,008	$	—	$	177,927	$	168,955	$	2,748
Life science	14,919		3,935		—		—		18,854		13,885		—
Medical office	154,918		25,172		—		3,895		183,985		115,402		—
Hospital	48,127		34		—		—		48,161		48,161		13,776
Skilled nursing	32,955		—		—		—		32,955		32,955		2,926
Total segments	413,838		29,141		15,008		3,895		461,882		379,358		19,450
Non-segment	—		—		—		—		—		—		15,242
Total	$	413,838	$	29,141	$	15,008	$	3,895	$	461,882	$	379,358	$	34,692

(1) Net Operating Income from Continuing Operations (“NOI”) is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. The Company defines NOI as rental revenues, including tenant recoveries and income from direct financing leases, less property-level operating expenses. NOI excludes investment management fee income, depreciation and amortization, general and administrative expenses, impairments, gain on sale of real estate interest, interest and other income, net, interest expense, income taxes, equity income from unconsolidated joint ventures, noncontrolling interests’ share in earnings and discontinued operations. The Company believes NOI provides investors relevant and useful information because it measures the operating performance of the Company’s real estate at the property level on an unleveraged basis. The Company uses NOI to make decisions about resource allocations and assess property-level performance. The Company believes that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since it does not reflect the aforementioned excluded items. Further, the Company’s definition of NOI may not be comparable to the definition used by other real estate investment trusts, as those companies may use different methodologies for calculating NOI.

The following is a reconciliation from NOI to reported net income, the most direct comparable financial measure calculated and presented in accordance with GAAP (in thousands):

	Years ended December 31,
	2008			2007			2006
Net operating income from continuing operations	$	826,915		$	716,810		$	379,358
Investment management fee income	5,923			13,581			3,895
Depreciation and amortization	(314,026		)	(258,947		)	(117,289		)
General and administrative	(75,600		)	(68,348		)	(46,865		)
Impairments	(18,276		)	—			(2,530		)
Gain on sale of real estate interest	—			10,141			—
Interest and other income, net	156,718			75,576			34,692
Interest expense	(348,402		)	(355,479		)	(211,494		)
Income taxes	(4,307		)	(1,444		)	(245		)
Equity income from unconsolidated joint ventures	3,326			5,645			8,331
Total discontinued operations	238,712			476,580			389,765
Net income	$	470,983		$	614,115		$	437,618

F-35

The Company’s total assets by segment were:

	December 31,
Segments	2008			2007
Senior housing	$	4,441,689		$	4,425,507
Life science	3,545,913			3,461,101
Medical office	2,281,103			2,247,850
Hospital	1,033,206			1,092,683
Skilled nursing	1,191,091			1,163,157
Gross segment assets	12,493,002			12,390,298
Accumulated depreciation and amortization	(933,651		)	(666,775		)
Net segment assets	11,559,351			11,723,523
Real estate held for sale, net	19,799			436,360
Non-segment assets	270,676			361,889
Total assets	$	11,849,826		$	12,521,772

Segment assets include an allocation of the carrying value of goodwill. At December 31, 2008, goodwill is allocated as follows: (i) senior housing—$30.5 million, (ii) life science—$1.4 million, (iii) medical office—$11.4 million, (iv) hospital—$5.1 million, and (v) skilled nursing—$3.3 million. In accordance with SFAS No. 142, the Company completed the required annual impairment test during the three months ended December 31, 2008. No impairment was recognized based on the results of the annual goodwill impairment test.

(17) Derivative Financial Instruments

The Company uses derivative instruments as hedges to mitigate interest rate fluctuations on specific forecasted transactions and recognized obligations. The Company does not use derivative instruments for speculative or trading purposes.

The primary risks associated with derivative instruments are market and credit risk. Market risk is defined as the potential for loss in value of the derivative instruments due to adverse changes in market prices (interest rates). Utilizing derivative instruments allows the Company to effectively manage the risk of increasing interest rates with respect to the potential effects these fluctuations could have on future earnings and cash flows.

Credit risk is the risk that one of the parties to a derivative contract fails to perform or meet their financial obligation. The Company does not obtain collateral associated with its derivative instruments, but monitors the credit standing of its counterparties, primarily global institutional banks, on a regular basis. Should a counterparty fail to perform, the Company would incur a financial loss to the extent that the associated derivative contract was in an asset position. At December 31, 2008, the Company does not anticipate non-performance by counterparties to its outstanding derivative contracts.

In July 2005, the Company entered into three interest rate swap contracts that are designated as hedging the variability of expected cash flows related to floating rate debt assumed in connection with the acquisition of a real estate portfolio. The cash flow hedges have a notional amount of $45.6 million and mature in July 2020. The aggregate fair value of the derivative contracts is a $2.3 million liability and is included in accounts payable and accrued liabilities. At December 31, 2008, no amounts of ineffectiveness for the derivative contracts were recorded.

In August 2006, the Company entered into two treasury lock contracts that were designated as hedging the variability in forecasted interest payments, attributable to changes in the U.S. Treasury rate, on the forecasted issuance of long-term, fixed rate debt between September 1 and October 31, 2006. The cash flow hedges had a notional amount of $560.5 million and were settled with the counterparty on September 16, 2006, which was the date that the forecasted debt was issued. The cash settlement value of these contracts at September 16, 2006, was $4.4 million. The unamortized amount of these contracts at December 31, 2008, is $3.2 million and is included in accumulated other comprehensive income (loss). The Company determined that these treasury lock agreements were highly effective in offsetting the variability in the forecasted interest payments. Amounts reported in accumulated other comprehensive income (loss) related to these hedges will be recognized as additional interest expense on the Company’s hedged fixed-rate debt, maturing 2011 and 2016. For the year ended December 31, 2008, the Company recognized increased interest expense of $0.5 million and expects to recognize an additional $0.5 million attributable to these contracts during 2009.

F-36

During October and November 2007, the Company entered into two forward-starting interest rate swap contracts with notional amounts aggregating $900 million. The interest rate swap contracts are designated in qualifying, cash flow hedging relationships, to hedge the Company’s exposure to fluctuations in the benchmark interest rate component of interest payments on forecasted, unsecured, fixed-rate debt expected to be issued during the current fiscal year. As of September 30, 2008, the Company terminated these hedges per the cash settlement provisions of the derivative contracts. The termination of the $500 million notional contract resulted in a payment of $14.8 million and the termination of the $400 million notional contract resulted in a cash receipt of $5.2 million. Upon settlement of these derivative contracts and at December 31, 2008, the Company revised its best estimate of the hedged forecasted transactions, and as a result an ineffectiveness charge of $3.5 million was recognized in interest and other income, net during the year ended December 31, 2008. At December 31, 2008, the Company expects that the hedged forecasted transactions remain probable of occurring. During the year ended December 31, 2007, there was no ineffective portion related to these hedges.

The following table summarizes the Company’s outstanding interest rate swap contracts as of December 31, 2008 (dollars in thousands):

Date Entered

Effective Date

Maturity Date

Pay
Fixed
Rate

Receive Floating
Rate Index

Notional
Amount

Fair Value

July 13, 2005

July 19, 2005

July 15, 2020

3.820

BMA Swap Index

45,600

(2,324

)

Other Financial Derivative Instruments

As part of the Company’s acquisition of SEUSA in August 2007, the Company received two warrants to purchase common stock in publicly traded corporations that expire in 2013 and 2015. At December 31, 2008 and 2007, these derivative instruments had an aggregate fair value of $1.5 million and $2.6 million, respectively, and are included in other assets. During the year ended December 31, 2008 and 2007, the Company recognized expense of $1.1 million and income of $1.8 million, respectively, in interest and other income, net due to changes in the fair value of the warrants.

(18) Income Taxes

During the years ended December 31, 2008 and 2007, the Company’s income tax expense was $3.8 million and $3.5 million, respectively. During the years ended December 31, 2008 and 2007, the Company’s income tax expense from continuing operations was $4.3 million and $1.4 million, respectively. The Company’s federal and state income tax expense in 2006 was insignificant. State taxes comprised $1.3 million, or 34%, of total income tax expense in 2008, and $1.7 million, or 49%, of total income tax expense in 2007. The Company’s deferred income tax expense and its ending balance in deferred tax assets and liabilities were insignificant in the years ended December 31, 2008, 2007 and 2006.

At December 31, 2008 and 2007, the tax basis of the Company’s net assets is less than the reported amounts by $2.3 billion and $2.4 billion, respectively. The difference between the reported amounts and the tax basis is primarily related to the Company’s acquisitions of SEUSA.

The Company files numerous U.S. federal, state and local income and franchise tax returns. With few exceptions, the Company is no longer subject to U.S. federal, state or local tax examinations by taxing authorities for years prior to 2004.

CRC Merger

On October 5, 2006, the Company merged with CRC, a corporation subject to federal and state income taxes. For federal income tax purposes, the CRC merger was treated as a tax-free transaction resulting in a carry-over tax basis in its assets. At December 31, 2008 and 2007, the Company’s net tax basis in the CRC assets is less than reported amounts by $70.1 million and $68.4 million, respectively.

SEUSA Acquisition

On August 1, 2007, HCP Life Science REIT, a wholly-owned subsidiary, acquired the stock of SEUSA, causing SEUSA to become a qualified REIT subsidiary. As a result of the acquisition, HCP Life Science REIT succeeded to SEUSA’s tax attributes, including SEUSA’s tax basis in its net assets. Prior to the acquisition, SEUSA was a corporation subject to federal and state income taxes. HCP Life Science REIT will be subject to a corporate-level tax on any taxable disposition of SEUSA’s pre-acquisition assets that occurred within ten years after the August 1, 2007 acquisition. The corporate-level tax would be assessed only to the extent of the built-in gain that existed on the date of acquisition, based on

F-37

the fair market value of the asset on August 1, 2007. The Company does not expect to dispose of any asset included in the SEUSA acquisition, if such a disposition would result in the imposition of a material tax liability. As a result, the Company has not recorded a deferred tax liability associated with this corporate-level tax. Gains from asset dispositions occurring more than 10 years after the acquisition will not be subject to this corporate-level tax. However, the Company may dispose of SEUSA assets before the 10-year period if it is able to affect a tax deferred exchange. At December 31, 2008 and 2007, the tax basis of the Company’s net assets included in the SEUSA acquisition is less than the reported amounts by $1.8 billion.

In connection with the SEUSA acquisition, the Company assumed SEUSA’s unrecognized tax benefits of $8.0 million. In addition, during 2008 the Company recognized other increases to unrecognized tax benefits of $0.9 million. A reconciliation of the Company’s beginning and ending unrecognized tax benefits follows (in thousands):

	Amount
Balance at January 1, 2007	$	—
Additions based on prior years’ tax positions	7,975
Additions based on 2007 tax positions	—
Balance at January 1, 2007	7,975
Additions based on prior years’ tax positions	587
Additions based on 2008 tax positions	294
Balance at December 31, 2008	$	8,856

The Company anticipates that the balance in unrecognized tax benefits will decrease by $0.9 million in 2009 related to a request the Company expects to file with federal and state taxing authorities to pay the unrecognized taxes. During the years ended December 31, 2008 and 2007, the Company recorded interest expense associated with the unrecognized tax benefits assumed in connection with the SEUSA acquisition of $0.7 million and $0.4 million, respectively. Interest expense associated with all other unrecognized tax benefits is not significant.

The Company has an agreement with the seller of SEUSA where any increases in taxes and associated interest and penalties related to years prior to the SEUSA acquisition will be the responsibility of the seller. Similarly, any pre-acquisition tax refunds and associated interest income will be refunded to the seller.

There would be no effect on the Company’s tax rate if the unrecognized tax benefits were to be recognized.

Taxable Income Reconciliation

The following is a reconciliation of net income available to common stockholders to taxable income available to common stockholders (in thousands):

	Year Ended December 31,
	2008			2007			2006
	(unaudited)
Net income available to common stockholders	$	425,368		$	565,080		$	393,681
Participating securities’ share in earnings	1,997			2,805			2,736
Net income available to common stockholders and participating securities	427,365			567,885			396,417
Book to tax differences:
Net gains on dispositions of real estate	73,887			(63,165		)	(173,920		)
Straight-line rent	(40,821		)	(42,796		)	(10,939		)
Depreciation and amortization	89,492			(22,433		)	(12,179		)
Capitalized interest	(25,345		)	(7,358		)	(302		)
Prepaid rent and other deferred income	17,250			11,532			1,659
Income from joint ventures	5,572			8,204			85
Income (loss) from taxable REIT subsidiaries	2,271			(6,085		)	588
Impairments	26,674			—			—
Interest income	(10,746		)	(4,705		)	—
Other book/tax differences, net	43			(4,366		)	6,803
Taxable income available to common stockholders	$	565,642		$	436,713		$	208,212

F-38

(19) Future Minimum Rents

Future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under non-cancelable operating leases as of December 31, 2008, are as follows (in thousands):

Year	Amount
2009	$	893,415
2010	858,357
2011	818,912
2012	781,192
2013	735,220
Thereafter	4,377,970
	$	8,465,066

(20) Impairments

During the year ended December 31, 2008, the Company recognized impairments of $27.5 million as follows: (i) $16.9 million related to intangible assets associated with the early termination of leases, (ii) $7.8 million related to three senior housing facilities and one hospital as a result of a decrease in expected cash flows, and (iii) $2.8 million, included in discontinued operations, related to the anticipated disposition of a senior housing asset. In addition, for the year ended December 31, 2008, we recognized $0.4 million of impairments related to two equity method investments, as a result of an other-than-temporary decline in fair value below the Company’s carrying amount of such investments. Impairments of equity method investments are included in interest and other income, net. No assets were determined to be impaired during the year ended December 31, 2007.

During the year ended December 31, 2006, the Company recognized impairments of $9.6 million as follows: (i) $1.0 million as a result of a decrease in expected cash flows from a senior housing facility, (ii) $2.6 million as a result of the contribution of 25 properties into a senior housing joint venture in January 2007, and (iii) $6.0 million, included in discontinued operations, as a result of the disposition of four skilled nursing facilities.

(21) Compensation Plans

Stock Based Compensation

On May 11, 2006, the Company’s stockholders approved the 2006 Performance Incentive Plan (the “2006 Incentive Plan”). The 2006 Incentive Plan replaces the Company’s 2000 Stock Incentive Plan (collectively, the “Stock Incentive Plans”) and provides for the granting of stock-based compensation, including stock options, restricted stock and performance restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company. The maximum number of shares originally reserved for awards under the 2006 Incentive Plan is 8.2 million shares. The maximum number of shares available for future awards under the 2006 Incentive Plan is 4.9 million shares at December 31, 2008, of which approximately 2.5 million shares may be issued as restricted stock and performance restricted stock units.

Stock Options

Stock options are generally granted with an exercise price equal to the fair market value of the underlying stock on the date of grant. Stock options generally vest ratably over a five-year period and have a 10-year contractual term. Vesting of certain options may accelerate upon retirement, a change in control of the Company, as defined, and other events.

F-39

A summary of the option activity is presented in the following table (in thousands, except per share amounts):

	Shares Under Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2007	4,236		$	26.25	6.7	$	39,083
Granted	1,843
Exercised	(634	)
Forfeited	(308	)
Outstanding as of December 31, 2008	5,137		$	29.08	7.2	$	6,838
Exercisable as of December 31, 2008	2,038		$	25.43	5.6	$	5,995

The following table summarizes additional information concerning outstanding and exercisable stock options at December 31, 2008 (shares in thousands):

				Weighted Average	Currently Exercisable
Range of Exercise Price	Shares Under Options	Weighted Average Exercise Price		Remaining Contractual Term (Years)	Shares Under Options	Weighted Average Exercise Price
$11.94 - $16.03	37	$	14.09	1.5	37	$	14.09
17.93 - 18.73	113	18.35		3.8	113	18.35
19.14 - 21.40	302	19.15		4.3	302	19.15
23.50 - 27.52	2,350	26.64		6.2	1,484	26.54
31.95 - 39.72	2,335	33.59		8.9	102	39.72
	5,137	29.08		7.2	2,038	25.43

The following table summarizes additional information concerning unvested stock options at December 31, 2008 (shares in thousands):

	Shares Under Options		Weighted Average Grant Date Fair Value
Unvested at December 31, 2007	2,277		$	2.70
Granted	1,843		2.91
Vested	(713	)	2.30
Forfeited	(308	)	3.10
Unvested at December 31, 2008	3,099		2.95

The weighted average fair value per share at the date of grant for options awarded during the years ended December 31, 2008, 2007 and 2006 was $2.91, $5.20 and $2.20, respectively. The total vesting date intrinsic values of shares under options vested during the years ended December 31, 2008, 2007 and 2006 was $3.5 million, $1.3 million and $1.0 million, respectively. The total intrinsic value of vested shares under options at December 31, 2008 was $6.0 million.

Proceeds received from options exercised under the Stock Incentive Plans for the years ended December 31, 2008, 2007 and 2006 were $12.2 million, $8.1 million and $7.9 million, respectively. The total intrinsic value of options exercised during the years ended December 31, 2008, 2007 and 2006 was $5.8 million, $5.3 million and $4.6 million, respectively.

The fair value of the stock options granted during the years ended December 31, 2008, 2007 and 2006 was estimated on the date of grant using a Black-Scholes option valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the historical exercise behavior of employees and turnover rates. Expected volatility was based on historical volatility for a period equal to the stock option’s expected life, ending on the day of grant, and calculated on a weekly basis.

F-40

	2008		2007		2006
Risk-free rate	3.15	%	4.87	%	4.50	%
Expected life (in years)	7.0		6.5		6.5
Expected volatility	20.0	%	20.0	%	20.0	%
Expected dividend yield	6.0	%	5.5	%	7.5	%

Restricted Stock and Performance Restricted Stock Units

Under the 2006 Incentive Plan, restricted stock and performance restricted stock units generally vest over a three- to five-year period and have a 10-year contractual term. The vesting of certain restricted shares and units may accelerate upon retirement, a change in control of the Company, as defined, and other events. When vested, each performance restricted stock unit is convertible into one share of common stock. The restricted stock and performance restricted stock units are valued on the grant date based on the market price of a common share on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. Upon any exercise or payment of restricted shares or units, the participant is required to pay the related tax withholding obligation. The 2006 Incentive Plan enables the participant to elect to have the Company reduce the number of shares to be delivered to pay the related tax withholding obligation. The value of the shares withheld is the closing price of the Company’s common stock on the date the relevant transaction occurs. During 2008, 2007 and 2006, the Company withheld 99,000, 84,000 and 50,000 shares, respectively, to offset tax withholding obligations.

The following table summarizes additional information concerning restricted stock and restricted stock units at December 31, 2008 (units and shares in thousands):

Unvested Shares	Restricted Stock Units		Weighted Average Grant Date Fair Value		Restricted Shares		Weighted Average Grant Date Fair Value
Unvested at December 31, 2007	788		$	30.84	489		$	29.21
Granted	259		31.95		157		32.90
Vested	(142	)	27.99		(152	)	28.47
Forfeited	(41	)	31.31		(114	)	28.23
Unvested at December 31, 2008	864		31.59		380		32.38

At December 31, 2008, the weighted average remaining contractual term of restricted stock units and restricted stock was 8 years. The total fair values of restricted stock and restricted stock units when vested for the years ended December 31, 2008, 2007 and 2006 were $9.5 million, $9.3 million and $6.6 million, respectively.

On August 14, 2006, the Company granted 219,000 restricted stock units to the Company’s Chairman and Chief Executive Officer. The restricted stock units vest over a period of ten years beginning in 2012. Additionally, as the Company pays dividends on its outstanding common stock, the original award will be credited with additional restricted stock units as dividend equivalents (as opposed to receiving a cash payment). The dividend equivalent restricted stock units will be subject to the same vesting and other conditions as applied to the grant generally.

Total share-based compensation expense recognized during the years ended December 31, 2008, 2007 and 2006 was $13.8 million, $11.4 million and $8.2 million, respectively. As of December 31, 2008, there was $32.5 million of total unrecognized compensation cost, related to unvested share-based compensation arrangements granted under the Company’s incentive plans, which is expected to be recognized over a weighted average period of 3 years.

Employee Benefit Plan

The Company maintains a 401(k) and profit sharing plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Code. The Company provides a matching contribution of up to 4% of each participant’s eligible compensation. During 2008, 2007 and 2006, the Company’s matching contributions were approximately $0.7 million, $0.8 million and $0.5 million, respectively.

F-41

(22) Supplemental Cash Flow Information

	Year Ended December 31,
	2008			2007			2006
	(in thousands)
Supplemental cash flow information:
Interest paid, net of capitalized interest and other	$	369,526		$	327,047		$	165,508
Taxes paid	4,551			1,785			13
Supplemental schedule of non-cash investing activities:
Capitalized interest	27,490			12,346			895
Increase (decrease) in accrued construction costs	(9,041		)	13,177			—
Real estate exchanged in real estate acquisitions	—			35,205			—
Loan received upon real estate disposition	3,200			—			—
Supplemental schedule of non-cash financing activities:
Mortgages assumed with real estate acquisitions	4,892			17,362			80,747
Mortgages included with real estate dispositions	—			3,792			91,730
Issuance of restricted stock	157			282			111
Vesting of restricted stock units	142			121			129
Cancellation of restricted stock	114			41			61
Conversion of non-managing member units into common stock	111,467			3,704			5,523
Non-managing member units issued in connection with acquisitions	—			180,698			2,752
Unrealized gains (losses), net on available for sale securities and derivatives designated as cash flow hedges	(89,751		)	(20,673		)	22,826

See also discussions of the SEUSA acquisition, CRP and CRC mergers, and HCP Ventures II and HCP Ventures IV transactions in Notes 3 and 8.

(23) Earnings Per Common Share

The following table illustrates the computation of basic and diluted earnings per share for the years ended December 31, (dollars in thousands, except per share and share amounts):

	2008			2007			2006
Numerator
Income from continuing operations	$	232,271		$	137,535		$	47,853
Noncontrolling interests’ and participating securities’ share in earnings	(24,485		)	(27,905		)	(22,807		)
Preferred stock dividends	(21,130		)	(21,130		)	(21,130		)
Income from continuing operations applicable to common shares	186,656			88,500			3,916
Discontinued operations	238,712			476,580			389,765
Net income applicable to common shares	$	425,368		$	565,080		$	393,681
Denominator
Basic weighted average common shares	237,301			207,924			148,236
Dilutive stock options and restricted stock	671			996			395
Diluted weighted average common shares	237,972			208,920			148,631
Basic earnings per common share
Income from continuing operations	$	0.79		$	0.43		$	0.03
Discontinued operations	1.00			2.29			2.63
Net income applicable to common stockholders	$	1.79		$	2.72		$	2.66
Diluted earnings per common share
Income from continuing operations	$	0.78		$	0.42		$	0.03
Discontinued operations	1.01			2.28			2.62
Net income applicable to common shares	$	1.79		$	2.70		$	2.65

Restricted stock and certain of the Company’s performance restricted stock units are considered participating securities which require the use of the two-class method for the computation of basic and diluted earnings per share. For the year ended December 31, 2008, 2007 and 2006, earnings representing nonforfeitable dividends of $2.0 million, $2.8 million and $2.7 million, respectively, were allocated to the participating securities.

F-42

Diluted earnings per common share is calculated by including the effect of dilutive securities. Options to purchase approximately 3.0 million and 0.6 million shares of common stock that had an exercise price in excess of the average market price of the common stock during the 2008 and 2007, respectively, were not included because they are anti-dilutive. For 2006, there were no anti-dilutive options to purchase shares of common stock. Restricted stock and performance restricted stock units convertible into 1.0 million shares, 1.1 million shares and 0.9 million shares, respectively, of common stock during the year ended December 31, 2008, 2007 and 2006, respectively, were not included because they are anti-dilutive. Additionally, 6.4 million shares issuable upon conversion of 4.8 million DownREIT units during 2008, 10.1 million shares issuable upon conversion of 7.6 million DownREIT units during 2007, and 6.0 million shares issuable upon conversion of 3.4 million non-managing member units in 2006 were not included since they are anti-dilutive.

(24) Transactions with Related Parties

Mr. Rhein, a director of the Company, is a director of Cohen & Steers, Inc. Cohen & Steers Capital Management, Inc., a wholly owned subsidiary of Cohen & Steers, Inc., is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. As of January 12, 2009, mutual funds managed by Cohen & Steers Capital Management, Inc., (“Cohen & Steers”) in the aggregate, owned approximately 2% of the Company’s common stock. In addition, an affiliate of Cohen & Steers provided financial advisory services to the Company in 2007 and 2006. The Company made payments in respect of such services of $5.5 million and $1.5 million during 2007 and 2006, respectively. No payments were made to the Cohen & Steers affiliate during 2008.

Mr. Sullivan, a director of the Company, was a director of Covenant Care, Inc. through March 2006. During 2006 Covenant Care made payments of approximately $8.2 million to the Company for the lease of certain of its nursing home properties.

Mr. Elcan, a former Executive Vice President of the Company through April 30, 2008, and certain members of Mr. Elcan’s immediate family, including without limitation his wife and father-in-law, may be deemed to own directly or indirectly, in the aggregate, greater than 10% of the outstanding common stock of HCA, Inc. (“HCA”) at April 29, 2008. During 2008, 2007 and 2006, HCA contributed $95 million, $83 million and $37 million, respectively, in aggregate revenues and interest income, for the lease of certain assets and obligations under debt securities.

Mr. Elcan and Mr. Klaritch, an Executive Vice President of the Company, were previously senior executives and limited liability company members of MedCap Properties, LLC, which was acquired in October 2003 by HCP and a joint venture of which HCP was the managing member. As part of that transaction, MedCap Properties, LLC contributed certain property interests to a newly-formed entity, HCPI/Tennessee LLC, in exchange for DownREIT units. In connection with the transactions, Messrs. Elcan and Klaritch received 610,397 and 113,431 non- managing member units, respectively, in HCPI/Tennessee, LLC in a distribution of their respective interests in MedCap Properties, LLC. Each DownREIT unit is redeemable for an amount of cash approximating the then-current market value of two shares of HCP’s common stock or, at HCP’s option, two shares of HCP’s common stock (subject to certain adjustments, such as stock splits, stock dividends and reclassifications). In addition, the HCPI/Tennessee, LLC agreement provides for a “make-whole” payment, intended to cover grossed-up tax liabilities, to the non-managing members upon the sale of certain properties acquired by HCPI/Tennessee, LLC in the MedCap transactions and other events.

The HCPI/Tennessee, LLC agreement was amended, with an effective date of January 1, 2007, to change the allocation of the taxable income among the members, to more closely correspond with the relative cash distributions each member receives. Previously, taxable income was allocated disproportionately to the non-managing members to reflect the priority rights of the non-managing member unit holders in distributions of cash. The amendment has no effect on the amounts of cash distributions to the non-managing members.

(25) Selected Quarterly Financial Data

Selected quarterly information for the years ended December 31, 2008 and 2007 is as follows (in thousands, except per share amounts). Results of operations for properties sold or to be sold have been classified as discontinued operations for all periods presented:

F-43

	Three Months Ended During 2008
	March 31		June 30		September 30		December 31
	(in thousands, except share data, unaudited)
Total revenues	$	244,794	$	248,775	$	268,203	$	263,007
Income before income taxes and equity income from unconsolidated joint ventures	37,555		49,449		100,647		45,601
Total discontinued operations	19,527		189,124		30,528		(467		)
Net income applicable to common shares	44,579		225,890		119,615		34,650
Dividends paid per common share	0.455		0.455		0.455		0.455
Basic earnings per common share	0.21		0.96		0.49		0.14
Diluted earnings per common share	0.21		0.96		0.49		0.14

	Three Months Ended During 2007
	March 31		June 30		September 30		December 31
	(in thousands, except share data, unaudited)
Total revenues	$	205,871	$	203,986	$	241,353	$	253,870
Income before income taxes and equity income from unconsolidated joint ventures	26,453		50,210		24,003		32,668
Total discontinued operations	123,784		25,646		302,581		24,569
Net income applicable to common shares	139,302		65,573		315,183		44,569
Dividends paid per common share	0.445		0.445		0.445		0.445
Basic earnings per common share	0.68		0.32		1.53		0.21
Diluted earnings per common share	0.68		0.32		1.52		0.21

The above selected quarterly financial data includes the following significant transactions:

· On January 5, 2007, the Company formed HCP Ventures II with an institutional capital partner. Upon the sale of a 65% interest, the Company received approximately $280 million in proceeds, including a one-time acquisition fee of $5.4 million. Effective on the date of formation, the Company accounted for the interest retained in the joint venture as an equity method investment.

· On April 30, 2007, the Company formed HCP Ventures IV with an institutional capital partner. Upon the sale of an 80% interest in the venture, the Company received proceeds of $196 million and recognized a gain on the sale of real estate interest of $10 million. These proceeds include a one-time acquisition fee of $3 million. Effective on the date of formation, the Company accounted for the interest retained in the joint venture as an equity method investment.

· The results for the quarter ended June 30, 2007, include income of $6 million, or $0.03 per diluted share of common stock, in discontinued operations, resulting from the Company’s change in estimate relating to the collectibility of straight-line rents due from Emeritus. The results for the quarter ended September 30, 2007, include income of $9 million, or $0.04 per diluted share of common stock, resulting from the Company’s change in estimate relating to the collectibility of straight-line rents due from Emeritus.

· On August 1, 2007, the Company acquired SEUSA. The impact of the Company’s acquisition of SEUSA is included in the results beginning in the quarter ended September 30, 2007.

· On August 15, 2007, the Company sold 41 senior housing facilities to Emeritus Corporation for an aggregate price of $501.5 million, resulting in gains of $284 million.

· On December 21, 2007, the Company made an investment in mezzanine loans having an aggregate face value of $1.0 billion. The impact of the Company’s investment in mezzanine loans is included in the results beginning in the quarter ended December 31, 2007.

· On July 30, 2008, the Company received and recognized lease termination income of $18 million from a tenant in connection with the early termination of three leases in its life science segment. Upon termination of the leases, the Company recognized an impairment of $4 million related to intangible assets associated with these leases.

· On September 19, 2008, the Company completed the restructuring of its hospital portfolio leased to Tenet and settled various disputes. The settlement provided for, among other things, the sale of its hospital in Tarzana, California, valued at $89 million, the purchase of Tenet’s noncontrolling interest in a joint venture valued at $29 million and the extension of the terms of three other hospitals leased by the Company to Tenet. As a result of the sale of its hospital in Tarzana, California and the settlement of the legal disputes with Tenet, the Company recognized income of $47 million.

F-44

HCP, Inc.

Schedule II: Valuation and Qualifying Accounts

December 31, 2008

(In thousands)

			Additions					Deductions
Allowance Accounts(1) Year Ended December 31,	Balance at Beginning of Year		Amounts Charged Against Operations, net		Acquired Properties			Uncollectible Accounts Written-off			Disposed/ Contributed Properties			Balance at End of Year
2008	$	59,131	$	9,747	$	—		$	(2,574	)	$	(7,393	)	$	58,911
2007	$	55,106	$	23,383	$	890		$	(1,964	)	$	(18,284	)	$	59,131
2006	$	25,050	$	10,387	$	21,592	(2)	$	(1,923	)	$	—		$	55,106

(1) Includes allowance for doubtful accounts, straight-line rent reserves and allowance for loan losses.

(2) Additions primarily related to the CNL Retirement Properties, Inc. and CNL Retirement Corp. mergers completed on November 30, 2006.

F-45

HCP, Inc.

Schedule III: Real Estate and Accumulated Depreciation

December 31, 2008

(In thousands)

				Initial Cost to Company				Costs Capitalized		Gross Amount at Which Carried As of December 31, 2008									Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)		Land		Buildings and Improvements		Subsequent to Acquisition		Land		Buildings and Improvements		Total(2)(3)		Accumulated Depreciation			Acquired/ Constructed	Statement is Computed
Senior housing
Birmingham	AL	$	34,930	$	4,682	$	86,200	$	—	$	4,682	$	86,200	$	90,882	$	(5,419	)	2006	40
Huntsville	AL	19,087		1,394		44,347		—		1,394		44,347		45,741		(2,783		)	2006	40
Huntsville	AL	—		307		5,813		—		307		5,813		6,120		(469		)	2006	40
Little Rock	AR	—		1,922		14,140		—		1,922		14,140		16,062		(1,010		)	2006	39
Douglas	AZ	—		110		703		—		110		703		813		(184		)	2005	35
Tucson	AZ	33,659		2,350		24,037		—		2,350		24,037		26,387		(4,207		)	2002	30
Beverly Hills	CA	—		9,872		33,590		—		9,872		33,590		43,462		(2,175		)	2006	40
Camarillo	CA	—		5,798		19,427		—		5,798		19,427		25,225		(1,398		)	2006	40
Carlsbad	CA	13,962		7,897		14,255		—		7,897		14,255		22,152		(1,113		)	2006	40
Carmichael	CA	6,768		4,270		13,846		—		4,270		13,846		18,116		(944		)	2006	40
Citrus Heights	CA	3,515		1,180		8,367		—		1,180		8,367		9,547		(861		)	2006	29
Concord	CA	25,000		6,010		39,601		—		6,010		39,601		45,611		(4,140		)	2005	40
Dana Point	CA	—		1,960		15,946		—		1,960		15,946		17,906		(1,649		)	2005	39
Elk Grove	CA	—		2,235		6,339		—		2,235		6,339		8,574		(463		)	2006	40
Escondido	CA	14,340		5,090		24,253		—		5,090		24,253		29,343		(2,610		)	2005	40
Fairfield	CA	—		149		2,835		—		149		2,835		2,984		(901		)	1997	35
Fremont	CA	9,744		2,360		11,672		—		2,360		11,672		14,032		(1,284		)	2005	40
Granada Hills	CA	—		2,200		18,257		—		2,200		18,257		20,457		(1,930		)	2005	39
Hemet	CA	—		1,270		5,966		—		1,270		5,966		7,236		(432		)	2006	40
Irvine	CA	—		8,220		14,104		—		8,220		14,104		22,324		(989		)	2006	45
Lodi	CA	9,083		732		5,453		—		732		5,453		6,185		(1,603		)	1997	35
Murietta	CA	6,103		435		5,729		—		435		5,729		6,164		(1,618		)	1997	35
Northridge	CA	—		6,718		26,309		—		6,718		26,309		33,027		(1,798		)	2006	40
Orangevale	CA	4,780		2,160		8,522		—		2,160		8,522		10,682		(278		)	2008	40
Palm Springs	CA	—		1,005		5,183		—		1,005		5,183		6,188		(434		)	2006	40
Pleasant Hill	CA	6,270		2,480		21,333		—		2,480		21,333		23,813		(2,241		)	2005	40
Rancho Mirage	CA	—		1,798		24,053		—		1,798		24,053		25,851		(1,713		)	2006	40
San Diego	CA	7,849		6,384		32,072		—		6,384		32,072		38,456		(2,238		)	2006	40
San Dimas	CA	12,536		5,628		31,374		—		5,628		31,374		37,002		(2,077		)	2006	40
San Juan Capistrano	CA	4,380		5,983		9,614		—		5,983		9,614		15,597		(740		)	2006	40
Santa Rosa	CA	—		3,582		21,113		—		3,582		21,113		24,695		(1,490		)	2006	40
South San Francisco	CA	11,239		3,000		16,586		—		3,000		16,586		19,586		(1,726		)	2005	40
Ventura	CA	10,619		2,030		17,379		—		2,030		17,379		19,409		(1,861		)	2005	40
Yorba Linda	CA	—		4,968		19,290		—		4,968		19,290		24,258		(1,398		)	2006	40
Colorado Springs	CO	—		1,910		24,479		—		1,910		24,479		26,389		(1,757		)	2006	40
Denver	CO	51,739		2,810		36,021		—		2,810		36,021		38,831		(6,304		)	2002	30
Denver	CO	—		2,511		30,641		—		2,511		30,641		33,152		(2,040		)	2006	40
Greenwood Village	CO	—		3,367		38,396		—		3,367		38,396		41,763		(2,473		)	2006	40
Lakewood	CO	—		3,012		31,913		—		3,012		31,913		34,925		(2,109		)	2006	40
Torrington	CT	12,855		166		11,001		—		166		11,001		11,167		(1,272		)	2005	40
Woodbridge	CT	3,777		2,352		9,929		—		2,352		9,929		12,281		(740		)	2006	40
Altamonte Springs	FL	—		1,530		7,956		—		1,530		7,956		9,486		(1,772		)	2002	40
Apopka	FL	6,000		920		4,816		—		920		4,816		5,736		(348		)	2006	35
Boca Raton	FL	11,585		4,730		17,532		—		4,730		17,532		22,262		(1,684		)	2006	30
Boca Raton	FL	11,786		2,415		15,784		—		2,415		15,784		18,199		(1,030		)	2006	40
Boynton Beach	FL	8,131		1,270		4,773		—		1,270		4,773		6,043		(696		)	2003	40
Clearwater	FL	—		2,250		2,627		—		2,250		2,627		4,877		(393		)	2002	40
Clearwater	FL	18,114		3,856		12,176		—		3,856		12,176		16,032		(2,035		)	2005	40
Clermont	FL	8,497		440		6,518		—		440		6,518		6,958		(458		)	2006	35
Coconut Creek	FL	14,093		2,461		14,104		—		2,461		14,104		16,565		(989		)	2006	40
Delray Beach	FL	11,574		850		6,637		—		850		6,637		7,487		(854		)	2002	43
Gainesville	FL	16,446		1,020		13,490		—		1,020		13,490		14,510		(1,052		)	2006	40
Gainesville	FL	—		1,221		12,226		—		1,221		12,226		13,447		(802		)	2006	40
Jacksonville	FL	44,752		3,250		25,936		—		3,250		25,936		29,186		(5,001		)	2002	35
Jacksonville	FL	—		1,587		15,616		—		1,587		15,616		17,203		(1,004		)	2006	40
Lantana	FL	—		3,520		26,452		—		3,520		26,452		29,972		(2,453		)	2006	30
Ocoee	FL	16,849		2,096		9,322		—		2,096		9,322		11,418		(1,189		)	2005	40
Oviedo	FL	8,760		670		8,071		—		670		8,071		8,741		(557		)	2006	35
Palm Harbor	FL	—		1,462		16,774		500		1,462		17,274		18,736		(1,104		)	2006	40
Pinellas Park	FL	4,051		480		3,911		—		480		3,911		4,391		(1,425		)	1996	35
Port Orange	FL	15,725		2,340		9,898		—		2,340		9,898		12,238		(1,242		)	2005	40
St. Augustine	FL	15,090		830		11,627		—		830		11,627		12,457		(1,336		)	2005	35
Sun City Center	FL	10,257		510		6,120		—		510		6,120		6,630		(984		)	2004	35
Sun City Center	FL	—		3,466		70,810		—		3,466		70,810		74,276		(9,866		)	2004	34
Tallahassee	FL	—		1,331		19,039		—		1,331		19,039		20,370		(1,206		)	2006	40
Tampa	FL	—		600		5,566		—		600		5,566		6,166		(1,197		)	1997	45
Tampa	FL	12,417		800		11,340		—		800		11,340		12,140		(913		)	2006	40
Vero Beach	FL	33,202		2,035		34,993		201		2,035		35,194		37,229		(2,590		)	2006	40
Alpharetta	GA	—		793		8,038		—		793		8,038		8,831		(565		)	2006	40
Atlanta	GA	—		1,211		5,363		—		1,211		5,363		6,574		(407		)	2006	40
Atlanta	GA	—		687		5,633		—		687		5,633		6,320		(475		)	2006	40
Atlanta	GA	—		702		3,567		—		702		3,567		4,269		(273		)	2006	40
Atlanta	GA	—		2,665		5,911		—		2,665		5,911		8,576		(520		)	2006	40
Lilburn	GA	—		907		17,340		—		907		17,340		18,247		(1,194		)	2006	40
Marietta	GA	—		894		6,436		—		894		6,436		7,330		(467		)	2006	40
Milledgeville	GA	—		150		1,957		—		150		1,547		1,697		(465		)	1997	45
Davenport	IA	3,278		511		8,039		—		511		8,039		8,550		(520		)	2006	40
Marion	IA	2,686		502		6,865		—		502		6,865		7,367		(446		)	2006	40
Bloomington	IL	—		798		13,091		—		798		13,091		13,889		(838		)	2006	40
Champaign	IL	—		101		4,207		—		101		4,207		4,308		(299		)	2006	40
Hoffman Estates	IL	—		1,701		12,037		118		1,701		12,155		13,856		(913		)	2006	40

F-46

				Initial Cost to Company		Costs Capitalized	Gross Amount at Which Carried As of December 31, 2008					Year	Life on Which Depreciation in Latest Income
City	State		Encumbrances at 12/31/08(1)	Land	Buildings and Improvements	Subsequent to Acquisition	Land	Buildings and Improvements	Total(2)(3)	Accumulated Depreciation		Acquired/ Constructed	Statement is Computed
Macomb	IL		—	81	6,062	—	81	6,062	6,143	(403	)	2006	40
Mt. Vernon	IL		—	296	15,935	—	296	15,935	16,231	(1,027	)	2006	40
Oak Park	IL		26,581	3,476	31,032	—	3,476	31,032	34,508	(1,961	)	2006	40
Orland Park	IL		—	2,623	23,154	—	2,623	23,154	25,777	(1,550	)	2006	40
Peoria	IL		—	404	10,050	—	404	10,050	10,454	(672	)	2006	40
Wilmette	IL		—	1,100	9,373	—	1,100	9,373	10,473	(615	)	2006	40
Anderson	IN		—	500	4,724	1,733	500	6,057	6,557	(1,295	)	1999	35
Evansville	IN		—	500	9,302	—	500	7,762	8,262	(1,503	)	1999	45
Indianapolis	IN		—	1,197	7,718	—	1,197	7,718	8,915	(525	)	2006	40
Indianapolis	IN		—	1,144	8,261	3,978	1,144	12,239	13,383	(583	)	2006	40
West Lafayette	IN		—	813	10,876	—	813	10,876	11,689	(710	)	2006	40
Mission	KS		—	340	9,322	—	340	8,736	9,076	(1,721	)	2002	35
Overland Park	KS		—	750	8,241	—	750	7,254	8,004	(2,104	)	1998	45
Edgewood	KY		—	1,868	4,934	—	1,868	4,934	6,802	(447	)	2006	40
Lexington	KY		8,010	2,093	16,917	—	2,093	16,917	19,010	(2,998	)	2004	30
Middletown	KY		—	1,499	24,607	—	1,499	24,607	26,106	(1,625	)	2006	40
Danvers	MA		4,958	4,616	30,692	—	4,616	30,692	35,308	(1,957	)	2006	40
Dartmouth	MA		—	3,145	6,880	—	3,145	6,880	10,025	(485	)	2006	40
Dedham	MA		11,055	3,930	21,340	—	3,930	21,340	25,270	(1,427	)	2006	40
Plymouth	MA		—	2,434	9,027	—	2,434	9,027	11,461	(696	)	2006	40
Baltimore	MD		14,646	1,416	8,854	—	1,416	8,854	10,270	(680	)	2006	40
Baltimore	MD		—	1,684	18,889	—	1,684	18,889	20,573	(1,229	)	2006	40
Frederick	MD		3,247	609	9,158	—	609	9,158	9,767	(611	)	2006	40
Westminster	MD		15,780	768	5,251	—	768	5,251	6,019	(1,415	)	1998	45
Cape Elizabeth	ME		—	630	3,524	93	630	3,617	4,247	(522	)	2003	40
Saco	ME		—	80	2,363	155	80	2,518	2,598	(359	)	2003	40
Auburn Hills	MI		—	2,281	10,692	—	2,281	10,692	12,973	(601	)	2006	40
Farmington Hills	MI		4,423	1,013	12,119	—	1,013	12,119	13,132	(817	)	2006	40
Holland	MI		43,618	787	51,410	—	787	51,410	52,197	(8,673	)	2004	29
Portage	MI		—	100	5,700	4,317	100	10,017	10,117	(560	)	2006	40
Sterling Heights	MI		—	920	7,326	—	920	7,326	8,246	(1,535	)	2001	35
Sterling Heights	MI		—	1,593	11,500	—	1,593	11,500	13,093	(772	)	2006	40
Des Peres	MO		—	4,361	20,664	—	4,361	20,664	25,025	(1,406	)	2006	40
Richmond Heights	MO		—	1,744	24,232	—	1,744	24,232	25,976	(1,632	)	2006	40
St. Louis	MO		12,849	2,500	20,343	—	2,500	20,343	22,843	(1,963	)	2006	30
Great Falls	MT		—	500	5,683	—	500	5,683	6,183	(531	)	2006	40
Charlotte	NC		—	710	9,559	—	710	9,559	10,269	(644	)	2006	40
Concord	NC		—	601	7,008	—	601	7,008	7,609	(482	)	2006	40
Raleigh	NC		2,964	1,191	11,532	—	1,191	11,532	12,723	(761	)	2006	40
Cresskill	NJ		—	4,684	35,408	—	4,684	35,408	40,092	(2,380	)	2006	40
Glassboro	NJ		—	162	2,875	—	162	2,875	3,037	(983	)	1997	35
Hillsborough	NJ		16,278	1,042	10,042	—	1,042	10,042	11,084	(1,219	)	2005	40
Madison	NJ		—	3,157	19,909	—	3,157	19,909	23,066	(1,351	)	2006	40
Manahawkin	NJ		14,202	921	9,927	—	921	9,927	10,848	(1,209	)	2005	40
Paramus	NJ		12,226	4,280	31,684	—	4,280	31,684	35,964	(2,058	)	2006	40
Saddle River	NJ		—	1,784	15,625	—	1,784	15,625	17,409	(1,054	)	2006	40
Vineland	NJ		—	177	2,897	—	177	2,897	3,074	(1,004	)	1997	35
Voorhees Township	NJ		8,812	900	7,629	—	900	7,629	8,529	(1,623	)	1998	45
Albuquerque	NM		—	767	9,324	—	767	9,324	10,091	(2,767	)	1996	45
Las Vegas	NV		—	1,960	5,816	—	1,960	5,816	7,776	(730	)	2005	40
Brooklyn	NY		11,388	8,117	23,627	—	8,117	23,627	31,744	(1,579	)	2006	40
Sheepshead Bay	NY		12,094	5,215	39,052	—	5,215	39,052	44,267	(2,532	)	2006	40
Cincinnati	OH		—	600	4,428	—	600	4,428	5,028	(928	)	2001	35
Columbus	OH		6,685	970	7,806	1,023	970	8,829	9,799	(771	)	2006	40
Fairborn	OH		6,862	810	8,311	—	810	8,311	9,121	(698	)	2006	36
Fairborn	OH		—	298	10,704	3,068	298	13,772	14,070	(713	)	2006	40
Marietta	OH		4,720	1,069	11,435	—	1,069	11,435	12,504	(484	)	2007	40
Poland	OH		4,063	695	10,444	—	695	10,444	11,139	(721	)	2006	40
Willoughby	OH		—	1,177	9,982	—	1,177	9,982	11,159	(721	)	2006	40
Oklahoma City	OK		—	801	4,904	—	801	4,904	5,705	(427	)	2006	40
Tulsa	OK		—	1,115	11,028	—	1,115	11,028	12,143	(891	)	2006	40
Haverford	PA		—	16,461	108,816	—	16,461	108,816	125,277	(6,756	)	2006	40
Aiken	SC		—	357	13,875	—	357	13,875	14,232	(980	)	2006	40
Charleston	SC		—	885	13,276	—	885	13,276	14,161	(914	)	2006	40
Columbia	SC		—	408	6,996	—	408	6,996	7,404	(471	)	2006	40
Georgetown	SC		—	239	3,008	—	239	3,008	3,247	(637	)	1998	45
Greenville	SC		—	1,090	12,558	—	1,090	12,558	13,648	(836	)	2006	40
Greenville	SC		—	993	16,314	—	993	16,314	17,307	(1,272	)	2006	40
Lancaster	SC		—	84	2,982	—	84	2,982	3,066	(547	)	1998	45
Myrtle Beach	SC		—	900	10,913	—	900	10,913	11,813	(714	)	2006	40
Rock Hill	SC		—	203	2,671	—	203	2,671	2,874	(545	)	1998	45
Rock Hill	SC		—	695	4,240	—	695	4,240	4,935	(329	)	2006	40
Sumter	SC		—	196	2,623	—	196	2,623	2,819	(556	)	1998	45
Nashville	TN		11,385	812	15,006	—	812	15,006	15,818	(1,139	)	2006	40
Oak Ridge	TN		8,785	500	4,741	—	500	4,741	5,241	(343	)	2006	35
Abilene	TX		2,036	300	2,830	—	300	2,830	3,130	(237	)	2006	39
Arlington	TX		14,568	2,002	16,829	—	2,002	16,829	18,831	(1,140	)	2006	40
Arlington	TX		—	2,494	12,438	—	2,494	12,438	14,932	(964	)	2006	40
Austin	TX		—	2,960	41,645	—	2,960	41,645	44,605	(7,288	)	2002	30
Beaumont	TX		—	145	10,404	—	145	10,404	10,549	(3,035	)	1996	45
Burleson	TX		4,649	1,050	5,242	—	1,050	5,242	6,292	(492	)	2006	40
Carthage	TX		—	83	1,461	—	83	1,461	1,544	(543	)	1995	35
Cedar Hill	TX		9,412	1,070	11,554	—	1,070	11,554	12,624	(950	)	2006	40
Cedar Hill	TX		—	440	7,494	—	440	7,494	7,934	(487	)	2007	40
Conroe	TX		—	167	1,885	—	167	1,885	2,052	(685	)	1996	35
Fort Worth	TX		—	2,830	50,832	—	2,830	50,832	53,662	(8,896	)	2002	30
Friendswood	TX		23,434	400	7,354	—	400	7,354	7,754	(1,062	)	2002	45
Gun Barrel	TX		—	34	1,528	—	34	1,528	1,562	(568	)	1995	35
Houston	TX		11,882	835	7,195	—	835	7,195	8,030	(1,699	)	1997	45
Houston	TX	��	—	2,470	21,710	—	2,470	21,710	24,180	(4,186	)	2002	35
Houston	TX		—	1,008	14,398	—	1,008	14,398	15,406	(970	)	2006	40
Houston	TX		—	1,877	23,916	—	1,877	23,916	25,793	(1,757	)	2006	40
Irving	TX		11,061	710	9,949	—	710	9,949	10,659	(1,156	)	2005	35

F-47

				Initial Cost to Company				Costs Capitalized		Gross Amount at Which Carried As of December 31, 2008									Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)		Land		Buildings and Improvements		Subsequent to Acquisition		Land		Buildings and Improvements		Total(2)(3)		Accumulated Depreciation			Acquired/ Constructed	Statement is Computed
Lubbock	TX	—		197		2,467		—		197		2,467		2,664		(896		)	1996	35
Mesquite	TX	—		100		2,466		—		100		2,466		2,566		(896		)	1995	35
North Richland Hills	TX	3,369		520		5,117		—		520		5,117		5,637		(471		)	2006	40
North Richland Hills	TX	7,138		870		9,259		—		870		9,259		10,129		(878		)	2006	35
Plano	TX	—		494		11,588		—		494		11,588		12,082		(811		)	2006	40
San Antonio	TX	7,991		730		3,961		—		730		3,961		4,691		(594		)	2002	45
Sherman	TX	—		145		1,491		—		145		1,491		1,636		(554		)	1995	35
Temple	TX	—		96		2,081		—		96		2,081		2,177		(683		)	1996	35
The Woodlands	TX	—		802		16,325		—		802		16,325		17,127		(1,094		)	2006	40
Victoria	TX	12,933		175		4,290		3,101		175		7,391		7,566		(1,531		)	1995	43
Waxahachie	TX	2,334		390		3,879		—		390		3,879		4,269		(350		)	2006	40
Salt Lake City	UT	—		2,621		22,072		—		2,621		22,072		24,693		(1,618		)	2006	40
Arlington	VA	10,029		4,320		19,567		—		4,320		19,567		23,887		(1,328		)	2006	40
Arlington	VA	3,342		3,833		7,076		—		3,833		7,076		10,909		(491		)	2006	40
Arlington	VA	13,224		7,278		37,407		—		7,278		37,407		44,685		(2,453		)	2006	40
Chesapeake	VA	—		1,090		12,444		—		1,090		12,444		13,534		(830		)	2006	40
Falls Church	VA	4,094		2,228		8,887		—		2,228		8,887		11,115		(585		)	2006	40
Fort Belvoir	VA	—		11,594		99,528		5,581		11,594		105,109		116,703		(6,551		)	2006	40
Leesburg	VA	988		607		3,236		—		607		3,236		3,843		(264		)	2006	35
Richmond	VA	4,584		2,110		11,469		—		2,110		11,469		13,579		(813		)	2006	40
Sterling	VA	6,918		2,360		22,932		—		2,360		22,932		25,292		(1,492		)	2006	40
Woodbridge	VA	—		950		6,983		—		950		6,983		7,933		(1,594		)	1997	45
Bellevue	WA	—		3,734		16,171		—		3,734		16,171		19,905		(1,132		)	2006	40
Edmonds	WA	—		1,418		16,502		—		1,418		16,502		17,920		(1,113		)	2006	40
Kirkland	WA	5,854		1,000		13,403		—		1,000		13,403		14,403		(1,360		)	2005	40
Lynnwood	WA	—		1,203		7,415		—		1,203		7,415		8,618		(417		)	2006	40
Mercer Island	WA	3,671		4,209		8,123		—		4,209		8,123		12,332		(538		)	2006	40
Shoreline	WA	9,866		1,590		10,671		—		1,590		10,671		12,261		(1,157		)	2005	40
Shoreline	WA	—		4,030		26,421		—		4,030		26,421		30,451		(2,629		)	2005	39
Snohomish	WA	—		1,541		10,228		—		1,541		10,228		11,769		(675		)	2006	40
		$	1,014,536	$	395,800	$	3,019,939	$	23,868	$	395,800	$	3,039,884	$	3,435,684	$	(288,725	)
Life Science
Brisbane	CA	$	—	$	50,989	$	1,789	$	11,259	$	50,989	$	13,048	$	64,037	$	—		2007		*
Carlsbad	CA	—		30,300		—		1,702		30,300		1,702		32,002		—			2007		*
Carlsbad	CA	—		23,475		—		2,469		23,475		2,469		25,944		—			2007		*
Hayward	CA	—		900		7,100		2		900		7,102		8,002		(251		)	2007	40
Hayward	CA	—		1,500		6,400		8		1,500		6,408		7,908		(227		)	2007	40
Hayward	CA	—		1,900		7,100		3		1,900		7,103		9,003		(251		)	2007	40
Hayward	CA	—		2,200		17,200		5		2,200		17,205		19,405		(609		)	2007	40
Hayward	CA	—		1,000		3,200		5		1,000		3,205		4,205		(113		)	2007	40
Hayward	CA	—		801		5,740		27		801		5,767		6,568		(280		)	2007	29
Hayward	CA	—		539		3,864		18		539		3,882		4,421		(188		)	2007	29
Hayward	CA	—		526		3,771		18		526		3,789		4,315		(184		)	2007	29
Hayward	CA	—		944		6,769		32		944		6,801		7,745		(330		)	2007	29
Hayward	CA	—		953		6,829		32		953		6,861		7,814		(333		)	2007	29
Hayward	CA	—		991		7,105		33		991		7,138		8,129		(346		)	2007	29
Hayward	CA	—		1,210		8,675		41		1,210		8,716		9,926		(423		)	2007	29
Hayward	CA	—		2,736		6,868		32		2,736		6,900		9,636		(335		)	2007	29
La Jolla	CA	—		5,200		—		—		5,200		—		5,200		—			2007	N/A
La Jolla	CA	—		9,600		25,283		1,026		9,615		26,294		35,909		(937		)	2007	40
La Jolla	CA	—		6,200		19,883		48		6,210		19,921		26,131		(704		)	2007	40
La Jolla	CA	—		7,200		12,412		1,449		7,212		13,849		21,061		(703		)	2007	27
La Jolla	CA	—		8,700		16,983		210		8,715		17,178		25,893		(785		)	2007	30
Mountain View	CA	—		7,300		25,410		179		7,300		25,589		32,889		(901		)	2007	40
Mountain View	CA	—		6,500		22,800		5		6,500		22,805		29,305		(808		)	2007	40
Mountain View	CA	—		4,800		9,500		286		4,800		9,786		14,586		(339		)	2007	40
Mountain View	CA	—		4,200		8,400		654		4,209		9,045		13,254		(316		)	2007	40
Mountain View	CA	—		3,600		9,700		13		3,600		9,713		13,313		(344		)	2007	40
Mountain View	CA	—		7,500		16,300		607		7,500		16,907		24,407		(769		)	2007	40
Mountain View	CA	—		9,800		24,000		8		9,800		24,008		33,808		(850		)	2007	40
Mountain View	CA	—		6,900		17,800		4		6,900		17,804		24,704		(630		)	2007	40
Mountain View	CA	—		7,000		17,000		7		7,000		17,007		24,007		(602		)	2007	40
Mountain View	CA	—		14,100		31,002		7,974		14,100		38,976		53,076		(1,176		)	2007	40
Mountain View	CA	—		7,100		25,800		8,151		7,100		33,951		41,051		(1,458		)	2007	40
Poway	CA	—		47,700		3,512		—		47,700		3,512		51,212		—			2007		*
Poway	CA	—		29,943		2,475		1,109		29,943		3,584		33,527		—			2007		*
Poway	CA	—		5,000		12,200		5,706		5,000		17,906		22,906		(491		)	2007	40
Poway	CA	—		5,200		14,200		4,253		5,200		18,453		23,653		(542		)	2007	40
Poway	CA	—		6,700		14,400		2,955		6,700		17,355		24,055		(510		)	2007	40
Redwood City	CA	—		3,400		5,500		464		3,400		5,964		9,364		(283		)	2007	40
Redwood City	CA	—		2,500		4,100		303		2,500		4,403		6,903		(187		)	2007	40
Redwood City	CA	—		3,600		4,600		285		3,600		4,885		8,485		(217		)	2007	30
Redwood City	CA	—		3,100		5,100		588		3,100		5,688		8,788		(251		)	2007	31
Redwood City	CA	—		4,800		17,300		271		4,800		17,571		22,371		(613		)	2007	31
Redwood City	CA	—		5,400		15,500		342		5,400		15,842		21,242		(549		)	2007	31
Redwood City	CA	—		3,000		3,500		245		3,000		3,745		6,745		(191		)	2007	40
Redwood City	CA	—		6,000		14,300		2,367		6,000		16,667		22,667		(533		)	2007	40
Redwood City	CA	—		1,900		12,800		1,255		1,900		14,055		15,955		(373		)	2007		*
Redwood City	CA	—		2,700		11,300		1,027		2,700		12,327		15,027		(330		)	2007		*
Redwood City	CA	—		2,700		10,900		1,231		2,700		12,131		14,831		(386		)	2007	40
Redwood City	CA	—		2,200		12,000		863		2,200		12,863		15,063		(425		)	2007	38
Redwood City	CA	—		2,600		9,300		750		2,600		10,050		12,650		(329		)	2007	26
Redwood City	CA	—		3,300		18,000		123		3,300		18,123		21,423		(638		)	2007	40
Redwood City	CA	—		3,300		17,900		123		3,300		18,023		21,323		(634		)	2007	40
San Diego	CA	—		7,872		34,617		17,143		7,872		51,760		59,632		(4,634		)	2002	39
San Diego	CA	11,843		7,740		22,654		63		7,740		22,717		30,457		(648		)	2007	38
San Diego	CA	—		2,040		903		—		2,040		903		2,943		(75		)	2006	35
San Diego	CA	—		4,630		2,028		—		4,630		2,028		6,658		(169		)	2006	35
San Diego	CA	—		3,940		3,184		2,554		3,940		5,738		9,678		(802		)	2006	40
San Diego	CA	—		5,690		4,579		586		5,690		5,165		10,855		(476		)	2006	40
San Diego	CA	—		6,524		—		744		6,524		744		7,268		—			2007		*
South San Francisco	CA	—		4,900		18,100		—		4,900		18,100		23,000		(641		)	2007	40
South San Francisco	CA	—		8,000		27,700		—		8,000		27,700		35,700		(981		)	2007	40

F-48

				Initial Cost to Company				Costs Capitalized		Gross Amount at Which Carried As of December 31, 2008									Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)		Land		Buildings and Improvements		Subsequent to Acquisition		Land		Buildings and Improvements		Total(2)(3)		Accumulated Depreciation			Acquired/ Constructed	Statement is Computed
South San Francisco	CA	—		8,000		28,299		—		8,000		28,299		36,299		(1,002		)	2007	40
South San Francisco	CA	—		3,700		20,800		—		3,700		20,800		24,500		(737		)	2007	40
South San Francisco	CA	—		11,700		31,243		—		11,700		31,243		42,943		(1,107		)	2007	40
South San Francisco	CA	—		7,000		33,779		—		7,000		33,779		40,779		(1,196		)	2007	40
South San Francisco	CA	—		14,800		7,600		1,704		14,800		9,304		24,104		(369		)	2007	30
South San Francisco	CA	—		8,400		33,144		—		8,400		33,144		41,544		(1,174		)	2007	40
South San Francisco	CA	—		7,000		15,500		—		7,000		15,500		22,500		(549		)	2007	40
South San Francisco	CA	—		11,900		68,848		—		11,900		68,848		80,748		(2,438		)	2007	40
South San Francisco	CA	—		10,000		57,954		—		10,000		57,954		67,954		(2,053		)	2007	40
South San Francisco	CA	—		9,300		43,549		—		9,300		43,549		52,849		(1,542		)	2007	40
South San Francisco	CA	—		11,000		47,289		—		11,000		47,289		58,289		(1,675		)	2007	40
South San Francisco	CA	—		13,200		60,932		1,013		13,200		61,945		75,145		(1,544		)	2007	40
South San Francisco	CA	—		10,500		33,776		—		10,500		33,776		44,276		(1,196		)	2007	40
South San Francisco	CA	—		10,600		34,083		—		10,600		34,083		44,683		(1,207		)	2007	40
South San Francisco	CA	—		14,100		71,344		52		14,100		71,396		85,496		(2,527		)	2007	40
South San Francisco	CA	—		12,800		63,600		472		12,800		64,072		76,872		(2,258		)	2007	40
South San Francisco	CA	—		11,200		79,222		20		11,200		79,242		90,442		(2,806		)	2007	40
South San Francisco	CA	—		7,200		50,856		66		7,200		50,922		58,122		(1,801		)	2007	40
South San Francisco	CA	—		14,400		101,362		106		14,400		101,468		115,868		(3,581		)	2007	40
South San Francisco	CA	—		10,900		20,900		4,040		10,900		24,940		35,840		(1,043		)	2007	40
South San Francisco	CA	—		3,600		100		3		3,600		103		3,703		(27		)	2007	5
South San Francisco	CA	—		2,300		100		3		2,300		103		2,403		(28		)	2007	5
South San Francisco	CA	—		3,900		200		3		3,900		203		4,103		(57		)	2007	5
South San Francisco	CA	—		6,000		600		380		6,000		980		6,980		(575		)	2007		*
South San Francisco	CA	—		6,100		700		—		6,100		700		6,800		(331		)	2007		*
South San Francisco	CA	—		6,700		—		10		6,700		10		6,710		—			2007		*
South San Francisco	CA	—		10,100		24,013		2,115		10,100		26,128		36,228		(1,044		)	2007	40
South San Francisco	CA	—		—		—		11		—		11		11		—			2007		*
South San Francisco	CA	—		11,100		47,738		9,281		11,100		57,019		68,119		(851		)	2007	40
South San Francisco	CA	—		9,700		41,937		5,196		9,700		47,133		56,833		(857		)	2007	40
South San Francisco	CA	—		6,300		22,900		8,147		6,300		31,047		37,347		(469		)	2007		*
South San Francisco	CA	—		32,210		3,110		217		32,210		3,327		35,537		—			2007		*
South San Francisco	CA	—		6,100		2,300		111		6,100		2,411		8,511		(652		)	2007		*
South San Francisco	CA	—		13,800		42,500		17,560		13,800		60,060		73,860		—			2007		*
South San Francisco	CA	—		14,500		45,300		18,564		14,500		63,864		78,364		—			2007		*
South San Francisco	CA	—		9,400		24,800		13,573		9,400		38,373		47,773		—			2007		*
South San Francisco	CA	—		5,666		5,773		119		5,666		5,892		11,558		(1,270		)	2007	5
South San Francisco	CA	—		1,205		1,293		—		1,205		1,293		2,498		(280		)	2007	5
South San Francisco	CA	3,414		9,000		17,800		(4)		9,000		17,796		26,796		(630		)	2007	40
South San Francisco	CA	4,546		10,100		22,521		—		10,100		22,521		32,621		(798		)	2007	40
South San Francisco	CA	4,656		10,700		23,621		—		10,700		23,621		34,321		(837		)	2007	40
South San Francisco	CA	7,291		18,000		38,043		—		18,000		38,043		56,043		(1,347		)	2007	40
South San Francisco	CA	7,618		28,600		48,700		33		28,600		48,733		77,333		(1,967		)	2007	35
Salt Lake City	UT	—		500		8,548		—		500		8,548		9,048		(1,881		)	2001	33
Salt Lake City	UT	—		890		15,623		1		890		15,624		16,514		(3,027		)	2001	38
Salt Lake City	UT	—		190		9,875		—		190		9,875		10,065		(1,644		)	2001	43
Salt Lake City	UT	—		630		6,921		—		630		6,921		7,551		(1,384		)	2001	38
Salt Lake City	UT	—		125		6,368		—		125		6,368		6,493		(1,060		)	2001	43
Salt Lake City	UT	—		—		14,614		—		—		14,614		14,614		(1,925		)	2001	43
Salt Lake City	UT	—		280		4,345		—		280		4,345		4,625		(627		)	2002	43
Salt Lake City	UT	—		—		6,517		—		—		6,517		6,517		(787		)	2002	35
Salt Lake City	UT	—		—		14,600		83		—		14,683		14,683		(666		)	2005	40
		$	39,368	$	868,439	$	2,102,875	$	164,536	$	868,500	$	2,267,350	$	3,135,850	$	(87,926	)
Medical office
Anchorage	AK	$	6,739	$	1,456	$	10,650	$	35	$	1,456	$	10,685	$	12,141	$	(678	)	2000	34
Chandler	AZ	—		3,669		13,503		1,132		3,669		14,635		18,304		(1,664		)	2002	40
Oro Valley	AZ	—		1,050		6,774		23		1,050		6,797		7,847		(1,438		)	2001	43
Phoenix	AZ	—		780		3,199		815		780		4,014		4,794		(1,233		)	1999	32
Phoenix	AZ	—		280		877		—		280		877		1,157		(142		)	2001	43
Scottsdale	AZ	—		5,115		14,064		254		5,115		14,318		19,433		(833		)	2006	40
Tucson	AZ	—		215		6,318		5		215		6,323		6,538		(1,478		)	2000	35
Tucson	AZ	—		215		3,940		104		215		4,044		4,259		(687		)	2003	43
Brentwood	CA	—		—		30,864		1,110		—		31,974		31,974		(1,783		)	2006	40
Encino	CA	7,089		6,151		10,438		627		6,181		11,035		17,216		(775		)	2006	33
Los Angeles	CA	—		2,848		5,879		558		2,947		6,338		9,285		(3,250		)	1997	21
Murietta	CA	—		400		9,266		981		439		10,208		10,647		(2,930		)	1999	33
Poway	CA	—		2,700		10,839		804		2,700		11,643		14,343		(4,148		)	1997	35
Sacramento	CA	12,116		2,860		21,850		—		2,860		21,080		23,940		(6,105		)	1998		*
San Diego	CA	7,657		2,863		8,913		1,839		3,006		10,609		13,615		(4,451		)	1997	21
San Diego	CA	—		4,619		19,370		2,981		4,619		22,351		26,970		(10,141		)	1997	21
San Diego	CA	—		2,910		17,362		—		2,910		17,362		20,272		(4,547		)	1999		*
San Jose	CA	2,764		1,935		1,728		587		1,935		2,315		4,250		(398		)	2003	37
San Jose	CA	6,436		1,460		7,672		146		1,460		7,818		9,278		(1,118		)	2003	37
San Jose	CA	3,290		1,718		3,124		104		1,718		3,228		4,946		(228		)	2000	34
Sherman Oaks	CA	—		7,472		10,075		1,023		7,492		11,078		18,570		(1,094		)	2006	22
Valencia	CA	—		2,300		6,967		807		2,309		7,365		9,674		(2,273		)	1999	35
Valencia	CA	—		1,344		7,507		150		1,344		7,657		9,001		(431		)	2006	40
West Hills	CA	—		2,100		11,595		1,107		2,100		11,802		13,902		(4,060		)	1999	32
Aurora	CO	—		—		8,764		500		—		9,264		9,264		(1,190		)	2005	39
Aurora	CO	4,565		210		12,362		243		210		12,605		12,815		(729		)	2006	40
Aurora	CO	5,090		200		8,414		213		200		8,627		8,827		(586		)	2006	33
Colorado Springs	CO	—		—		12,933		3,706		—		16,639		16,639		(687		)	2007	40
Conifer	CO	804		—		1,485		22		—		1,507		1,507		(118		)	2005	40
Denver	CO	4,428		493		7,897		34		493		7,931		8,424		(539		)	2006	33
Englewood	CO	—		—		8,616		1,021		—		9,637		9,637		(972		)	2005	35
Englewood	CO	—		—		8,449		755		—		9,204		9,204		(932		)	2005	35
Englewood	CO	—		—		8,040		1,231		—		9,271		9,271		(760		)	2005	35
Englewood	CO	4,410		—		8,472		506		—		8,978		8,978		(801		)	2005	35
Littleton	CO	—		—		4,562		535		—		5,097		5,097		(521		)	2005	35
Littleton	CO	—		—		4,926		568		—		5,494		5,494		(440		)	2005	38
Lone Tree	CO	—		—		—		18,102		—		18,102		18,102		(2,076		)	2003	39
Lone Tree	CO	15,239		—		23,274		35		—		23,309		23,309		(1,331		)	2000	37
Parker	CO	—		—		13,388		61		—		13,449		13,449		(818		)	2006	40

F-49

			Initial Cost to Company		Costs Capitalized	Gross Amount at Which Carried As of December 31, 2008					Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)	Land	Buildings and Improvements	Subsequent to Acquisition	Land	Buildings and Improvements	Total(2)(3)	Accumulated Depreciation		Acquired/ Constructed	Statement is Computed
Thornton	CO	—	236	10,206	798	236	11,004	11,240	(1,687	)	2002	43
Atlantis	FL	—	—	5,651	270	4	5,917	5,921	(1,795	)	1999	35
Atlantis	FL	—	—	2,027	24	—	2,051	2,051	(525	)	1999	34
Atlantis	FL	—	—	2,000	266	—	2,266	2,266	(621	)	1999	32
Atlantis	FL	—	455	2,231	212	455	2,443	2,898	(196	)	2000	34
Atlantis	FL	2,796	1,507	2,894	112	1,507	3,006	4,513	(234	)	2000	34
Englewood	FL	—	170	1,134	51	170	1,185	1,355	(79	)	2000	34
Kissimmee	FL	318	788	174	56	788	230	1,018	(16	)	2000	34
Kissimmee	FL	483	481	347	132	481	479	960	(35	)	2000	34
Kissimmee	FL	5,982	—	7,574	570	—	8,144	8,144	(606	)	2000	36
Margate	FL	4,605	1,553	6,898	97	1,553	6,995	8,548	(445	)	2000	34
Miami	FL	9,226	4,392	11,841	568	4,392	12,409	16,801	(815	)	2000	34
Milton	FL	—	—	8,566	122	—	8,688	8,688	(490	)	2006	40
Orlando	FL	—	2,144	5,136	904	2,144	6,040	8,184	(953	)	2003	37
Pace	FL	—	—	10,309	2,304	—	12,613	12,613	(1,230	)	2006	44
Pensacola	FL	—	—	11,166	—	—	11,166	11,166	(703	)	2006	45
Plantation	FL	850	969	3,241	346	969	3,587	4,556	(240	)	2000	34
Plantation	FL	5,482	1,091	7,176	279	1,091	7,455	8,546	(507	)	2002	36
St. Petersburg	FL	13,000	—	10,141	908	—	11,049	11,049	(687	)	2004	38
Tampa	FL	5,743	1,967	6,602	1,064	2,042	7,591	9,633	(709	)	2006	25
McCaysville	GA	—	—	3,231	18	—	3,249	3,249	(183	)	2006	40
Marion	IL	—	100	11,484	46	100	11,530	11,630	(691	)	2006	40
Newburgh	IN	8,766	—	14,019	1,075	—	15,094	15,094	(823	)	2006	40
Wichita	KS	2,242	530	3,341	23	530	3,364	3,894	(535	)	2001	45
Lexington	KY	—	—	12,726	553	—	13,279	13,279	(787	)	2006	40
Louisville	KY	6,070	936	8,426	2,061	936	10,487	11,423	(3,046	)	2005	11
Louisville	KY	19,901	835	27,627	1,011	835	28,638	29,473	(3,154	)	2005	37
Louisville	KY	5,061	780	8,582	1,293	780	9,875	10,655	(1,989	)	2005	18
Louisville	KY	8,181	826	13,814	1,297	826	15,111	15,937	(1,768	)	2005	38
Louisville	KY	8,858	2,983	13,171	1,213	2,983	14,384	17,367	(1,895	)	2005	30
Haverhill	MA	—	800	8,537	15	800	8,552	9,352	(392	)	2007	40
Columbia	MD	3,604	1,115	3,206	456	1,115	3,662	4,777	(264	)	2006	34
Glen Burnie	MD	3,476	670	5,085	—	670	5,085	5,755	(1,404	)	1999	35
Towson	MD	11,293	—	14,233	3,470	—	17,703	17,703	(1,622	)	2006	40
Minneapolis	MN	8,136	117	13,213	432	117	13,645	13,762	(4,260	)	1997	32
Minneapolis	MN	2,810	160	10,131	338	160	10,469	10,629	(3,257	)	1997	35
St. Louis/Shrews	MO	3,342	1,650	3,767	447	1,650	4,214	5,864	(1,073	)	1999	35
Jackson	MS	—	—	8,869	8	—	8,877	8,877	(499	)	2006	40
Jackson	MS	5,390	—	7,187	1,325	—	8,512	8,512	(459	)	2006	40
Jackson	MS	—	—	8,413	148	—	8,561	8,561	(493	)	2006	40
Omaha	NE	13,729	—	16,243	24	—	16,267	16,267	(957	)	2006	40
Albuquerque	NM	—	—	5,380	—	—	5,380	5,380	(416	)	2005	39
Elko	NV	—	55	2,637	—	55	2,637	2,692	(746	)	1999	35
Las Vegas	NV	—	—	—	17,250	—	17,250	17,250	(2,308	)	2003	40
Las Vegas	NV	3,768	1,121	4,363	1,122	1,121	5,485	6,606	(389	)	2000	34
Las Vegas	NV	3,928	2,125	4,829	792	2,125	5,621	7,746	(484	)	2000	34
Las Vegas	NV	7,513	3,480	12,305	854	3,480	13,159	16,639	(986	)	2000	34
Las Vegas	NV	1,085	1,717	3,597	1,125	1,717	4,722	6,439	(365	)	2000	34
Las Vegas	NV	2,211	1,172	1,550	274	1,172	1,824	2,996	(189	)	2000	34
Las Vegas	NV	—	3,244	18,339	1,401	3,273	19,711	22,984	(2,993	)	2004	30
Cleveland	OH	—	823	2,726	167	828	2,888	3,716	(435	)	2006	40
Harrison	OH	2,578	—	4,561	—	—	4,561	4,561	(1,195	)	1999	35
Durant	OK	—	619	9,256	1,039	619	10,295	10,914	(549	)	2006	40
Owasso	OK	—	—	6,582	211	—	6,793	6,793	(668	)	2005	40
Roseburg	OR	—	—	5,707	—	—	5,707	5,707	(1,413	)	1999	35
Clarksville	TN	—	765	4,184	—	765	4,184	4,949	(1,284	)	1998	35
Hendersonville	TN	—	256	1,530	443	256	1,973	2,229	(196	)	2000	34
Hermitage	TN	—	830	5,036	4,311	830	9,347	10,177	(1,189	)	2003	35
Hermitage	TN	—	596	9,698	725	596	10,423	11,019	(1,672	)	2003	37
Hermitage	TN	—	317	6,528	503	317	7,031	7,348	(1,145	)	2003	37
Knoxville	TN	—	700	4,559	—	700	4,559	5,259	(1,888	)	1994	35
Murfreesboro	TN	6,221	900	12,706	—	900	12,706	13,606	(3,264	)	1999	35
Nashville	TN	9,822	955	14,289	356	955	14,645	15,600	(1,006	)	2000	34
Nashville	TN	4,043	2,050	5,211	349	2,050	5,560	7,610	(380	)	2000	34
Nashville	TN	573	1,007	181	76	1,007	257	1,264	(28	)	2000	34
Nashville	TN	5,725	2,980	7,164	181	2,980	7,345	10,325	(476	)	2000	34
Nashville	TN	578	515	848	—	515	848	1,363	(53	)	2000	34
Nashville	TN	962	266	1,305	228	266	1,533	1,799	(131	)	2000	34
Nashville	TN	5,472	827	7,642	421	827	8,063	8,890	(527	)	2000	34
Nashville	TN	10,338	5,425	12,577	305	5,425	12,882	18,307	(857	)	2000	34
Nashville	TN	9,452	3,818	15,185	1,346	3,818	16,531	20,349	(1,181	)	2000	34
Nashville	TN	471	583	450	—	583	450	1,033	(28	)	2000	34
Arlington	TX	9,220	769	12,355	497	769	12,852	13,621	(835	)	2003	34
Conroe	TX	3,011	324	4,842	1,140	324	5,982	6,306	(451	)	2000	34
Conroe	TX	5,538	397	7,966	650	397	8,616	9,013	(610	)	2000	34
Conroe	TX	5,787	388	7,975	37	388	8,012	8,400	(466	)	2000	37
Conroe	TX	1,892	188	3,618	25	188	3,643	3,831	(232	)	2000	34
Corpus Christi	TX	5,462	717	8,181	1,646	717	9,827	10,544	(708	)	2000	34
Corpus Christi	TX	3,191	328	3,210	1,197	328	4,407	4,735	(320	)	2000	34
Corpus Christi	TX	1,524	313	1,771	249	313	2,020	2,333	(147	)	2000	34
Dallas	TX	5,692	1,664	6,785	816	1,664	7,601	9,265	(544	)	2000	34
Dallas	TX	—	15,230	162,971	1,545	15,230	164,516	179,746	(9,064	)	2006	35
Fort Worth	TX	3,141	898	4,866	528	898	5,394	6,292	(370	)	2000	34
Fort Worth	TX	2,249	—	2,481	246	2	2,725	2,727	(380	)	2005	25
Fort Worth	TX	4,600	—	6,070	116	5	6,181	6,186	(522	)	2005	40
Granbury	TX	—	—	6,863	80	—	6,943	6,943	(393	)	2006	40
Houston	TX	10,574	1,927	33,140	—	1,927	33,140	35,067	(8,887	)	1999	35
Houston	TX	10,146	2,200	19,585	1,454	2,203	21,036	23,239	(10,325	)	1999	17
Houston	TX	3,373	1,033	3,165	341	1,033	3,506	4,539	(269	)	2000	34
Houston	TX	10,469	1,676	12,602	289	1,706	12,861	14,567	(923	)	2000	34
Houston	TX	2,051	257	2,884	201	257	3,085	3,342	(205	)	2000	35
Houston	TX	—	—	7,414	464	7	7,871	7,878	(566	)	2004	36
Houston	TX	7,680	—	4,838	3,171	—	8,009	8,009	(455	)	2006	40

F-50

				Initial Cost to Company				Costs Capitalized		Gross Amount at Which Carried As of December 31, 2008									Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)		Land		Buildings and Improvements		Subsequent to Acquisition		Land		Buildings and Improvements		Total(2)(3)		Accumulated Depreciation			Acquired/ Constructed	Statement is Computed
Irving	TX	5,954		828		6,160		189		828		6,349		7,177		(426		)	2000	34
Irving	TX	—		—		8,550		446		—		8,996		8,996		(583		)	2004	34
Irving	TX	7,230		1,604		16,107		425		1,604		16,532		18,136		(937		)	2006	40
Irving	TX	6,538		1,955		12,793		19		1,955		12,812		14,767		(721		)	2006	40
Lancaster	TX	—		162		3,830		241		162		4,071		4,233		(251		)	2006	39
Lewisville	TX	5,562		561		8,043		86		561		8,129		8,690		(528		)	2000	34
Longview	TX	—		102		7,998		—		102		7,998		8,100		(2,625		)	1992	45
Lufkin	TX	—		338		2,383		—		338		2,383		2,721		(745		)	1992	45
McKinney	TX	—		541		6,217		182		541		6,399		6,940		(1,202		)	2003	36
McKinney	TX	—		—		636		7,353		—		7,989		7,989		(1,221		)	2003	40
Nassau Bay	TX	5,816		812		8,883		290		812		9,173		9,985		(588		)	2000	37
North Richland Hills	TX	—		—		8,942		175		—		9,117		9,117		(538		)	2006	40
Pampa	TX	—		84		3,242		54		84		3,296		3,380		(1,057		)	1992	45
Pearland	TX	6,752		—		4,014		3,598		—		7,612		7,612		(431		)	2006	40
Plano	TX	4,307		1,700		7,810		335		1,700		8,145		9,845		(2,862		)	1999	25
Plano	TX	8,179		1,210		9,588		461		1,210		10,049		11,259		(703		)	2000	34
Plano	TX	11,116		1,389		12,768		476		1,389		13,244		14,633		(909		)	2002	36
Plano	TX	—		2,049		18,793		825		2,059		19,608		21,667		(2,166		)	2006	40
Plano	TX	—		3,300		—		—		3,300		—		3,300		—			2006	N/A
San Antonio	TX	—		—		9,193		516		12		9,697		9,709		(833		)	2006	35
San Antonio	TX	5,146		—		8,699		370		—		9,069		9,069		(778		)	2006	35
Sugarland	TX	4,122		1,078		5,158		443		1,084		5,595		6,679		(415		)	2000	34
Texarkana	TX	7,036		1,117		7,423		78		1,177		7,441		8,618		(448		)	2006	40
Texas City	TX	6,739		—		9,519		157		—		9,676		9,676		(570		)	2000	37
Victoria	TX	—		125		8,977		—		125		8,977		9,102		(2,807		)	1994	45
Bountiful	UT	—		276		5,237		—		276		5,237		5,513		(1,531		)	1995	45
Castle Dale	UT	—		50		1,818		63		50		1,881		1,931		(521		)	1998	35
Centerville	UT	255		300		1,288		170		300		1,458		1,758		(401		)	1999	35
Grantsville	UT	—		50		429		—		50		429		479		(121		)	1999	35
Kaysville	UT	—		530		4,493		—		530		4,493		5,023		(732		)	2001	43
Layton	UT	473		—		2,827		—		—		2,827		2,827		(740		)	1999	35
Layton	UT	—		371		7,073		90		389		7,145		7,534		(1,608		)	2001	35
Ogden	UT	311		180		1,695		52		180		1,747		1,927		(518		)	1999	35
Ogden	UT	—		106		4,464		225		106		4,689		4,795		(453		)	2006	40
Orem	UT	—		337		8,744		528		306		9,303		9,609		(3,051		)	1999	35
Providence	UT	—		240		3,876		130		240		4,006		4,246		(1,249		)	1999	35
Salt Lake City	UT	—		190		779		61		201		829		1,030		(228		)	1999	35
Salt Lake City	UT	1,803		180		14,792		297		180		15,089		15,269		(4,291		)	1999	35
Salt Lake City	UT	—		3,000		7,541		152		3,000		7,693		10,693		(1,431		)	2001	38
Salt Lake City	UT	—		509		4,044		442		509		4,486		4,995		(701		)	2003	37
Salt Lake City	UT	—		220		10,732		481		220		11,213		11,433		(3,241		)	1999	35
Springville	UT	—		85		1,493		52		85		1,545		1,630		(427		)	1999	35
Stansbury	UT	2,170		450		3,201		87		450		3,288		3,738		(557		)	2001	45
Washington Terrace	UT	—		—		4,573		142		—		4,715		4,715		(1,519		)	1999	35
Washington Terrace	UT	—		—		2,692		100		—		2,792		2,792		(938		)	1999	35
West Valley	UT	—		410		8,266		1,002		410		9,268		9,678		(1,606		)	2002	35
West Valley	UT	—		1,070		17,463		15		1,070		17,478		18,548		(4,928		)	1999	35
Fairfax	VA	—		8,396		16,710		1,251		8,396		17,961		26,357		(1,395		)	2006	28
Reston	VA	—		—		11,902		43		—		11,945		11,945		(1,492		)	2003	43
Renton	WA	—		—		18,724		333		—		19,057		19,057		(5,299		)	1999	35
Seattle	WA	—		—		52,703		1,511		—		54,214		54,214		(8,073		)	2004	39
Seattle	WA	—		—		24,382		1,274		21		25,635		25,656		(3,598		)	2004	36
Seattle	WA	—		—		5,625		500		—		6,125		6,125		(2,344		)	2004	10
Seattle	WA	—		—		7,293		765		—		8,058		8,058		(1,553		)	2004	33
Seattle	WA	—		—		38,925		91		—		39,016		39,016		(1,957		)	2007	30
Charleston	WV	—		465		271		53		465		324		789		(34		)	2000	34
Charleston	WV	—		803		1,436		372		803		1,808		2,611		(155		)	2000	34
Mexico City	DF	—		415		3,739		—		415		3,739		4,154		(522		)	2006	40
		$	499,820	$	187,661	$	1,714,438	$	142,232	$	188,268	$	1,853,993	$	2,042,261	$	(257,180	)
Hospital
Little Rock	AR	$	—	$	709	$	9,604	$	—	$	709	$	9,604	$	10,313	$	(3,883	)	1990	45
Peoria	AZ	—		1,565		7,050		—		1,565		7,050		8,615		(2,955		)	1988	45
Fresno	CA	—		3,652		29,113		1,994		3,652		31,107		34,759		(1,652		)	2006	40
Irvine	CA	—		18,000		70,800		—		18,000		70,800		88,800		(18,549		)	1999	35
Colorado Springs	CO	—		690		8,338		—		690		8,338		9,028		(3,335		)	1989	45
Palm Beach Garden	FL	—		4,200		58,250		—		4,200		58,250		62,450		(15,258		)	1999	35
Roswell	GA	—		6,900		55,300		—		6,900		54,859		61,759		(14,426		)	1999	35
Atlanta	GA	—		4,300		13,690		—		4,300		13,690		17,990		(1,750		)	2007	40
Overland Park	KS	—		2,316		10,681		—		2,316		10,681		12,997		(4,635		)	1989	45
Slidell	LA	—		3,514		23,410		—		3,514		23,410		26,924		(11,452		)	1985	40
Slidell	LA	—		1,490		22,034		—		1,490		22,034		23,524		(1,611		)	2006	40
Baton Rouge	LA	—		690		8,545		—		690		8,545		9,235		(394		)	2007	40
Hickory	NC	—		2,600		69,900		—		2,600		69,900		72,500		(18,307		)	1999	35
Dallas	TX	—		1,820		8,508		26		1,820		8,534		10,354		(738		)	2007	40
Dallas	TX	—		18,840		138,235		—		18,840		138,235		157,075		(7,523		)	2007	35
Plano	TX	—		6,290		22,686		—		6,290		22,686		28,976		(959		)	2007	25
San Antonio	TX	—		1,990		11,184		—		1,990		11,174		13,164		(5,114		)	1987	45
Greenfield	WI	—		620		9,542		—		620		9,542		10,162		(700		)	2006	40
		$	—	$	80,186	$	576,870	$	2,020	$	80,186	$	578,439	$	658,625	$	(113,241	)
Skilled nursing
Livermore	CA	$	—	$	610	$	1,711	$	1,125	$	610	$	2,836	$	3,446	$	(1,720	)	1985	25
Perris	CA	—		336		3,021		—		336		3,021		3,357		(1,112		)	1998	25
Vista	CA	—		653		6,012		90		653		6,102		6,755		(2,441		)	1997	25
Fort Collins	CO	—		499		1,913		1,454		499		3,367		3,866		(2,058		)	1985	25
Morrison	CO	—		1,429		5,464		4,019		1,429		9,483		10,912		(5,457		)	1985	24
Statesboro	GA	—		168		1,508		—		168		1,508		1,676		(578		)	1992	25
Rexburg	ID	—		200		5,310		—		200		5,310		5,510		(1,764		)	1998	35
Angola	IN	—		130		2,900		—		130		2,900		3,030		(760		)	1999	35
Fort Wayne	IN	—		200		4,150		2,667		200		6,817		7,017		(1,187		)	1999	38
Fort Wayne	IN	—		140		3,760		—		140		3,760		3,900		(985		)	1999	35
Huntington	IN	—		30		2,970		338		30		3,308		3,338		(786		)	1999	35
Jasper	IN	—		165		5,952		359		165		6,311		6,476		(1,354		)	2001	35

F-51

				Initial Cost to Company				Costs Capitalized		Gross Amount at Which Carried As of December 31, 2008									Year	Life on Which Depreciation in Latest Income
City	State	Encumbrances at 12/31/08(1)		Land		Buildings and Improvements		Subsequent to Acquisition		Land		Buildings and Improvements		Total(2)(3)		Accumulated Depreciation			Acquired/ Constructed	Statement is Computed
Kokomo	IN	—		250		4,622		1,294		250		5,916		6,166		(1,219		)	1999	45
New Albany	IN	—		230		6,595		—		230		6,595		6,825		(1,460		)	2001	35
Tell City	IN	—		95		6,208		1,301		95		7,509		7,604		(1,127		)	2001	45
Cynthiana	KY	—		192		4,875		—		192		4,875		5,067		(473		)	2004	40
Mayfield	KY	—		218		2,797		—		218		2,797		3,015		(1,560		)	1986	40
Franklin	LA	—		405		3,424		—		405		3,424		3,829		(1,208		)	1998	25
Morgan City	LA	—		203		2,050		—		203		2,050		2,253		(841		)	1998	25
Westborough	MA	—		858		2,975		2,894		858		5,869		6,727		(2,446		)	1985	30
Bad Axe	MI	—		400		4,386		—		400		4,386		4,786		(1,115		)	1998	40
Deckerville	MI	—		39		2,966		—		39		2,966		3,005		(1,453		)	1986	45
Mc Bain	MI	—		12		2,424		—		12		2,424		2,436		(1,196		)	1986	45
Las Vegas	NV	—		1,300		3,950		—		1,300		3,950		5,250		(1,035		)	1999	35
Las Vegas	NV	—		1,300		5,800		—		1,300		5,800		7,100		(1,519		)	1999	35
Fairborn	OH	—		250		4,850		��		250		4,850		5,100		(1,270		)	1999	35
Georgetown	OH	—		130		4,970		—		130		4,970		5,100		(1,302		)	1999	35
Marion	OH	—		218		2,971		—		218		2,971		3,189		(2,129		)	1986	30
Newark	OH	—		400		8,588		—		400		8,588		8,988		(5,282		)	1986	35
Port Clinton	OH	—		370		3,630		—		370		3,630		4,000		(951		)	1999	35
Springfield	OH	—		250		3,950		1,711		250		5,661		5,911		(1,035		)	1999	35
Toledo	OH	—		120		5,130		—		120		5,130		5,250		(1,344		)	1999	35
Versailles	OH	—		120		4,980		—		120		4,980		5,100		(1,304		)	1999	35
Carthage	TN	—		129		2,406		—		129		2,406		2,535		(441		)	2004	35
Loudon	TN	—		26		3,879		—		26		3,879		3,905		(2,434		)	1986	35
Maryville	TN	—		160		1,472		—		160		1,472		1,632		(735		)	1986	45
Maryville	TN	—		307		4,376		—		307		4,376		4,683		(2,106		)	1986	45
Fort Worth	TX	—		243		2,036		270		243		2,306		2,549		(877		)	1998	25
Ogden	UT	—		250		4,685		—		250		4,685		4,935		(1,555		)	1998	35
Fishersville	VA	—		751		7,734		—		751		7,734		8,485		(1,332		)	2004	40
Floyd	VA	—		309		2,263		—		309		2,263		2,572		(690		)	2004	25
Independence	VA	—		206		8,366		—		206		8,366		8,572		(1,404		)	2004	40
Newport News	VA	—		535		6,192		—		535		6,192		6,727		(1,112		)	2004	40
Roanoke	VA	—		586		7,159		—		586		7,159		7,745		(1,219		)	2004	40
Staunton	VA	—		422		8,681		—		422		8,681		9,103		(1,464		)	2004	40
Williamsburg	VA	—		699		4,886		—		699		4,886		5,585		(917		)	2004	40
Windsor	VA	—		319		7,543		—		319		7,543		7,862		(1,285		)	2004	40
Woodstock	VA	—		603		5,395		—		603		5,395		5,998		(970		)	2004	40
		$	—	$	17,465	$	213,885	$	17,522	$	17,465	$	231,407	$	248,872	$	(70,012	)
*Total continuing operations properties*		$	1,553,724	$	1,549,551	$	7,628,007	$	350,178	$	1,550,219	$	7,971,073	$	9,521,292	$	(817,084	)
Corporate and other assets		—		—		2,729		3,249		—		5,978		5,978		(3,357		)
Total		$	1,553,724	$	1,549,551	$	7,630,736	$	353,427	$	1,550,219	$	7,977,051	$	9,527,270	$	(820,441	)

* Property is in development and not yet placed in service.

(1) Encumbrances include mortgage debt and other debt aggregating $1.6 billion. At December 31, 2008, $88 million of mortgage debt encumbered assets accounted for as direct financing leases, which are excluded from Schedule III above.

(2) The Company recognized impairment losses of $7.8 million during the year ended December 31, 2008, as a result of a decrease in expected cash flows.

(3) At December 31, 2008, the tax basis of the Company’s net assets is less than the reported amounts by $1.5 billion.

(b) A summary of activity for real estate and accumulated depreciation for the year ended December 31, 2008, 2007 and 2006 follows (in thousands):

	Year ended December 31,
	2008			2007			2006
Real estate:
Balances at beginning of year	$	9,414,490		$	5,883,924		$	2,530,013
Acquisition of real state, development and improvements	194,325			3,552,069			5,271,493
Disposition of real estate	(523,687		)	(2,229,454		)	(493,997		)
Impairments	(1,390		)	—			(2,530		)
Balances associated with changes in reporting presentation(4)	443,532			2,207,951			(1,421,055		)
Balances at end of year	$	9,527,270		$	9,414,490		$	5,883,924
Accumulated depreciation:
Balances at beginning of year	$	598,946		$	402,877		$	311,903
Depreciation expense	236,907			199,509			98,728
Disposition of real estate	(112,738		)	(113,518		)	(121,476		)
Balances associated with changes in reporting presentation(4)	97,326			110,078			113,722
Balances at end of year	$	820,441		$	598,946		$	402,877

(4) The balances associated with changes in reporting presentation represent real estate and accumulated depreciation related to properties placed into discontinued operations as of December 31, 2008.

F-52

Healthpeak Properties (DOC) 8-KOther Events